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A. Introduction 
1. The Piancatelli Rearrangement: New Developments and Applications 
Since its discovery in 19761 the Piancatelli rearrangement has been widely employed in the 
synthesis of 4-hydroxy-2-cyclopentenones from α-furylcarbinols, and particularly in the last 
decade several interesting novel developments in this field emerged. This acid catalyzed 
rearrangement is typically observed in a water containing environment with furfuryl alcohol 
and derivatives thereof, whereas various substituents can be situated at different positions on 
the furan ring or at the hydroxymethyl-functionality.2 The reaction is completely atom 
economic, as the number of atoms in the molecule involved is being preserved. The products 
of this type of chemical transformation are substituted 4-hydroxy-2-cyclopentenones, which are 
highly valuable intermediates in the synthesis of natural products.3,4 The mechanism proposed 
by Piancatelli (Scheme 1)1 commences with the protonation of the α-hydroxymethyl-moiety in 
(±)-1, which leads to the expulsion of water as leaving group. A subsequent nucleophilic attack 
of another water molecule on the opposite α-position of the furan ring leads to the formation of 
intermediate B.  
 
Scheme 1: Mechanism proposed by Piancatelli et al.1,5 
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Ring opening and a prototropic shift furnishes the pentadienyl cation E, which is believed to 
undergo a 4-π conrotatory electrocyclic ring-closure similar to a Nazarov-cyclisation.6 The 
deprotonation of F gives product trans-2 with the substituents showing in most cases a trans-
configuration on the newly formed carbocyclic scaffold. The mechanism, particularly the ring-
closing step, is still under ongoing debate. Mostly an electrocyclic process is favored because 
of the high diastereoselectivity of the reaction, but also an aldol-type mechanism is proposed. 
DFT calculations corroborate the electrocyclic nature of ring-closure.7 Compound trans-2 can 
be subject of a further isomerization to cyclopentenone (±)-3.5 
The synthesis of 4-hydroxy-2-cyclopentenone derivatives via Piancatelli rearrangement has 
been reviewed by D’Onofrio in 1994,2 and since then many publications of diverse 
developments concerning this reaction and various applications have appeared. This chapter 
will give an overview about the progress in this field from 1994 up to 2013, which will include 
new types of the Piancatelli rearrangement like the aza-variant and intramolecular versions. 
Novel processes to increase the efficiency of the reaction will be elucidated, such as the use of 
continuous flow systems. Furthermore, new insights about the mechanism and kinetics of the 
reaction will be explained, and at last also a variety of particular applications will be illustrated.  
 
2. The Aza-Piancatelli Rearrangement 
Read de Alaniz et al. developed a Lewis acid catalyzed methodology to employ aromatic 
amines as nucleophiles instead of the conventionally used water (Table 1).8 This procedure 
allows the synthesis of exclusively trans-substituted 4-amino-5-aryl(alkyl)-2-cyclo-
pentenones 5. Suitable catalysts for this reaction are Brønsted or Lewis acids, preferably 
Dy(OTf)3.
9 With furan-2-yl(phenyl)methanol (±)-1a as α-furylcarbinol various successful 
examples are presented by combination with different electron-rich and -deficient aromatic 
amines as nucleophiles, providing yields between 33–92% (entry 1–11, Table 1). Consistently 
good results were achieved with diverse substitution patterns on the anilines, including 
sterically bulky examples bearing 2,4,6-trimethyl substituents (entry 7, Table 1). The only 
exception made the reaction with 2,6-dimethylanilin, in which the product was obtained in 33% 
yield because of a competing side-reaction, in which 2,6-dimethylaniline participated in a 
Friedel-Crafts alkylation with the carbocation formed from starting material (±)-1a by loss of 
water (entry 11, Table 1). 
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Table 1: Dy(OTf)3 catalyzed aza-Piancatelli rearrangement.a,8 
 
Entry 1 R1 t [h] Yield [%]b Entry 1 R1 t [h] Yield [%]b 
1 1a p-I 0.5  92 12e 1b p-I 1.5 68 
2 1a p-MeO2C 1 86 13e 1b m-Cl 6.5 82 
3c 1a p-MeO 18 62 14e 1b 2,4,6-tri-Me 5 89 
4 1a 3,5-di-Me 3 81 15 1c p-I 4.5 83 
5d 1a 3,5-di-F3C 24 75 16 1c m-Cl 2 87 
6 1a m-Cl 0.33 82 17f 1c 2,4,6-tri-Me 8 78 
7 1a 2,4,6-tri-Me 4 91 18 1d p-I 2.5 68 
8d 1a 2,4,6-tri-F 3 74 19 1d m-Cl 3 10 
9 1a H 1.5 86 20 1d 2,4,6-tri-Me 3.5 74 
10 1a p-Me(OH)CH 2 88 21 1e p-I 5 73 
11 1a 2,6-di-Me 3 33 22 1e m-Cl 6 52 
a) (±)-1:4 1:1 equiv. b) isolated yield. c) Dy(OTf)3 (20 mol%). d) (±)-1:4 1:3 equiv. e) reaction at rt. f) Dy(OTf)3 
(10 mol%). 
Moreover, in place of the phenyl substituent in α-position on the furylcarbinols, a p-
methoxyphenyl, p-trifluoromethylphenyl, methyl and an isopropyl group could be used with 
comparably good results (1b–1e, entry 12–22, Table 1). In case of the alkyl substituted α-
furylcarbinols 1d and 1e in combination with an m-chloro group on the aniline the yield was 
decreased by a Friedel-Crafts side reaction (entry 19 and 22, Table 1). Generally, no 
isomerization to cyclopentenones of type 3 (Scheme 1) was observed, as it was also not the case 
in the following examples of Lewis acid catalyzed aza-Piancatelli rearrangements.  
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The mechanism proposed (Scheme 2) is similar to the one suggested by Piancatelli, with the 
key step involving a 4π-electrocyclisation, though instead of water an amine attacks as 
nucleophile in α-position of the furan ring. Furthermore, evidence of the formation of the 
stabilized carbocation A (Scheme 2) was found, based on the fact that a Friedel-Crafts 
alkylation product of A and the aniline component could be isolated in certain instances as a 
by-product (entry 11, 19 and 22, Table 1). In another publication, Yadav et al. showed that the 
same type of transformation (Scheme 2) was achievable by the use of phosphomolybdic acid 
(PMA, H3PMo12O40) in a similar trans-selective manner.
10  
 
Scheme 2: Aza-Piancatelli mechanism proposed by Read de Alaniz.13 
A recent publication by Kunwar and co-workers further exploited the idea of an aza-Piancatelli 
rearrangement by using 2-aminophenols and -thiophenols 6 as nucleophiles, but in their case a 
subsequent Michael reaction took place to furnish cis-fused benzo[1,4]oxazines and -thiazines 
7 (Table 2, entry 1–13) with yields of 73–88% as single diastereomers.11 10 mol% In(OTf)3 
proved to be the most effective catalyst, but also other Lewis acids and even acidic ion exchange 
resins could be applied. Different aryl-substituted α-furylcarbinols (±)-1 were employed 
successfully with various 2-aminophenols or 2-aminothiophenols 6 as the nucleophilic 
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component. Generally, 2-aminothiophenols gave higher yields in shorter reaction times 
compared to 2-aminophenols. 
At approximately the same time Wang et al. published their results of the tandem 
Piancatelli/Michael reaction, in their case with 5 mol% La(OTf)3 as the preferred catalyst (entry 
14–41, Table 2).12 A comparison of reactions with 2-aminophenol as substrate shows that furan-
2-yl(phenyl)methanol (±)-1a gave the best results (entry 14, Table 2), whereas substitutions 
with electron-withdrawing or -donating groups on the phenyl moiety on the α-furylcarbinol 
decreased the yield significantly (entry 15–17, Table 2). On the contrary, introducing a 3-chloro 
group on the 2-aminophenol gave favorable results for α-furylcarbinols with a fluoro and 
trifluoromethyl group on the phenyl substituent (entry 20 and 21, Table 2). Alkyl substituted 2-
aminophenols gave generally inferior results (entry 22–29, Table 2), as well as 4-nitro-2-
aminophenol which led only to trace amounts of the desired product (entry 30–32, Table 2). A 
deviation from this trend was observed with the combination of 4-nitro-2-aminophenol and 
furan-2-yl(4-(trifluoromethyl)phenyl)methanol (±)-1c resulting in the exceptionally high yield 
of 92% (entry 33, Table 2). Furthermore, the applicability of N-substituted 1,2-
diaminobenzenes as substrates (entry 34–41, Table 2) is presented, though  the scope is limited 
to less electron-deficient aryl substituted α-furylcarbinols (entry 34, 35, 38 and Table 2).  
Table 2: Aza-Piancatelli/Michael cascade reaction reported by Kunwar and Wang et al.11,12 
 
Entry 1 X R1 t [h] Yield [%]a Entry 1 X R1 t [h] Yield [%]a 
1b 1a S H 2 86 22c 1a O 3-Me 4 48 
2b 1a O 5-Me 3.5 73 23c 1b O 3-Me 4 60 
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Entry 1 X R1 t [h] Yield [%]a Entry 1 X R1 t [h] Yield [%]a 
3b 1a O 4-Cl 3.5 78 24c 1f O 3-Me 4 48 
4b 1a S 4-Cl 2.5 85 25c 1c O 3-Me 4 trace 
5b 1b O H 3 75 26c 1a O 3-tBu 4 53 
6b 1b S H 2 87 27c 1b O 3-tBu 4 41 
7b 1b O 5-Me 2.5 80 28c 1f O 3-tBu 4 74 
8b 1b O 4-Cl 2.5 82 29c 1c O 3-tBu 4 trace 
9b 1b S 4-Cl 2.5 88 30c 1a O 4-O2N 4 trace 
10b 1f O H 3.5 81 31c 1b O 4-O2N 4 trace 
11b 1f S H 2.5 85 32c 1f O 4-O2N 4 trace 
12b 1f O 3-Me 3.5 78 33c 1c O 4-O2N 4 92 
13b 1f O 4-Cl 3.5 80 34c,d 1a N H 2 88 
14c 1a O H 4 81 35c,e 1a N H 2 83 
15c 1b O H 4 46 36c,f 1a N H 2 trace 
16c 1f O H 4 46 37c,d 1g N H 2 trace 
17c 1c O H 4 10 38c,d 1b N H 2 45 
18c 1a O 3-Cl 4 66 39c,d 1f N H 2 68 
19c 1b O 3-Cl 4 51 40c,d 1c N H 2 trace 
20c 1f O 3-Cl 4 78 41c,d 1h N H 2 trace 
21c 1c O 3-Cl 4 82       
a) isolated yield. b) ref. 11, In(OTf)3 (10 mol%), reaction at rt, (±)-1:6 1.2:1 equiv. c) ref. 12, La(OTf)3 (5 mol%), 
reaction at 80 °C, (±)-1:6 1.2:1 equiv. d) R2 = Ts. e) R2 = Ms. f) R2 = Ac. 
The mechanism Kunwar et al. suggest (Scheme 3) starts with the coordination of the Lewis 
acid to the hydroxy group of the α-furylcarbinol (±)-1, which is followed by the formation of 
the oxocarbenium ion B. The amine 6 then attacks at the furan ring in α-position which affords 
after formation of intermediate C the ring-opened species D. The ring-closure proceeds through 
an aldol-type reaction and subsequent 1,4-addition from the other nucleophilic position -XH of 
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6 to furnish product 7 with a cis-fused ring scaffold and the aryl-substituent arranged in a trans-
position with respect to the heterocycle. 
 
Scheme 3: Mechanism proposed by Kunwar et al.11 
The mechanism proposed by Wang et al. (Scheme 4) differs from the one displayed in Scheme 
3 by completing first the Piancatelli rearrangement before the nucleophilic amine species 6 does 
even interact with the α-furylcarbinol. They believe that after the rearrangement a C-N-coupling 
takes places followed by an intramolecular Michael-addition to give the product cis,trans-7 
with the same stereochemical characteristics as described before for the other mechanism 
(Scheme 3). 
 
Scheme 4: Mechanism proposed by Wang et al.12 
In 2013 Read de Alaniz et al. described an aza-Piancatelli rearrangement initiated by ring 
opening of donor-acceptor-cyclopropanes (±)-8 (Table 3).13 In this type of reaction the Lewis 
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acid catalyzed opening of the cyclopropyl ring in (±)-8 leads to the intermediate stabilized 
cation that undergoes the rearrangement to cyclopentenones 10. This methodology to 
synthesize α-quaternary cyclopentenones provides an alternative to the Piancatelli 
rearrangement of tertiary α-furylcarbinols in which a competitive dehydration pathway 
decreases the efficiency of the conversion.14 Among several Lewis acids Dy(OTf)3 was selected 
to investigate the scope of the reaction, as this catalyst gave superior results with respect to 
diastereoselectivity and conversion. Various cyclopentenones 10 were obtained with yields 
ranging from 57–89% and diastereoselectivities from 1:1 to 60:1. Reactions in which the aryl 
substituent on the cyclopropane was electron-rich (entry 8–10, Table 3) proved to be superior 
to electron-deficient ones (entry 11-13, Table 3) in terms of diastereoselectivity. Moreover, 
different primary anilines and also secondary anilines could be employed, showing that 
electron-withdrawing groups on the aniline had a beneficial effect on the diastereoselectivity 
(entry 4 and 13, Table 3). In some instances an inverse relationship between selectivity and 
temperature was observed, i. e. higher reaction temperatures resulted in better selectivities. 
Table 3: D-A cyclopropane initiated Piancatelli rearrangement.13 
 
Entry Ar Ar1 R Yield [%]a dra Entry Ar Ar1 R Yield [%]a dra 
1 Ph p-MeO-Ph H 57 6:1 8 p-MeO-Ph p-MeO-Ph H 87 25:1 
2 Ph Ph H 89 13:1 9 p-MeO-Ph Ph H 84 32:1 
3 Ph p-Me-Ph H 80 10:1 10 p-MeO-Ph p-F3C-Ph H 63 22:1 
4 Ph p-F3C-Ph H 72 60:1 11 p-NC-Ph p-MeO-Ph H 58 2:1 
5 Ph p-I-Ph H 82 28:1 12 p-NC-Ph Ph H 76 1:1 
6 Ph m-Cl-Ph H 81 29:1 13 p-NC-Ph p-F3C-Ph H 65 5:1 
7 Ph Ph Me 76 57:1       
a) Diastereoselectivity and yield determined by 1H-NMR spectroscopy using dimethyl terephthalate as the internal 
standard.  
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An intramolecular modification of the aza-Piancatelli rearrangement has been developed by 
Read de Alaniz and co-workers.15 They were able to synthesize azaspirocycles 12 from α-
furylcarbinols (±)-11 that possess an amino group connected by an alkyl chain to the furan ring 
(Table 4). The proposed mechanism is an intramolecular version of the previously reported one 
by the same group (Scheme 2) and consistent with the Piancatelli mechanism (Scheme 1). The 
products 12 were isolated in yields from 37–97% as single diastereomers, in which R1 and the 
nitrogen nucleophile are arranged in a trans-relation. With substituent R1 being hydrogen, alkyl 
or aryl the reaction proceeded smoothly, and moreover different aryl substituents on the amine 
nucleophile could be employed. The best substitution pattern proved to be an electron-donating 
group in α-position on the furylcarbinol and an electron-withdrawing group on the nitrogen. 
This is an observation indicating the electrocyclic nature of the rearrangement, as the related 
Nazarov reaction also benefits from polarized substrates.6 
Table 4: Intramolecular aza-Piancatelli rearrangement.15 
 
Entry n R R1 t Yield [%]a Entry n R R1 t Yield [%]a 
1 1 Ph Ph 15 min 96 11 1 Ph nBu 15 min 97 
2 1 p-MeO-Ph Ph 150 min 74 12 1 p-I-Ph nBu 15 min 79 
3 1 Ph p-O2N-Ph 5 h 67 13 2 p-I-Ph H 8 h 90 
4 1 Ph p-Br-Ph 5 h 84 14 2 Ph H 48 h 70 
5 1 Ph 2,4,6-tri-Me-Ph 2 h 74 15c 2 p-MeO-Ph H 72 h 37 
6 1 Ph p-MeO-Ph 15 min 81 16 2 p-I-Ph Ph 5 min 69 
7 1 Ph H 15 h 90 17 2 Ph Ph 1 h 75 
8b 1 p-MeO-Ph H 48 h 57 18 2 p-MeO-Ph Ph 75 h 74 
9 1 Ph diphenylmethyl 15 h 53 19 2 p-I-Ph nBu 2 h 65 
10 1 Ph Me 15 min 91 20 2 Ph nBu 15 h 54 
a) isolated yield. b) Dy(OTf)3 (10 mol%). c) Dy(OTf)3 (20 mol%). 
Another variant reported by Batey et al. utilizes furfural 13 as starting material instead of α-
furylcarbinols. The addition of secondary amines 14 under lanthanide(III) catalysis resulted in 
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the formation of 4,5-diamino-2-cyclopentenones trans-15 (Table 5).16 This reaction was first 
discovered by Lewis and co-workers, but it suffered from low yields and long reaction times, 
moreover the formation of the thermodynamically stable species similar to (±)-3 (Scheme 1) 
posed a serious problem.17,18 By using Lewis acids as catalysts this could be avoided and the 
formation of 15 with exclusive trans-stereoselectivity was achieved using secondary amines 
(78–100% yield, entry 1–8, Table 5) and anilines (17–52% yield, entry 10-12, Table 5). 
Benzylamine was not reactive under the described conditions (entry 9, Table 5). 
Table 5: Formation of 4,5-diamino-2-cyclopentenones from furfural.16 
 
Entry R1R2NH Yield [%]a Entry R1R2NH Yield [%]a 
1 morpholine quant. 7 1,2,3,4-tetrahydroquinoline 81 
2 (allyl)2NH 82 8 indoline 99 
3 Bn2NH 98 9 BnNH2 0 
4 (p-MeO-Bn)2NH quant. 10 PhNH2 17 
5 1,2,3,4-tetrahydroisoquinoline 92 11 PhNH2 78b 
6 PhMeNH 78 12 (o-MeO-Ph)NH2 52b 
a) isolated yields using Dy(OTf)3. b) isolated yields using Sc(OTf)3. 
The proposed mechanism (Scheme 5) is similar to the Piancatelli rearrangement with α-
furylcarbinols, including the thermal conrotatory 4π-electrocyclisation step and was supported 
by computational studies (UHF/6-31G**) on the ring closure. The initial condensation of 
furfural 13 and the amine gives the iminium-ion A, on which a second amine molecule as 
nucleophile can attack at the opposite position of the furan ring. Subsequent ring opening of B 
affords the deprotonated Stenhouse salt C, which is then capable of the electrocyclic ring 
closure providing 4,5-diamino-2-cyclopentenones trans-15. This strategy was used in a 
following publication to synthesize the marine sponge pyrrole-2-aminoimidazole alkaloid (±)-
agelastatin A.19 
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Scheme 5: Proposed mechanism by Batey and co-workers.16 
Caddick and co-workers developed this approach further by adding a nucleophile under basic 
conditions after the formation of the diaminocyclopentenone trans-17 (Table 6).20 This resulted 
in a Michael-addition of the nucleophile to trans-17 and ensuing elimination of morpholine 16 
gave product (±)-18, a process similar to the formation of (±)-3 from trans-2 (Scheme 1). As 
nucleophiles NaOMe (entry 1, Table 6), propylamine (entry 15, Table 6), lithium di-n-
butylcuprate (entry 16, Table 6) and a variety of different thiols (entry 2–14, Table 6) were 
employed successfully, though a drawback was the competing reaction with morpholine 16 
when using other alkoxide nucleophiles and propylamine. 
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Table 6: Synthesis of 2,4-bifunctionalized cyclopentenones from furfural.20 
 
Entrya NuH Yield [%]b Entrya NuH Yield [%]b 
1 NaOMe 67 9 m-MeO-Ph-SH 79 
2 Et-SH 73 10 MeO2C-C2H4-SH 74 
3 iPr-SH 77 11c HO2C-C2H4-SH 55 
4 cyclohexyl-SH 72 12 HO-C2H4-SH 77 
5 tBu-SH 76 13 (Et)2N-C2H4-SH 76 
6 Ph-SH 71 14 (MeO)3Si-C3H6-SH 52 
7 Bn-SH 80 15d H3C-C2H4-NH 29 
8 trityl-SH 63 16e LiCu(nBu)2 30 
a) morpholine (2 equiv). b) isolated yield. c) KOtBu (1.25 equiv). d) plus (±)-18 with Nu = OMe and Nu = 
morpholine in 21% and 20% yields, respectively. e) work-up of 17 before addition of NuH. 
The mechanism (Scheme 6)17,20,21 for the formation of 2,4-disubstituted cyclopentenones (±)-
18 from 4,5-diamino-2-cyclopentenones trans-17 proceeds via 1,4-addition of the nucleophile 
to form intermediate A, which undergoes successive enolisation to B. E1cB-elimination of 
morpholine 16 furnishes the 2,4-disubstituted product (±)-18. 
 
Scheme 6: Proposed mechanism for the formation of 2,4-disubstituted cyclopentenones.17,20,21 
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3. Intramolecular Variants with Alcohols 
While working on the total synthesis of the antifeedant component of plants of the tribe 
Athemideae tonghaosu (±)-20 and derivatives thereof (Scheme 7),22 Wu et al. discovered the 
rearrangement of the spiroketal enol ethers (±)-22 (Table 7), which offered in one case access 
to the natural product chrycorin (±)-23e.23,24 Spiroketal enol ethers (±)-22 were found to be 
intermediates in the Piancatelli rearrangement, and the overall process depicted here (Table 7) 
represents an intramolecular Piancatelli variant with an alcohol as the attacking nucleophile. In 
contrast to the classical version of the rearrangement, the overall process is a two-step procedure 
in which the intermediate spiroketal enol ethers (±)-22 could be isolated. 
 
Scheme 7: Synthesis of tonghaosu.22 
The first step consists of a copper(II) sulfate catalyzed dehydration and spiroketalization of the 
α-furylcarbinols (±)-21, which undergo the rearrangement to 2,3,4-trisubstituted bicyclic 
cyclopentenones (±)-23 in aqueous ethylene glycol dimethyl ether with zinc chloride as 
catalyst. The reaction could be performed with either electron-rich or deficient aryl-substituents 
with yields ranging from 70–90% for the second step (in case of chrycorin (±)-23e in 83%, 
entry 5, Table 7). The proposed mechanism is in agreement with the one depicted in Scheme 1, 
including the further isomerization of the product to the thermodynamically more stable (±)-
23.23 Later in 2009 the same group published results24 concluding a different mechanism, in 
which an intramolecular aldol-like version of the ring-closing step is proposed. Furthermore, in 
this publication the one-step conversion of different α-furylcarbinols of type (±)-21 to 
cyclopentenones (±)-23 is described by directly applying the aqueous zinc chloride conditions 
to (±)-21. 
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Table 7: Acid catalyzed rearrangement of spiroketal enol ethers.23,24 
  
Entry X R n t [h] Product Yield [%]a Entry X R n t [h] Product Yield [%]a 
1 CH2 Ph 0 5 23a 81 6 CH2 Ph 1 6 23f 78 
2 CH2 p-Me-Ph 0 4 23b 85 7 O Ph 1 6 23g 75 
3 CH2 p-MeO-Ph 0 3.5 23c 90 8 O p-MeO-Ph 1 5 23h 86 
4 CH2 p-O2N-Ph 0 6 23d 75 9 O p-O2N-Ph 1 8 23i 70 
5 CH2 thiophene-2-yl 0 4 23e 83 10 CH2 trans-styryl 0 3 23j 84 
a) isolated yield. 
Read de Alaniz et al. observed the same intramolecular rearrangement by using Dy(OTf)3 as 
catalyst and in addition they were able to avoid the isomerization of the product and achieve 
the formation of spirocyclic ethers 25 (Table 8).25 The screening of different catalysts and 
solvents showed that the resulting product depended on the Lewis acid used in the reaction. 
When neat PhMe, CuSO4·5H2O in MeCN or Dy(OTf)3 in MeCN under basic conditions were 
applied, the spiroketalization product of type (±)-22 was observed. ZnCl2 in MeCN/H2O gave 
the further isomerized species of type (±)-23. Only Dy(OTf)3 in PhMe afforded 25 as the single 
product. A variety of different electron-rich and deficient aryl substituents were tolerated on 
the hydroxymethyl-functionality on the α-furylcarbinol giving yields between 75–91% (entry 
1–9, Table 8). However, alkyl groups in this position proved to be challenging (entry 10 and 
12, Table 8), but this could be solved by attaching a dimethyl substituent next to the hydroxy 
group on the opposite alkyl chain (entry 11 and 13, Table 8). 
 
 
 
A. Introduction 
___________________________________________________________________________ 
15 
 
Table 8: Intramolecular rearrangement of α-furylcarbinols to spirocyclic cyclopentenones.25 
 
Entry R R1 Yield [%]a Entry R R1 Yield [%]a 
1 H Ph 91 8 H 2-naphthalenyl 86 
2 H p-MeO-Ph 89 9 Me Ph 74 
3b H p-Br-Ph 83 10 H nBu 0 
4b H p-F3C-Ph 88 11 Me nBu 98 
5b,c H p-O2N-Ph 75 12 H iPr 0 
6 H 2,4,6-trimethyl-Ph 78 13 Me iPr 25 
7 H 1-thiophenyl 90     
a) isolated yield. b) reaction at 100 °C. c) inseparable mixture of diastereomers with 9:1 ratio in this case. 
The proposed mechanism is analogous to the aza-version published previously by the same 
group.15 The Lewis acid serves two functions in this process, firstly it enhances the leaving 
group abilities of the α-alcohol functionality in (±)-24 and secondly it facilitates the ring 
opening in oxaspirocycles A to form the intermediate oxocarbenium ion B. The following step 
proceeds via a 4π-electrocyclic ring closure to give eventually the spirocyclic cyclopentenone 
25. 
A. Introduction 
___________________________________________________________________________ 
16 
 
 
Scheme 8: Mechanism proposed by Read de Alaniz et al.25 
 
4. C-Piancatelli Rearrangement 
Jiang et al. discovered another intramolecular modification of α-furylcarbinol rearrangements 
to cyclopentenones 28 (Table 9), in which compounds 27 represent intermediates (Scheme 
9).26,27 The overall transformation is a two-step process and is similar to the intramolecular 
version with alcohols described in chapter 3 (Scheme 7, Table 7). CuSO4·5H2O and catalytic 
amounts of acetic acid proved to be the most effective catalysts for the first step, the formation 
of spirofurooxindoles 27 (Scheme 9). The scope of the reaction is limited to aromatic rings on 
the amide with electron-rich substituents, as it participates in an intramolecular Friedel-Crafts 
reaction with the intermediately formed stabilized cation A.  
Scheme 9: Trapping of the oxocarbenium intermediate by a Friedel-Crafts reaction.26 
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The second step (Table 9), the ring opening of 27 and closure to form cyclopentenones 28 was 
found to be most successful by heating 27 in DCE as solvent without the use of any catalyst. 
For this reaction, yields between 84–94% and diastereoselectivities of 1.2:1 up to >99:1 could 
be realized. The overall process can be regarded as a C-Piancatelli rearrangement, as the 
attacking nucleophile on the intermediate oxocarbenium ion is a carbon nucleophile. 
Table 9: Rearrangement of spirofurooxindoles into spiropentenoneoxindoles.27 
 
Entry Ar R Yield [%]a drb Entry Ar R Yield [%]a drb 
1 Ph 3,4,5-tri-MeO 94 4:1 8 o-F-Ph 3,4,5-tri-MeO 87 >99:1 
 
2 Ph 3,5-di-MeO 91 5:1 9 o-F-Ph 3,5-di-MeO 85 3:2  
3 Ph 4,5-di-MeO 89 1.5:1 10 o-Cl-Ph 3,4,5-tri-MeO 92 >99:1  
4 p-Cl-Ph 3,4,5-tri-MeO 93 5.6:1 11 o-Cl-Ph 3,5-di-MeO 90 >99:1  
5 p-Cl-Ph 3,5-di-MeO 90 3:1 12 o-Cl-Ph 4,5-di-MeO 89 1.2:1  
6 p-O2N-Ph 3,4,5-tri-MeO 86 1.8:1 13 o-Me-Ph 3,4,5-tri-MeO 94 >99:1  
7 p-O2N-Ph 3,5-di-MeO 84 2.3:1 14 o-Me-Ph 3,5-di-MeO 91 5:1  
a) isolated yield. b) determined by NMR. 
 
5. Rearrangement in a Continuous Flow Process 
A new catalyst-free process to convert furfuryl alcohol 1g and derivatives thereof in an aqueous 
solution to 4-hydroxy-2-cyclopentenone (±)-2a either in the microwave or a continuous flow 
system was developed by Reiser et al.28 Different derivatives of furfuryl alcohol featuring an 
alkyl- or phenyl substituent adjacent to the hydroxyl-functionality could be employed in this 
reaction with yields ranging from 43–96% (Table 10). Furthermore, very short reaction times 
of 2–15 min by applying microwave heating could be reached. The selectivities observed fall 
in a range between 5:1 to 12:1 in favor of the more stable trans- to cis-diastereomer. A study 
on the kinetics of the rearrangement of furfuryl alcohol 1g by Hronec et al. confirms the 
beneficial effects of high temperatures on this reaction.29 
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Table 10: Rearrangement of different α-furylcarbinols in the microwave.a,28 
 
Entry R c [mol/L] t [min] Yield [%]b dr (trans/cis) 
1 1g 0.25 4 43 - 
2 1a 0.14 2 96 5:1 
3 1i 0.15 5 73 12:1 
4 1h 0.14 15 54 7:1 
5 1j 0.15 5 65 7:1 
6 1k 0.15 30 0 - 
                a) 1 (1.5 mmol) in H2O (6 mL), microwave irradiation (300 W) under closed vessel conditions  
                (200–210 °C, 15 bar). b) isolated yield. 
The application of a continuous flow system for the rearrangement of 4-hydroxy-2-
cyclopentenone (±)-2a in water under subcritical conditions (240 °C, >15 bar) was achieved 
with a high throughput and very short reaction time (<1 min, 87% yield), making this process 
an attractive alternative for the large-scale synthesis of (±)-2a compared to conventional batch 
methods.  
 
Figure 1: Setup of continuous flow system for rearrangement reaction.28 
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This optimized process was adapted by another group successfully with an additional 
subsequent photoreaction.30 The procedure comprises 3 steps in which two of them are 
conducted in continuous flow systems. At first a slightly modified procedure of the 
rearrangement of furfuryl alcohol 1g to 4-hydroxy-2-cyclopentenone (±)-2a provided the 
product in 66% yield on a 100 g scale. The following reaction of (±)-2a with 3-chloromethoxy-
propene 29 afforded compound (±)-30, which is used in the subsequent photochemical process 
as starting material. The intramolecular [2+2]-cycloaddition leading to product (±)-31 was 
again conducted in a flow process, which facilitates the irradiation with 254 nm UV-lamps by 
providing a high surface area and the exact reaction time by a controllable flow rate. 
 
Scheme 10: Rearrangement process with a subsequent photoreaction.30  
 
6. Rearrangement and Hydrogenation  
In 2012 Hronec et al. discovered the formation of cyclopentanone 32 and cyclopentanol 33 as 
the main products while studying high-pressure hydrogenations of furfural 13 (Table 11).31 
They investigated the performance of Ni, Pt, Pd and Ru catalysts under different hydrogen 
pressures of 30–80 bar at 140–190 °C (entry 1–5, Table 11). When the hydrogenations were 
conducted in non-aqueous media, the product range comprised the typically expected 
compounds from the direct hydrogenation of furfural, like furfuryl alcohol, tetrahydrofurfuryl 
alcohol, 2-methylfuran and 2-methyltetrahydrofuran. In contrast to this it was observed that 
reactions carried out in a water containing environment yielded cyclopentanone 32 and 
cyclopentanol 33 as the main products. Therefore, it can be assumed that after the 
hydrogenation of the aldehyde functionality of furfural 13 the Piancatelli rearrangement of 
furfuryl alcohol 1g took place yielding 4-hydroxy-2-cyclopentenone (±)-2a. Thereupon the 
double bond of the rearranged product 4-hydroxy-2-cyclopentenone (±)-2a was hydrogenated 
and the hydroxy group eliminated. This afforded 2-cyclopentenone which was again 
hydrogenated leading to cyclopentanone 32 or its reduction product cyclopentanol 33. 
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Table 11: Cyclopentanone from furfural.31,32 
 
Entry Catalyst t  T [°C] H2 p [bar] Conversion [%] 
Yield [%] 
32 
Yield [%] 
33 
1a 5% Pt/C 30 min 160 80 100 77 5 
2a 5% Pd/C 60 min 160 30 98 67 1 
3a 5% Ru/C 60 min 175 80 100 57 10 
4a CoMnCr 60 min 175 80 100 8 16 
5b Raney Ni  60 min 160 30 100 17 40 
6c NiCu-50/SBA-15 4 h 160 40 >99 62 3 
a) 13 (1 g), H2O (20 mL), catalyst (0.1 g), ref. 31. b) 13 (1 g), H2O (20 mL), catalyst (0.1 g), ref. 31. c) 13 (10 g), 
catalyst (0.2 g), ref. 32. 
At the same time Xu et al. described the identical process using a bimetallic Ni/Cu-catalyst and 
hydrogen pressures of 40 bar at 160 °C (entry 6, Table 11).32 In their case also cyclopentanol 
33 or cyclopentanone 32 were identified as the main products. Furthermore, the intermediate 
species cyclopentenone could be isolated by using restricted amounts of hydrogen. 
 
7. Application in Total Synthesis 
Because the cyclopentenone scaffold has been recognized as a motif in many natural products, 
new synthetic procedures providing this structure are highly valuable. The rearrangement of α-
furylcarbinols presents a straightforward method for this purpose and is an essential step of 
many synthetic methodologies. The latest publications concerning this issue are exemplified in 
the following subsection.  
One of the most recent instances was published by Nukada et al. who synthesized the core 
framework 2-homoprenyl-1-methyl-3-(5-methylfuran-2-yl)cyclopenta-2,4-dien-1-ol (±)-36 of 
the proposed structure of the brown alga derived natural product sargafuran in 4 steps from 
intermediate 35, which was prepared by a Piancatelli rearrangement of α-furylcarbinol (±)-34 
in 58% yield (Scheme 11).33 The latter was obtained by a Grignard reaction of commercially 
available 5-methylfurfural and the appropriate alkylbromide. 
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Scheme 11: Synthesis of the core structure of sargafuran.33 
Another frequently used method is the preparation of racemic or enantiomerically pure TBS-
protected 4-hydroxy-2-cylopentenone from 2a as the starting point for the synthesis of natural 
products, e.g. (-)-tenuipyrone,34 (±)-havellockate,35 and all 15-F2 isoprostanes.
36 In these 
examples the rearrangement of furfuryl alcohol 1g is utilized to allow access to 4-
tert(butyldimethylsilyloxy)-2-cyclopentenone. 
The preparation of prostaglandins and analogues is still in the focus of ongoing research as 
proven by the following three literature precedents. In the US patent by Yeh et al. intermediates 
(±)-39 in the synthesis of benzindene prostaglandins were obtained by the rearrangement of α-
furylcarbinol (±)-37 and the further isomerization to the thermodynamically more stable 
compound (±)-39 (Scheme 12).37 P is an acid stable protecting group (e. g. Me, Bn) and the 
transformation was carried out in an aqueous medium with pH values in the range of 2.5–6.5 
and temperatures between 60–200 °C. The isomerization of 38 could be facilitated by the 
addition of chloral hydrate and triethylamine to give the racemic product (±)-39 (e. g. 81% for 
39a, 62% for 39b, Scheme 12). In the following step the synthesis of the enantiomerically pure 
product from (±)-39 was achieved by enzymatic kinetic resolution. 
  
Scheme 12: Process for preparing benzindene prostaglandins.37 
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Qiu and co-workers describe the preparation of cyclopentenones (±)-42 via Piancatelli 
rearrangement, which are intermediates for the synthesis of prostaglandin analogues (Scheme 
13).38 The same strategy is pursued by Sung, published in a US patent.39 
 
Scheme 13: Intermediate for the synthesis of prostaglandin analogues.38,39 
De Lera et al. explored the synthesis of potent PPARγ (peroxisome proliferator-activated 
receptors) agonists with a cyclopentenone core structure.40,41,42  This has been achieved by the 
functionalization of 5-heptyl-4-hydroxycyclopentenone trans-44 in 7 steps, which has been 
synthesized by a Piancatelli rearrangement of (±)-43 (Scheme 14, a). The rearrangement was 
carried out at 65 °C for 48 h in the presence of substoichiometric amounts of polyphosphoric 
acid in a 2:1 acetone/water mixture with 50% yield. The starting material (±)-43 was obtained 
by a Grignard reaction of furfural and heptylmagnesium bromide. 
 
Scheme 14: Synthesis of PPAR receptor modulators with cyclopentenone core structure.40,41,42 
 
Two other publications from different groups appeared using the same α-furylcarbinol (±)-46 
as starting material for the preparation of natural products 48 and 50. Firstly, Yang et al. 
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describe the total synthesis of C8-epi-guanacastepene O 48 (Scheme 15, a), which has potential 
anti-bacterial activity.43 The starting point for the preparation of 48 was the rearrangement of 
α-furylcarbinol (±)-46 in a refluxing dioxane/water mixture with ZnCl2 as catalyst, which 
afforded after methylation cyclopentanol trans-47 in 68% yield.  
 
Scheme 15: Total Synthesis of C8-epi-Guanacastepene and (+)-prelactone B.43,44 
Starting the synthesis from the same compound (±)-46 Csákÿ et al. developed a strategy for the 
enantioselective synthesis of (+)-prelactone B 50, isolated from Streptomyces griseus, and its 
C-4 epimer (Scheme 15, b).44 The rearrangement was conducted under identical conditions as 
described before (Scheme 15, a, 1). Enzymatic kinetic resolution afforded the enantiomerically 
pure compound from (+)-49, which was then converted to (+)-prelactone B 50 in 4 steps.  
Dias and co-workers describe a short synthesis of the new cyclopentene-1,3-dione derivative 
54 isolated from Piper carniconnectivum (Scheme 16).45 After reduction of commercially 
available 2-acetylfuran with NaBH4 yielding α-furylcarbinol (±)-51, the latter was heated in a 
refluxing dioxane/water mixture with ZnCl2 as catalyst at pH 6. This resulted in the 
rearrangement of (±)-51 to furnish 5-methyl-4-hydroxy-2-cyclopentenone trans-52, which 
underwent a further isomerization under basic conditions to 2-methyl-4-hydroxy-2-
cyclopentenone (±)-53. Finally this compound could be transformed in 2 steps to the desired 
natural product 54. 
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Scheme 16: Synthesis of cyclopentene-1,3-dione derivative isolated from Piper carniconnec- 
                    tivum.45____ 
The Piancatelli rearrangement of α-furylcarbinol (±)-55 was exploited by Sharma et al. to 
prepare cyclopentenone 57 for the synthesis of prostaglandins PGFα and analogues 58 (Scheme 
17).46 From a practical point of view, it is worth mentioning that they could perform the 
rearrangement of (±)-55 on a 0.5 kg scale. 
 
Scheme 17: Prostaglandin synthesis by Sharma et al.46 
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Not only for the preparation of prostaglandins, but also in the field of phytoprostane synthesis 
examples can be found in literature. Spur et al. used the Piancatelli rearrangement for the first 
total synthesis of two E type I phytoprostanes 61.47 They performed the rearrangement of (±)-
59, which was obtained from furan and commercially available azelaic monomethyl ester and 
subsequent reduction to the alcohol, in refluxing water. By treatment with catalytic amounts of 
chloral in the presence of triethylamine the following isomerization to (±)-60 was achieved in 
70% for the two steps. Then cyclopentenone (±)-60 was transformed either to ent-phytoprostane 
E1 ent-61 or 16-epi-phytoprostane E1 16-epi-61 in 7 steps, in which the stereochemistry of the 
hydroxy group at C4 was introduced by enzymatic kinetic resolution. 
 
Scheme 18: First total synthesis of two E type I phytoprostanes by Spur et al.47 
Yadav et al. used the Piancatelli rearrangement for the synthesis of cyclopentenone derivatives 
64 for cancer therapy (Scheme 19).48 Some compounds of type 64 showed a high activity 
against human cancer cell lines. The rearrangement of compounds (±)-62 was conducted with 
Lewis acids like zinc chloride, though in this case the rearrangement did not stop at the 4,5-
disubstiuted cyclopentenones but directly led through isomerization to the more stable 2,4-
disubstituted cyclopentenones (±)-63.  
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Scheme 19: Cyclopentenone derivatives for cancer therapy.48 
Sato et al. describe an efficient approach to optically active benzoprostacyclins 68 
(prostaglandin I2 analogue) by a two-component coupling process from cyclopentenone (±)-67, 
which was prepared from α-furylcarbinol (±)-66 via Piancatelli rearrangement (Scheme 20).49 
The stereochemical information in 68 was introduced by enzymatic kinetic resolution. 
 
Scheme 20: Approach to optically active benzoprostacyclins.49 
A novel enantioselective method to synthesize 4‑heterosubstituted cyclopentenones and the 
application of this strategy for the formal synthesis of ent-noraristeromycin 74 was developed 
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by Reiser et al. (Table 12).50 This was achieved by the kinetic resolution of racemic O-Ac- or 
O-Boc-substituted cyclopentenones 69a and 69b by employing the well-established 
methodology of nucleophilic allylic substitution, a concept developed by Trost and Tsuji (see 
chapter 2, main part). The reaction with the Boc-protected cyclopentenone 69b worked more 
smoothly than with 69a, and various N-, O- and S-nucleophiles could be applied. With 
Pd2(dba)3 and the Trost ligand (R,R)-72 as catalyst remarkably high selectivities with >99% in 
some cases were reported. Moreover, by using this method a short formal synthesis of ent-
noraristeromycin 73 was developed (via the product from reaction with 70h, entry 12, Table 
12).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
A. Introduction 
___________________________________________________________________________ 
28 
 
Table 12: Synthesis of 4‑heterosubstituted cyclopentenones according to Reiser et al.50 
 
Entrya 69 70 t [h] T [°C] Yield [%] 69 ee [%] 69 Yield [%] 71 ee [%] 71 sb 
1 69a 70b 18 25 23 26 12 91 24 
2 69a 70c 4 0 50 25 30 77 11 
3 69b 70a 1 0 46 96 35 (69a) 90 31 
4 69b 70b 2 0 34 99 34 93 44 
5 69b 70c 1 0 31 90 46 90 44 
6 69b 70cc 4 –20 43 >99 45 >99 501 
7 69b 70d 1 0 44 95 41 91 41 
8 69b 70e 17 –78 33 >99 42 93 56 
9 69b 70f 17 –78 38 92 39 93 50 
10 69b 70g 18 rt 31 >99 50d 96d 194 
11 69b 70gc 16 rt 42 >99 48e 95e 113 
12 69b 70hc 24 0 47 >99 46 94 80 
a) (±)-69 (0.5 mmol), 70 (0.24 mmol), Pd2(dba)3 (1.2 mol%, 2.3 mol% Pd based on the nucleophile), (R,R)-72 (3.7 
mol% based on the nucleophile) in DCM (2 mL); absolute configurations of 71a and 71d were obtained by 
comparison of specific rotation values with literature (see Experimental Part) as well as by X-ray crystallography 
(70g, see Appendix). b) selectivity factor. c) 5 mmol scale, Pd2(dba)3 (0.5 mol%; 1 mol% of Pd based on the 
nucleophile), (R,R)-72 (2 mol % based on the nucleophile). d) 36%, 99% ee after single recrystallization from 
ethanol. e) 43%, 97% ee after single recrystallization from ethanol. f) 39%, 98% ee after single recrystallization 
from PE/EA. 
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8. Conclusion 
Especially in the last 10 years, the scope of the Piancatelli rearrangement was expanded 
significantly. The aza- and the C-Piancatelli versions now allow the use of nitrogen and carbon 
nucleophiles instead of solely water as nucleophile, and moreover intramolecular variants of 
this reaction have been developed. This gives new perspectives regarding potential future 
applications, which were until now limited to the classical version. Furthermore, a few technical 
approaches have been realized, giving the possibility to perform the rearrangement in a 
continuous flow reactor. This gives now the opportunity for the convenient large-scale 
production of cyclopentenones. Besides this, a method was developed to synthesize 
cyclopentanone or cyclopentanol directly from furfuryl alcohol, which is highly valuable in 
view of the growing interest in using renewable resources. Apart from these new advancements 
there are frequently appearing publications about applications for the classical Piancatelli 
rearrangement, proven by the numerous examples in chapter 7. As an outlook, taking the 
increasing interest in variations of this reaction in the last decade into account, new interesting 
developments and also applications concerning this issue can be anticipated. 
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B. Main Part 
1. Cycloaddition Approach 
1.1 Introduction 
The basic objective of this project was to establish new methods to convert chemicals which 
are fabricated from a renewable feedstock into valuable building blocks for synthesis in organic 
chemistry. Ideally, processes in which renewable materials are used for the synthesis of 
compounds that are otherwise typically produced from fossil resources should be developed. In 
this respect, an interesting class of compounds are certain furan derivatives that are easily 
accessible from biomass commodities. Therefore, the main focus of this work will be placed on 
the investigation of the transformation of these particular furanic compounds. The first chapter 
starts with exploring the conversion of the heterocyclic compound furfuryl alcohol 1g to the 
carbocyclic substance 4-hydroxy-2-cyclopentenone (±)-2a which then should be transformed 
in a subsequent cycloaddition reaction. Furfuryl alcohol 1g was selected as it is manufactured 
industrially on a large scale from agricultural residues like bran, bagasse, wheat straw, and 
wood or paper waste for instance51,52 and therefore it is inexpensively available in great 
quantities. These waste products consist principally of cellulose, hemicellulose and lignin. 
Cellulose is a glucose polymer and hemicellulose a polymer consisting mainly of xylose, a C5-
sugar. Hydrolysis of these so-called lignocellulosic materials under acidic conditions results in 
the cleavage of the polymeric structures to yield the monomeric carbohydrates. In case of the 
hemicellulosic fraction (Scheme 21) this gives primarily D-xylose 74, which is then further 
dehydrated to furfural 13.53,54 Reduction affords eventually furfuryl alcohol 1g.55 
 
Scheme 21: Process for furfuryl alcohol production. 
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There exist two mechanisms proposed for the dehydration of pentoses to furfural 13 in 
literature, an open-chain version and a variant basing on the cyclic form of the carbohydrates 
(Scheme 22, Scheme 23).56 
 
Scheme 22: Open-chain mechanism for dehydration of pentoses to furfural.56 
 
 
Scheme 23: Cyclic-structure mechanism for dehydration of pentoses to furfural.56 
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A procedure to convert furfuryl alcohol 1g in an aqueous solution to 4-hydroxy-2-
cyclopentenone (±)-2a in notably high yield and purity either in the microwave or a continuous 
flow system was developed in our group.28 There are many other different ways to synthesize 
racemic cyclopentenones,57 but this method proved to be especially straightforward and fast. 
The reason for this are the high temperatures applied, which results in a significant decrease in 
reaction time (2–15 min for the microwave reactions and even less for the continuous flow 
system) compared to conventional heating methods. In the microwave reactions also different 
derivatives of furfuryl alcohol 1g featuring an alkyl- (1h–1k) or phenyl (1a) substituent adjacent 
to the hydroxy functionality could be employed with yields ranging from 43–96% and 
selectivities from a 5:1 to 12:1 ratio of the more stable trans- to cis-diastereomer (Table 13). A 
study on the kinetics of the rearrangement of furfuryl alcohol 1g by Hronec et al. confirms the 
beneficial effects of high temperatures on this reaction.58 
Table 13: Rearrangement of different α-furylcarbinols in the microwave.a,28 
 
Entry R c [mol/L] t [min] Yield [%]b dr (trans/cis) 
1 1g 0.25 4 43 - 
2 1a 0.14 2 96 5:1 
3 1i 0.15 5 73 12:1 
4 1h 0.14 15 54 7:1 
5 1j 0.15 5 65 7:1 
6 1k 0.15 30 0 - 
            a) 1 (1.5 mmol) in H2O (6 mL), microwave irradiation (300 W) under closed vessel conditions  
              (200–210 °C, 15 bar). b) isolated yield. 
Detrimental for the application in actual synthesis are the limited reaction volumes the 
microwave can be operated with (CEM Discover, 10 or 30 mL closed vessels). In combination 
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with the relatively high dilution of the reaction mixture, which is required for a clean reaction, 
the quantity of product producible in a given amount of time is restricted.  
The employment of a continuous flow system (Figure 2) for the rearrangement of 4-hydroxy-
2-cyclopentenone (±)-2a could solve this problem by reaching a high throughput and achieving 
a further enhancement of the yield. Therefore, despite the dilute conditions great quantities of 
material could be synthesized. Under subcritical conditions (240 °C, >15 bar) 4-hydroxy-2-
cyclopentenone (±)-2a was produced in an exceptionally short reaction time (<1 min, 87% 
yield), making this process an attractive alternative for large-scale synthesis compared to 
conventional batch methods. 
 
Figure 2: Setup of continuous flow system for rearrangement reaction.28  
One of the main drawbacks of this method is the fact that the product is obtained as a dilute 
aqueous solution requiring the complete removal of water in the work-up. 4-Hydroxy-2-
cyclopentenone (±)-2a is too water-soluble to be extracted with an organic solvent, therefore 
the water has to be evaporated in an energy-intensive step. Thus, a solution for this issue could 
be a further transformation of (±)-2a directly in the aqueous solution obtained from the 
continuous flow system. As one of the conceivable possibilities a Diels-Alder reaction was 
considered, in which the highly reactive cyclopentadienone 76, generated from (±)-2a by 
elimination of the hydroxy group, reacts with a suitable dienophile (Scheme 24). After 
decarbonylation this would lead to aromatic compounds, preferably benzoic acid 78, which 
could be easily precipitated from an aqueous solution. 
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Scheme 24: Hypothetical synthesis of benzoic acid. 
The industrial process for the production of benzoic acid 78 is generally predicated on the 
catalytic oxidation of toluene with molecular oxygen.59 Toluene, however, emerges from the 
refinement of crude oil, more precisely from the reforming of naphtha and the distillation of 
BTX (benzene-toluene-xylene).60 Consequently, through the envisioned Diels-Alder process 
benzoic acid 78 could be produced from renewable resources rather than from fossil material. 
 
1.2 Generation of Cyclopentadienone by Pyrolysis 
To perform a cycloaddition with a suitable diene and cyclopentadienone 76, this elusive 
intermediate first had to be generated from 4-hydroxy-2-cyclopentenone (±)-2a. First test 
reactions were conducted in the microwave to investigate whether this reaction can be 
accomplished in an aqueous solution (Scheme 25).61 Evidence of the existence of 
cyclopentadienone 76 during the reaction was found in the formation of 1-indanone 81 in 10% 
yield, in which two cyclopentadienone 76 molecules reacted via Diels-Alder reaction and form 
the dimerization adduct 79; subsequent decarbonylation62 and rearomatization63 afforded the 
stable 1-indanone 81. 
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Scheme 25: Elimination of the hydroxy group in water under microwave irradiation.61 
Thus the generation of cyclopentadienone 76 in water was demonstrated, but the reaction 
produced a considerable amount of black tar and therefore could not provide a sufficient amount 
of the product 81. A more effective way to generate cyclopentadienone 76 (Table 14) was found 
in literature64,65 by pyrolysis of 4-acetoxy-2-cyclopentone (±)-69a. 
Table 14: Pyrolysis of 4-acetoxy-2-cyclopentenone (±)-69a.64,65 
 
Conditions Aa Bb 
Vaporization temperature [°C] –20 N/A 
Pyrolysis temperature 850 455 
Vacuum [Torr] 10 -4 N/A 
Conversion Complete N/A 
Products 79 + acetic acid 81 + acetic acid 
            a) ref 64. b) ref 65. 
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That idea was leading away from the pursued path of finding reaction conditions in water, but 
the possibility of trapping 76 via Diels-Alder reactions could be investigated. In Table 14 the 
conditions for the pyrolysis of 4-acetoxy-2-cyclopentone (±)-69a from the two literature 
examples are described. 
First of all a device (Figure 3) to perform a pyrolysis reaction was constructed. Through a 
pyrolysis oven, heatable to a maximum temperature of 1000 °C, a quartz glass tube was directed 
on which one end the compound could be evaporated. On the other end of the tube a specifically 
manufactured cooling trap was installed that could be charged with a cooling mixture of dry ice 
and acetone achieving a temperature of –78 °C. Vacuum could be applied with a minimum 
pressure of 0.07 mbar. 
  
Figure 3: Setup of the pyrolysis device. 
 
- 
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Figure 4: Picture of the pyrolysis device. 
 
 
Figure 5: Picture of crystals forming on the cooling trap. 
4-Acetoxy-2-cyclopentone (±)-69a, 4-hydroxy-2-cyclopentenone (±)-2a, (±)-4-acryloyloxy-2-
cyclopentenone (±)-82 and the cyclopentadienone dimerization adduct 79 were subjected to 
pyrolysis at different temperatures (Table 15). The primary objective of these pyrolysis 
experiments was to generate cyclopentadienone 76 and by addition of a dienophile to 
accomplish a Diels-Alder reaction in the pyrolysis apparatus resulting in benzoic acid or a 
derivative thereof. To prevent the dimerization of cyclopentadienone 76 before reaching the 
cooling trap, its concentration in the pyrolysis tube was kept very low by vaporizing the starting 
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material steadily at a low rate (1.5 h for approximately 0.5 g of substance). Initially, the 
behaviour of the pure compounds without the addition of a dienophile under pyrolysis 
conditions was studied. First 4-acetoxy-2-cyclopentenone (±)-69a was examined which 
eliminated acetic acid smoothly in the pyrolysis device (entry 3–7, Table 15). By observing the 
dimerization product 79 on the cooling trap, a brief existence of cyclopentadienone 76 can be 
assumed. At temperatures of less than 500 °C significant amounts of starting material (±)-69a 
were recovered (entry 3 and 4, Table 15). At 600 °C the yield of dimerization product 79 peaked 
with 76%, but also compounds like 93, 94 and 83 were observed (entry 5, Table 15). The yield 
of 79 decreased again with rising temperatures, and increasingly complex mixtures made the 
isolation of distinct compounds more difficult (entry 6 and 7, Table 15). Literature examples 
state that by dimerization of cyclopentadienone 76 exclusively the endo-isomer of 79 is 
formed,66 which was confirmed by comparison with NMR data found in the literature.67,68 
Table 15: Pyrolysis of different 4-substituted 2-cyclopentenones.a 
 
Entry R Vaporization T [°C] Pyrolysis T [°C] Yield [%]b 
1 H 100 600 2a: 40 
2 H 100 800 2a: 22, 79: 2  
3 COCH3 50 350 69a: 91  
4 COCH3 50 500 69a: 52, 79: 21  
5 COCH3 50 600 69a: 2, 79: 76, 80: 4, 81: 2  
6 COCH3 50 700 79: 43  
7 COCH3 50 800 79: 15, 83: 9  
8 COCH=CH2 50 600 79: 50, 81: 5  
9 79 100 600 80, 81, 83: 30 combined 
  a) 2a/69a/82/79 (500 mg). b) isolated yield. 
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Using 4-hydroxy-2-cyclopentenone (±)-2a as starting material resulted mainly in the formation 
of black tar in the pyrolysis tube (entry 1 and 2, Table 15). To confirm the origin of the side 
products 80, 81 and 83, which were assumingly derived from the dimerization product 79, the 
latter compound was subjected to pyrolysis resulting in the previously observed side products 
and some other unidentified compounds (entry 9, Table 15). Generally, the dimerization 
product 79 and acetic acid condensed mostly at the cooling trap (Figure 5), but some amount 
of those compounds also accumulated at the end of the pyrolysis tube. Moreover, at 
temperatures over 600 °C independent of the starting material, increasing amounts of a black 
precipitate emerged in the pyrolysis tube. In all pyrolysis experiments, 1-indanone 81, which 
was the main product in the example published by DePuy,65 was not observed at all or only in 
traces. 
After confirming the formation of 79, one major obstacle was the addition of the dienophile to 
the incoming cyclopentadienone 76 in the pyrolysis tube or the cooling trap. This proved to be 
technically difficult, therefore, as a solution the covalent binding of the dienophile directly to 
the cyclopentenone moiety which should be evaporated was considered. By experiencing the 
high temperatures in the pyrolysis tube, the bond would be cleaved via elimination to generate 
cyclopentadienone 76 and simultaneously release the dienophile. Therefore, with every 
cyclopentadienone 76 that occurs one dienophile would be present in its vicinity. Compound 
(±)-82, prepared from 4-hydroxy-2-cyclopentenone (±)-2a and acryloyl chloride 84, could lose 
acrylic acid 85, functioning as the dienophile, upon heating (Scheme 26). 
 
Scheme 26: Attempted Diels-Alder reaction of 76 with covalently bound dienophile. 
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Unfortunately, by pyrolysing (±)-82 only the dimerization product 79 and 1-indanone 81 could 
be observed (entry 8, Table 15). Therefore, another approach to the generation of 
cyclopentadienone 76 was investigated, which is described in the next chapter that explicates 
more closely this reaction in solution. 
 
1.3 Diels-Alder Reaction in Solution 
Goliasch et al. describe in their paper the generation and reactions of the highly reactive 
cyclopentadienone 76.69 Their experiments are conducted with 5-bromo-2-cyclopentenone (±)-
87 as precursor for the generation of 76. By treatment of (±)-87 with diethylamine at –30 °C in 
Et2O they observed the cyclopentadienone dimer 79 as the single product, whereas higher 
temperatures over 20 °C led to more polymerization products and a decline in the yield of 79. 
Treatment of (±)-87 with other bases led to similar results but varying amounts of 79 (influence 
of base on yield of dimerization product 79: diethylamine 78%, piperidin 39%, N-methylanillin 
18%, pyridine 12%, N-ethyl-cyclohexylamine 4.1%, dimethylamin 0.4%, chinolin and 
triphenylphosphin did not react). Reaction of 5-bromo-2-cyclopentenone (±)-87 with 
diethylamine and a huge excess of phenylacetylene resulted in a minor amount of Diels-Alder 
adduct (2%). The main product of the reaction was the dimerization product 79. Diels-Alder 
reactions with maleic anhydride, cyclohexene, acetylenedicarboxylic dimethylester and 
tetracyanoethylene failed to yield any Diels-Alder adduct (Table 16). By using diethylamine in 
cyclopentadiene as solvent at –70 °C and adding 5-bromo-2-cyclopentenone (±)-87 over 2 h, 
the Diels-Alder adducts 89 and 90 (Table 16, entry 1) were observed in 15% yield (combined 
yield, unspecified ratio). 
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Table 16: Diels-Alder reactions with cyclopentadienone 76.69 
 
Entry Dienophile/Diene Solvent T [°C] Result 
1 Cyclopentadiene - –70 79,a  89/90: 15%  
2 Phenylacetylene - –30 79: 84%, 88: 2%  
3 Cyclohexene N/A N/A 79b 
4 Maleic anhydride N/A N/A 79b 
5 Dimethylacetylenedicarboxylate N/A N/A 79b 
6 Tetracyanoethylene N/A N/A - 
       a) ratio not specified. b) yield not specified. 
In an own test experiment 4-acetoxy-2-cyclopentenone (±)-69a was reacted with 10 equivalents 
of cyclopentadiene in iPrOH at rt (Scheme 27). This gave 81% of the Diels-Alder adduct endo-
90 (from NMR spectra70,71 of endo- and exo-isomer of 90 it can be concluded that only the 
endo-product was formed) which leads to the conclusion that (±)-69a reacted as dienophile and 
the leaving group was expelled later (on the column by purifying the compound, because the 
crude 1H-NMR did not match the clean spectrum of 90). Consequently, this could also apply to 
the literature example (Table 16), and partly not cyclopentadienone 76 reacted as diene, but the 
starting material (±)-87 to form adduct 90. However, the formation of 89 in the literature 
example69 can only be explained by a Diels-Alder reaction in which cyclopentadienone 76 acts 
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as the diene, but as the ratio of 89/90 is not specified a definitive statement about 76 reacting 
as diene cannot be given. 
 
Scheme 27: Diels-Alder reaction of 4-acetoxy-2-cyclopentenone and cyclopentadiene. 
In another publication covering the topic of Diels-Alder reactions with cyclopentadienone 76 
Simoni et al. showed that with heating of (±)-91 for 3 days and an excess of dienophile a Diels-
Alder reaction took place and the mixed adduct could be obtained in low yield.72 It has to be 
emphasized that the key to success as the authors stated was the very slow generation of 76 
(over 3 days), to prevent it from reacting with itself to form the dimerization product 79 rather 
than the mixed adducts. 
Table 17: Diels-Alder reaction with cyclopentadienone 76.72 
 
R1 R2 Yield [%] 
-H -CO2Et 20 
-CH3 -CO2Me 12.5 
-CO2Me -CO2Me 7 
 
Another instance of a successful demonstration of cyclopentadienone 76 acting as diene or 
dienophile is the three-phase-test (to prove the existence of cyclopentadienone 76) by Gavina 
et al.73 They could react polymer-bound dienes 95 or dienophiles 96 with cyclopentadienone 
76 being generated from a likewise polymer-bound precursor 94. Both polymers were separated 
spatially in a solvent filled confined volume, so that a reaction of the polymer-bound 
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diene/dienophile with the polymer-bound cyclopentadienone precursor implies a diffusion of 
cyclopentadienone 76 through the solvent to reach the other reactant. This should prove the 
intermediate existence of cyclopentadienone 76. In Table 18 the different trapping resins used 
for the 3-phase test are described and the yields of the related Diels-Alder adducts are given. 
Table 18: Three-phase test by Gavina et al.73 
 
Entry Trapping Resin Yield [%] 
1 P-CH2O2C-C≡C-CO2H 17 
2 P-CH2O2C-HC=CH-CO2H 11 
3 P-CH2-(NC4H2O2) 6 
4 P-CH2-O2C-HC=CH-CH3 51 
5 P-O2C-C6H4-N=N-C6H2(OH)2 21 
6 P-CH2O2C-C4H3O 2 
7 P-CH2-CO2-HC=CH-HC=CH2 72 
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To perform Diels-Alder attempts in solution, it was ascertained beforehand if the dimerization 
product 79 could be generated smoothly with satisfactory yields and the most suitable 
conditions for the elimination reaction were determined. The optimum reaction conditions, 
reaching a yield of 77%, in which also the reaction time was in an acceptable time range, are 
displayed in entry 4 (Table 19), using NaOH as a base in iPrOH. Therefore, these conditions 
were selected for the attempts of the Diels-Alder reactions. Na2CO3 and Cs2CO3 could also be 
employed in this reaction (entry 5 and 6, Table 19). Moreover, it was examined if tertiary amines 
like Et3N work as bases, but this proved to be not the case (entry 7 and 8, Table 19). 
Table 19: Elimination and dimerization under basic conditions.a 
 
Entry Base Solvent T [°C] t [h] Yield [%]b 
1 NaOH H2O 65 24 26 
2 NaOH MeOH 65 24 28 
2 NaOH EtOH 65 24 43 
3 NaOH iPrOH 65 24 55 
4 NaOH iPrOH rt 24 77 
5 Na2CO3 
iPrOH rt 12 d 86 
6 Cs2CO3 
iPrOH rt 17 72 
7 Et3N 
iPrOH rt 5 d 0c 
8 Et3N 
iPrOH reflux 24 0c 
         a) 69a (0.7 mmol). b) isolated yield. c) quant. recovery of starting material. 
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After those preliminary experiments Diels-Alder reactions were explored (Scheme 28, Table 
20 and Table 21). To ensure that cyclopentadienone 76 was generated slowly and did not react 
with itself or the starting material 4-acetoxy-2-cyclopentenone (±)-69a, it was added steadily 
over 24 h in a dilute solution to the diene or dienophile in a basic solution via syringe pump. 
 
Scheme 28: Intended synthesis of aromatic compounds. 
As detailed in the literature example69 mentioned earlier in this chapter, phenylacetylene gave 
a small amount of Diels-Alder adduct when reacted with 5-bromo-2-cyclopentenone (±)-100 
and a suitable base to provoke the elimination to cyclopentadienone 76. Therefore, this was 
considered to be a viable dienophile in the Diels-Alder reaction, hence this and also 
diphenylacetylene were examined (entry 1 and 2, Table 20). But unfortunately just the 
dimerization product 79 of cyclopentadienone 76 was observed. Other dienophiles tested were 
acetylene carboxylic acid or an ester thereof, because these compounds worked in the literature 
precedents63,73 already mentioned. This did not lead to the desired product, and again 
cyclopentadienone dimer 79 and also some of the starting material (±)-69a were the only 
compounds isolated. 
Table 20: Different acetylene derivatives as dienophiles.a 
Entry R1 R2 Solvent Base Temperature Product 
1 -Ph H iPrOH NaOH rt 79 
2 -Ph -Ph iPrOH NaOH rt 79 
3 -CO2H -CO2H 
iPrOH NaOH rt (±)-69a 
4 -CO2Me -CO2Me 
iPrOH NaOH rt 79, (±)-69a 
a) (±)-69a (0.7 mmol, added over 24 h in 17 mL iPrOH via syringe pump), NaOH (1 equiv, 0.7 mmol), 100 (10 
equiv, 7 mmol) in 20 mL iPrOH. 
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As those attempts failed, other dienophiles and also dienes were investigated. But again no 
Diels-Alder product could be observed as displayed in Table 21. Therefore, the only successful 
Diels-Alder reaction so far (Scheme 27) was the reaction of (±)-69a and cyclopentadiene as 
diene without using a base so that cyclopentadiene could react directly with (±)-69a to form 
adduct 90 by eliminating the hydroxy group afterwards.  
Table 21: Experiments with other dienes/dienophiles.a 
Entry Diene/Dienophile Solvent Base T [°C] Result 
1 furan 
furan/ iPrOH 
20:1 
NaOH rt 79 
2 maleic anhydride iPrOH NaOH rt (±)-69a 
3 maleic anhydride EtOAc NaOHa rt (±)-69a 
4 maleic anhydride DCM NaOHa rt (±)-69a 
5 cyclopentadiene iPrOH NaOH rt 79 
6 ethyl acrylate iPrOH NaOH rt 79 
a) (±)-69a (0.7 mmol, added over 24 h in 17 mL iPrOH via syringe pump), NaOH (1 equiv, 0.7 mmol), 
diene/dienophile (10 equiv, 7 mmol) in 20 mL iPrOH. b) plus methyltrioctylammmoium chloride (1 equiv). 
Cyclopentadienone 76 is a remarkably reactive intermediate (it could be observed and 
spectroscopically analyzed only in a 10 K Argon-matrix)64 and seems to prefer to react rather 
with itself in a dimerization reaction than with other dienophiles. This observation is supported 
by B3LYP/6-31G* calculations that come to the conclusion that the loss of anti-aromaticity of 
76 in the transition structure of the cycloaddition of two molecules of 76 is the driving force for 
the enhanced dimerization preference.66 Nonetheless, the dimerization product 79, which can 
be obtained in reasonable yields from furfuryl alcohol 1g as a renewable resource, can be used 
to synthesize 1-indanone 81,74 which is itself a valuable compound. 
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1.4 Oxidation before Cycloaddition 
As the approach of employing cyclopentadienone 76 in a Diels-Alder reaction failed, the use 
of 4-hydroxy-2-cyclopentenone (±)-2a directly in a Diels-Alder reaction was considered. But 
(±)-2a itself is a rather unreactive dienophile in Diels-Alder reactions (mostly requiring forcing 
reaction conditions or the stoichiometric use of Lewis acids),75 therefore its transformation to 
dione 103 as a better dienophile was contemplated to solve this problem. 
 
Scheme 29: Diels-Alder reaction with cyclopentenedione. 
Since a subsequent process to the rearrangement of furfuryl alcohol 1g in the continuous flow 
system (to prevent the energy wasting work-up by converting the product to a less water-soluble 
compound) was envisioned, the oxidation had to be ultimately conducted in water. 
Consequently, an oxidation method had to be found that was environmentally benign and that 
would also work in water before any cycloaddition reactions could be investigated. The 
oxidation of (±)-2a is not known in literature, but oxidations starting from cyclopent-4-ene-1,3-
diol to give cyclopentenedione 103 typically are carried out in acidic CrO3 solutions76 (Jones-
oxidation). As chromium reagents are highly toxic and cancerogenic, a less hazardous 
alternative had to be developed. Shiota et al. reported the oxidation of the allylic alcohol 
functionality of a similar molecule to (±)-2a with MnO2 as the oxidant (Scheme 30).77 
 
Scheme 30: Oxidation of (±)-4-hydroxy-2-methyl-2-cyclopentenone with MnO2.77 
The reaction with MnO2 and 4-hydroxy-2-cyclopentenone (±)-2a as substrate gave the enedione 
103 in good yields (Scheme 31). Nevertheless, these conditions still did not meet the 
requirements for a sustainable reaction, as it was carried out in DCM and 20 equiv of MnO2 
were used. 
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Scheme 31: Oxidation of (±)-4-hydroxy-2-cyclopentenone with MnO2. 
Therefore, catalytic methods employing hydrogen peroxide or oxygen as the oxidant in aqueous 
medium were investigated. 
Initially oxidations with H2O2 as the oxidant were tested, as the only byproduct of those 
reactions is water. Different literature known oxidation methods in aqueous solution were 
applied to compound (±)-2a (Table 22). Sain et al. describe the oxidation of various secondary 
and one allylic secondary alcohol with an aqueous H2O2/HBr-solution.
78 Unfortunately, applied 
on substrate (±)-2a this did not lead to any conversion (entry 1, Table 22). Similarly, for the 
oxidation of secondary and allylic secondary alcohols in water applicable is the method 
described by Noyori et al. with Na2WO4 as catalyst.
79 As the recommended 90 °C reaction 
temperature led to decomposition of the material, the temperature was lowered to 40 °C 
producing similar results (entry 2 and 3, Table 22). The same reaction at rt did not give any 
conversion (entry 4, Table 22). Also the use of another tungsten-based catalyst, Na9[SbW9O33], 
which was described in a publication by Manikandan et al.,80 resulted mostly in decomposition 
(entry 5 and 6, Table 22). Only when the reaction was performed at rt, besides the decomposed 
material traces of the product 103 have been detected and also 5% of the epoxidation product 
could be isolated (entry 7, Table 22). Furthermore, a method published by Beller et al. was 
applied, using Fe(NO3)3/KH2PO4 as catalyst system.
81 This resulted again only in the 
decomposition of the starting material (±)-2a (entry 8 and 9, Table 22). 
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Table 22: Oxidation of (±)-2a with H2O2.a 
 
Entry Catalyst T [°C] t Result 
1b HBr 80 3 d no conversion 
2c Na2WO4 90 18 h decomposition 
3c Na2WO4 40 24 h decomposition 
4c Na2WO4 25 18 h no conversion 
5d Na9[SbW9O33] 80 24 h decomposition 
6d Na9[SbW9O33] 40 24 h decomposition 
7d Na9[SbW9O33] 25 5 d decompositione 
8f Fe(NO3)3/KH2PO4 75 5 h decomposition 
9f Fe(NO3)3/KH2PO4 25 24 h decomposition 
a) (±)-2a (2 mmol). b) (±)-2a (1 mmol), HBr (20 mol%), H2O2 30% (2 equiv). c) Na2WO4 (0.2 mol%), (CH3(n-
C8H17)3N)Cl (0.2 mol%), H2O2 30% (l equiv). d) Na9[SbW9O33] (0.01 mol%), (CH3(n-C8H17)3N)Cl (0.09 mol%), 
H2O2 30% (5 equiv). d) 5% epoxide (10:1 trans/cis), traces of 116. f) (±)-2a (3 mmol), Fe(NO3)3 (0.02 mol%), 
KH2PO4 (1 mol%), H2O2 30% (1.5 equiv).                                       
Since the oxidations with H2O2 were unsuccessful, also oxidations with molecular oxygen were 
studied (Table 23). Kaneda et al. published a method for oxidizing a great variety of different 
alcohols, including allylic alcohols, with Pd/Hydroxyapatit as the catalyst and O2 at atmospheric 
pressure.82 Applying these conditions to substrate (±)-2a led to no conversion (entry 1 and 2, 
Table 23). The method of Rhee et al. for oxidizing benzylic and allylic alcohols83 resulted only 
in decomposition (entry 3, Table 23). Also Pt/C, which was used by Matsumura et al. in aqueous 
medium,84 did not give any conversion of the starting material (entry 4, Table 23). Different 
ruthenium-based catalyst which were known for their use in oxidations with O2 were 
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examined,85 but again this led not to the desired product 103 (entry 5–8, Table 23). Furthermore, 
different palladium catalysts were tested unsuccessfully (entry 9–11, Table 23).86 
Table 23: Oxidation of (±)-2a with O2.a 
 
Entry Catalyst Solvent T [°C] t Result 
1b Pd/Hydroxyapatit toluene reflux 3 d no conversion 
2b Pd/Hydroxyapatit H2O reflux 3 d no conversion 
3c Pd/C, NaBH4  H2O 25 5 d decomposition 
4d Pt/C H2O 80 2 d no conversion 
5e RuCl3 H2O/toluene 80 24 h decomposition 
6f Ru2(OAc)2(CO3)2 H2O/toluene 80 2 d decomposition 
7g Ru(PPh3)3Cl2 DCM 25 5 d 
partial 
decomposition 
8g Ru(PPh3)3Cl2 H2O/MeOH 25 5 d no conversion 
9h Pd/C H2O 80 5 d no conversion 
10i PdCl2 DCM 25 2 d  no conversion 
11i PdCl2 DCM reflux 2 d no conversion 
a) (±)-2a (1 mmol). b) Pd/Hydroxyapatit (0.2 mol%). c) Pd/C 10% (2.5 mol%  Pd), NaBH4 (10 mol%). d) (±)-2a 
(0.51 mmol), Pt/C 10% (10 mol% Pt). e) RuCl3 (10 mol%),  H2O/toluene 3:2. f) Ru(OAc)4Cl (10 mol%), Na2CO3 
(20 mol%), H2O/toluene 5:2. g) RuCl3·H2O (10 mol%), PPh3 (10 mol%), H2O/MeOH 1:1. h) Pd/C 10% (10 mol% 
Pd). i) PdCl2 (10 mol%). 
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One obstacle was the fact that the addition of any stronger base to 4-hydroxy-2-cyclopentenone 
(±)-2a (only tertiary amines are compatible) led to instantaneous decomposition, therefore basic 
conditions had to be avoided. Another complication was that according to literature the product 
of the oxidation 103 itself is not very stable in basic aqueous solution and will decompose 
eventually (Scheme 32).87 
 
Scheme 32: Polymerization of cyclopentenedione.87 
 
1.5  [2+2]-Cycloaddition 
As an alternative strategy for converting 4-hydroxy-2-cyclopentenone (±)-2a an acylation of 
(±)-2a as described by Albini et al. with cyclopentenone 105 was taken into consideration.88 
Hereby a photochemically generated acyl radical, catalyzed by tetrabutylammonium 
decatungstate (TBADT), added to an α,β-unsaturated system (Scheme 33). Albini and co-
workers irradiated the reaction mixture with six 15 W lamps with an emission centered at 
310 nm. 
 
Scheme 33: Photocatalyzed acylation.88 
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The experiments with 4-hydroxy-2-cyclopentenone (±)-2a were conducted using conventional 
UV-lamps normally used for thin layer chromatography (40 W UV-lamp with an emission at 
366 nm). Using (±)-2a as substrate, besides the recovered starting material (±)-2a unfortunately 
only a complex mixture was obtained (entry 1, Table 24). 
 
Scheme 34: [2+2]-Cycloaddition products instead of acylation. 
Switching the starting material to (±)-69a gave not the acylation product but instead the [2+2]-
cycloaddition products 108a and 108b were isolated (entry 2, Table 24). Without adding the 
aldehyde this transformation even gave better results with 88% combined yield of cycloaddition 
products (entry 3, Table 24). Leaving out both the catalyst and the aldehyde, the reaction 
furnished the cycloaddition products in almost the same quantity (entry 4, Table 24). By 
comparison of the crude NMR data with the isolated products after column chromatography, it 
can be concluded that the acetyl group was eliminated during work-up. The two different 
isomers were identified by comparison with published NMR data.89,90 Furthermore, the same 
products were observed by another group, irradiating (±)-69a with a high pressure mercury 
lamp.91 
Table 24: Reaction conditions for the photoreaction. 
Entry R Aldehyde [equiv] Catalyst [mol%] t [h] Yield [%]a 
1b H 1.1 2 24 106: 36c 
2b OAc 1.1 2 24 69a: 27, 108a+108b: 72d 
3b OAc 0 2 40 108a+108b: 88d  
4e OAc 0 0 48 108a+108b: 80d 
a) isolated yield. b) (±)-2a/69a (0.5 mmol). c) as inseparable mixture with other by-products. d) 1:1 ratio. e) (±)-
69a (1 mmol).  
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1.6 Conclusion 
The main task to produce benzoic acid from 4-hydroxy-2-cyclopentnenone (±)-2a by Diels-
Alder reactions with cyclopentadienone 76 and a suitable dienophile was not achieved. Instead, 
the dimerization product 79 was observed. This compound could be synthesized from 4-
acetoxy-2-cyclopentenone (±)-69a in a facile procedure and with good yields. Oxidations of 4-
hydroxy-2-cyclopentenone (±)-2a under sustainable conditions were not accomplished, though 
the oxidation with MnO2 in DCM was successful. 
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2. Enantioselective Synthesis of 4-Heterosubstituted Cyclopentenones 
2.1 Introduction 
Enantiomerically pure 4-hydroxy-2-cyclopentenone 2a and derivatives thereof have served as 
valuable building blocks in the synthesis of many important organic compounds. It has been 
used in the synthesis of prostaglandin PGE1 methyl ester 109,92 the farnesyltransferase inhibitor 
Arglabin™ 110,93 the HIV protease inhibitor GRL-06579 11194 and the Didemnenones A 112a 
and B 112b95 (Scheme 35). 
 
Scheme 35: Natural products and pharmaceuticals from enantiomerically pure 4-hydroxy-2- 
                     cyclopentenone 2a.92,93,94,95 
Many ways to synthesize enantiopure 2a and derivatives thereof utilizing the chiral pool,96 
chiral reagents97 or catalysts98 have been developed. A majority of these transformations 
involve selective changing of the oxidation state of the corresponding 1,3-cis-diol99 or 1,3-
diketone.100 The direct deracemization of (±)-2a or its O-acyl derivative (±)-69a was achieved 
by enzymatic resolution with lipases101 or penicillin G acylase.102 Kinetic resolution of (±)-2a 
had also been achieved by catalytic asymmetric isomerization103 or hydrogenation.104 A review 
summarizing the synthesis of both enantiopure and racemic (±)-2a as well as its use in synthesis 
has been published in 2010.4 
The application of π-allylpalladium chemistry105,106 for the purpose of synthesizing enantiopure 
2a has not been investigated, despite the remarkable progress that was made in this field since 
the discovery of the reactivity of π-allylpalladium complexes towards nucleophilic species.107  
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The reaction principle of the palladium-catalyzed allylic substitution, which has been developed 
in the early 1970s,108 is outlined in Scheme 36. The allylic compound 113 
(e. g. X = -OAc, -OCO2R, -OCONHR, -epoxide, -OPh, -OH, -OP(O)(OR)2, -Cl, -NO2, -SO2R, 
-NR2) forms the π-allylpalladium-complex 114 via oxidative addition to a Pd(0)-species. These 
complexes are electrophilic and are able to react with nucleophiles. After the reaction Pd(0) is 
regenerated and takes part in the catalytic cycle again. 
 
Scheme 36: Reaction principle of palladium-catalyzed allylic substitution.105 
The stereochemical outcome of the overall reaction follows the concepts depicted in Scheme 
37, which have been investigated thoroughly.109 The attack of the Pd(0)-species on the allylic 
compound 116 proceeds by inversion of configuration (anti-attack) to form π-allylpalladium-
complex 117. In the next step the direction of the addition of the incoming nucleophile depends 
on its nature. Soft carbon nucleophiles, N- and O-nucleophiles react by inversion, which leads 
to an overall retention of configuration (compound 118). In contrast, organometallic 
compounds as nucleophiles first add via transmetallation to form complex 119, and by reductive 
elimination give product 120 with an overall inversion of configuration. 
 
Scheme 37: Stereochemical aspects of palladium-catalyzed allylic substitution.105 
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2.2 Literature Examples of Pd-Catalyzed Allylic Substitution 
As 4-hydroxy-2-cyclopentenone (±)-2a is obtained as a racemic mixture from the continuous 
flow reactor developed in our group,28 it would be an interesting perspective if the different 
enantiomers could be separated by simple kinetic resolution. Asymmetric allylic alkylation 
reactions with either carbon-nucleophiles (Tsuji-Trost reaction) or heteroatom-nucleophiles are 
known to provide the means for this purpose,110 as the compound of interest (±)-2a possesses a 
single stereocenter in allylic position with an alcohol functionality. Moreover, by this 
methodology various enantiopure 4-substituted cyclopentenones could be obtained, which 
offers new possibilities for this compound class as building blocks in organic synthesis. 
Some examples of compounds exhibiting a γ-hydroxyenone system, similar to 4-hydroxy-2-
cyclopentenone (±)-2a, that are employed in a Pd-catalyzed allylic substitution with either an 
O-Boc- or O-Ac- leaving group can be found in literature (Scheme 38–Scheme 40).  
 
Scheme 38: Dynamic kinetic resolution of the racemic butenolide (±)-121 and 2-naphthol as 
                     nucleophile.111 
The first example (Scheme 38) describes an asymmetric allylic substitution reaction discovered 
by Trost et al. that leads to a dynamic kinetic resolution with racemic butenolide (±)-121 and a 
nucleophile yielding the enantiomerically enriched species (R)-123.111 Another study published 
by Trost explicates the successful use of butenolide (±)-121 in a kinetic resolution mode and a 
dynamic kinetic resolution with other phenolic nucleophiles.112  
 
Scheme 39: Allylic substitution on enantiomerically pure allylic acetate (R)-125.113 
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The second example (Scheme 39) is a palladium-catalyzed allylic substitution using 
enantiomerically pure acetate (R)-125 and the achiral ligand triphenylphosphine oxide. 
 
Scheme 40: Allylic substitution on enantiomerically pure allylic carbonate 127.114 
Example three depicts the same reaction principle with the allylic carbonate (S,S)-127 as 
substrate (Scheme 40). Therefore, in general it should be possible to carry out this type of 
reaction with substrate (±)-2a after protection of the hydroxyfunctionality with either an acetyl 
or tert-butylcarbonate group, as it contains the same γ-hydroxyenone system. Nevertheless, no 
literature evidence was found applying this reaction on O-protected derivatives of compound 
(±)-2a.  
 
2.3 Kinetic Resolution of 4-Hydroxy-2-Cyclopentenone 
For first test experiments the literature known compound butenolide (±)-121 (Scheme 38) was 
prepared to investigate if not only the O-Boc-leaving group but also the O-Ac-leaving group 
can be used on this system with similar results when subjected to palladium-catalyzed allylic 
substitution. Both protecting groups display different advantages and detriments. The O-Ac-
leaving group is environmentally more benign and also less expensive,115 therefore this one 
should be preferably used. On the other hand it is a worse leaving group and often requires base 
for a successful reaction.105 Moreover, the formation of the π-allylpalladium-complex is 
reversible. But as allylic acetate (±)-69a is a considerably base sensitive compound (chapter 
1.3), base free conditions are more desirable. The O-Boc-group in an allylic position is among 
the most reactive functional groups (Scheme 41) for allylic substitution reactions and 
furthermore these reactions proceed without the need for basic conditions.105 The oxidative 
addition of the palladium species to carbonates is accompanied by a decarboxylation leading to 
the π-allylpalladium alkoxide 130, which makes the overall process irreversible. The generated 
alkoxide is basic enough to abstract a proton from the nucleophile to promote the following 
attack of the nucleophile on the π-allylpalladium complex 131.  
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Scheme 41: Behaviour of carbonates in allylic susbtitutions.105 
Both butenolides (±)-135 and (±)-121 with either an O-Ac- and O-Boc-leaving group were 
synthesized from alcohol (±)-134. Compound (±)-134 was prepared by a known procedure171 
from furan-2-carboxylic acid 133 (Scheme 42) by a [4+2]-cycloaddition of singlet oxygen, 
which could be further transformed by acetylation or Boc-protection into compounds (±)-135 
and (±)-121, in case of the latter following a literature known procedure.112 
 
Scheme 42: Preparation of butenolides (±)-121 and (±)-135. 
Both compounds (±)-121 and (±)-135 were used in the palladium catalyzed allylic alkylation 
with phenol 70b as nucleophile and the achiral ligand triphenylphosphine to yield the racemic 
product (±)-136 (Table 25). Both variants worked almost equally well, giving in case of the 
Boc-protected substrate product (±)-136 in quantitative yield and in the other case (±)-136 in 
93% yield. Therefore, presumably both possibilities should be applicable to the allylic system 
in 4-hydroxy-2-cyclopentenone (±)-2a. 
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Table 25: Comparison of leaving groups.a 
 
Entry Compound Yield [%]b 
1 (±)-121 quant. 
2 (±)-135 93 
                 a) (±)-121/135 (0.31 mmol), 70b (0.46 mmol, 1.5 equiv), Pd2(dba)3 (3.2 mol%, 6.4 mol%  
                   Pd based on the nucleophile), PPh3 (15 mol% based on the nucleophile) in DCM (10 mL).  
                 b) isolated yield. 
The synthesis of both the Boc-protected (±)-69b and the acylated 4-hydroxy-2-cyclopentenone 
(±)-69a worked smoothly, in case of (±)-69a, following a known procedure,103 in 80% yield 
and in case of (±)-69b in 87–90% yield. 
 
Scheme 43: Synthesis of O-Ac- and O-Boc-substituted (±)-cyclopentenones. 
Initially racemic 4-acetoxy-2-cyclopentenone (±)-69a was used as starting material to examine 
its behaviour in the palladium-catalyzed allylic substitution. As nucleophiles phenol 70b, p-
methoxyphenol 70i or benzyl alcohol 124 were utilized, because phenols and benzyl alcohol 
have been approved as nucleophiles in this type of reaction (Scheme 38–Scheme 
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40).111,112,113,114 For the first test reactions (Table 26)  and to produce racemic mixtures for 
HPLC analysis triphenylphosphine served as ligand for the palladium catalyst whereas in the 
subsequent experiments on kinetic resolution chiral ligands have been used. The comparison of 
the solvents diethyl ether, tetrahydrofuran and dichloromethane with the nucleophile phenol 
70b showed that with the first two no product was observed, instead the generation of dimer 79 
was detected (entry 1 and 2, Table 26). In dichloromethane the product was formed, although 
the reactions turned out to be rather sluggish unless a large amount of catalyst and excess of 
nucleophile were used (entry 3 and 4, Table 26). p-Methoxyphenol 70i could also be employed 
successfully in this reaction (entry 5, Table 26), whereas benzyl alcohol 124 did not react at all 
(entry 6, Table 26). The test reactions proved that compound (±)-69a could be used in allylic 
substitution reactions using an achiral ligand, although in most cases the dimerization product 
of cyclopentadienone 79 was formed to some extent.  
Table 26: First test reactions with (±)-4-acetoxy-2-cyclopentenone.a 
 
Entry NuH Nu [equiv] t [h] Solvent Yield [%]b 
1 70b  1.5 1.5 Et2O 0c 
2 70b 1.5 1.5 THF 0c 
3 70b 1.5 24 DCM 69a: 24, 79: 37 
4 70b 6 1.5 DCM 59e 
5 70i 6.3 1.5 DCM 61 
6 124 6.3 15 DCM 0e 
a) (±)-69a (0.31 mmol), Pd2(dba)3 (5 mol%, 10 mol% Pd based on 69a), PPh3 (22 mol% based on (±)-69a). b) 
isolated yield. c) only 79 observed. d) conversion incomplete, inseparable impurities. e) 36% 79. 
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The generation of 79 as a side-product in many cases can be explained by elimination of 
HPdXL2 from the π-allylpalladium complex which leads to the transient formation of 
cyclopentadienone 76 that dimerizes rapidly (Scheme 44). This kind of elimination reaction is 
known to be a typical side reaction of pathways involving π-allylpalladium complexes and also 
found its application in the synthesis of dienes.116 
 
Scheme 44: Elimination of HPdXL2 furnishes cyclopentadienone dimer 79. 
The next step included the application of chiral ligands to try the kinetic resolution and optimize 
the reaction conditions. Some ligands were screened for this reaction (screening by Tirayut 
Vilaivan, Table 27), and the Trost ligand (R,R)-72 proved to be superior for this purpose (entry 
2, Table 27). As a benchmark reaction, the substitution with phenol as nucleophile was selected. 
(S)-BINAP 139 and the (S,S)-Bn-azabox 140 ligands gave no conversion at all when applied in 
the Pd-catalyzed allylic substitution with phenol (entry 3 and 4, Table 27). In contrast, with the 
achiral phosphine-ligand PPh3 the desired product (±)-71b could be observed in 30% yield 
besides the dimerization adduct 79 (entry 1, Table 27). 
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Table 27: Screening of ligands for allylic alkylation.a 
 
Entry Ligand Ligand [mol%] Yield [%]b 
1 PPh3 3.5 71b: 30, 79: 47  
2 (R,R)-72 2 71b: 63, 79: 5  
3 (S)-139 2 no reaction 
4 (S,S)-140 2 no reaction 
             a) (±)-69 (0.5 mmol), 70b (0.6 mmol, 1.2 equiv), Pd2(dba)3, (0.5 mol%, 1 mol% Pd based on 
               the nucleophile), ligand (amount of ligand based on the nucleophile), results by Tirayut Vilai- 
               van. b) isolated yield. 
The Trost ligand (R,R)-72 showed the best results among the four ligands screened, 
consequently it was selected for further investigations. N,N'-((1R,2R)-cyclohexane-1,2-
diyl)bis(2-(diphenylphosphino)benzamide) (R,R)-72, was prepared according to a known 
procedure.117  
 
Scheme 45: Preparation of (R,R)-Trost ligand.117 
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The performance of acetate (±)-69a in comparison to tert-butylcarbonate (±)-69b in the kinetic 
resolution was evaluated. Generally, the results for (±)-69a were only moderate, whereas (±)-
69b gave excellent values for yields and the enantiomeric excess. In Table 28 the results for 
(±)-69a in the kinetic resolution with different O-nucleophiles are presented. Using phenol 70b 
as the nucleophile (entry 2, Table 28) with (±)-69a as substrate, the observed yield was low 
(12%), but nonetheless product (S)-70b displayed an ee value of 91%. Also only a small amount 
of the starting material could be recovered. This can be explained by a substantial amount of 
by-products formed during the reaction, as (±)-69a reacts rather sluggish in this kind of 
transformation and is inclined to form the dimerization adduct of cyclopentadienone 79.  
Table 28: Kinetic resolution with acetate (±)-69a and carbonate (±)-69c.a 
 
Entry R NuH t [h] T [°C] 
Recovered Starting 
Material 
Product 
Yield [%]b ee [%] Yield [%]b ee [%] sc 
1 CO2Me 70b 2 25 - n.d. 49 0 1 
2 Ac 70b 18 25 23 26 12 91 24 
3 Ac 70c 48 25 32 0 32 0 1 
4 Ac 70c 24 25 33 0 34 0 1 
5 Ac 70c 4 0 50 25 30 77 11 
6 Ac 70c 1.5 0 60 25 26 86 18 
a) (±)-69 (0.5 mmol), 70 (0.24 mmol), Pd2(dba)3 (1.2 mol%, 2.3 mol% Pd based on the nucleophile), (R,R)-72 (3.7 
mol% based on the nucleophile) in DCM (2 mL). b) isolated yield. c) selectivity factor.118 
The fact that the reaction with (±)-69a is slower than with (±)-69b can be seen by comparing 
entry 6 (Table 28) and entry 5 (Table 29) in which both (±)-69a and (±)-69b react with the 
nucleophile 70c at 0° C. With (±)-69b the reaction is complete after 1 h, but only 40% of (±)-
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69a is converted after 1.5 h. The replacement of the acetoxy group with the more reactive 
methylcarbonate moiety as a leaving group yielded the substitution product in almost 
quantitative yield, but the obtained compound (±)-70b was racemic (entry 1, Table 28). As a 
conclusion, the substrate was presumably too reactive and both enantiomers reacted fast enough 
to inhibit a successful enantiodiscrimination. When 1-naphtylcarboxylic acid 70c was used as 
the nucleophile, the reactions at rt gave full conversion and a yield of about 30% was reached 
for both 48 h and 24 h (entry 3 and 4, Table 28), but the product (±)-71c was obtained as a 
racemic mixture. Decreasing the reaction temperature to 0 °C within a reaction time of 4 h, 
complete conversion could still be achieved and an improvement of enantioselectivity to an ee 
of 77% could be denoted (entry 5, Table 28). An even shorter reaction time of 1.5 h resulted in 
an incomplete conversion in which 40% of the starting material (±)-69a was consumed (entry 
6, Table 28). Furthermore, it was observed that at room temperature small amounts of 
cyclopentadienone dimer 79 were formed, whereas at 0 °C no dimerization product 79 was 
detected. 
The enantiomeric excess was determined by chiral HPLC and the yields in the following tables 
in this chapter are all isolated yields. The selectivity factor s was calculated by using the 
equation Kagan et al. describe in their publication118 using both the enantiomeric excess and 
the conversion of the reaction as variables. 
                                                           s = 
ln [1 – C (1 + ee)]
ln [1 – C (1 – ee)]
                                                      eq. 1 
C represents the conversion and ee the enantiomeric excess of the product. 
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In the following scheme the catalytic cycle of the palladium-catalyzed allylic substitution with 
4-substituted cyclopentenones is depicted. In the first step, the palladium complex coordinates 
to the π-bond in cyclopentenone 137, which is followed by expulsion of leaving group X¯. 
After formation of the π-allylpalladium complex 138 a nucleophile can attack, which results in 
formation of π-complex 145, which generates after loss of the palladium complex 
cyclopentenone 71. 
 
Scheme 46: Catalytic cycle for asymmetric allylic substitutions.119 
The different reaction pathways concerning this process are outlined in Scheme 47 to explain 
the occurrence of a kinetic resolution under certain conditions. To allow the kinetic resolution 
to take place efficiently process E and F should not play a role and process A has to be much 
faster than process B (or vice versa, Scheme 47). For substrate (±)-69b this seems to be the case 
because after the reaction the remaining substrate can be recovered in excellent yield. This 
confirms the absence of any racemization of the substrate (path E). In a publication by Trost et 
al.112 they observed the recovered starting material with low ee values in the kinetic resolution 
(i. e. racemization of the starting material takes place) and therefore they could perform a 
dynamic kinetic resolution successfully. In view of those facts the dynamic mode with (±)-69b 
seems not overly promising, but still path F could play a role. 
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Scheme 47: Reaction pathways of allylic substitution. 
The reactions with compound (±)-69b as starting material in the kinetic resolution revealed 
excellent results, using various O-, N- and S- nucleophiles in the reaction. As oxygen-
nucleophiles both carboxylic acids and phenols could be employed. 
Phenol 70b as nucleophile afforded moderate yields both for the product (S)-71b and the 
recovered starting material (R)-69b, but the observed enantioselectivity was very high with ee 
values of 93% and 99%, respectively (entry 2, Table 29). Acetic acid 70a as nucleophile 
performed comparable in terms of yield and selectivity, only the yield of the recovered substrate 
(±)-69b was higher (entry 1, Table 29). When 1-naphtylcarboxylic acid 70c was employed as 
nucleophile, the same observation as before (entry 3–6, Table 28) with (±)-69a as starting 
material was made, i.e. reactions at rt led to a racemic product. In case of entry 4 (Table 29), 
the recovered starting material (R)-69b showed an ee of >99% despite the product was almost 
racemic. This outcome might be explained by a racemization process of the product (S)-71c  
occurring during the reaction at rt. Interestingly, the product (R)-71c was obtained in 43% ee at 
rt and a reaction time of 22 h (entry 3, Table 29). Nevertheless, at 0 °C (entry 5, Table 29) both 
substitution product (S)-71c and recovered starting material (R)-69b were obtained in almost 
quantitative yield and ee values of 90% for both compounds. In an equally successful way, 
para-bromobenzoic acid 70d could be employed as another carboxylic acid nucleophile (entry 
6, Table 29). In summary, for all the O-nucleophiles selectivity factors of 31 for acetic acid and 
over 40 for the other nucleophiles were calculated. Benzyl alcohol 124 did not show any 
conversion under the kinetic resolution conditions with (±)-69b.  
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Table 29: Kinetic resolution with O-nucleophiles.a 
 
Entry NuH t [h] T [°C] 
Recovered Starting Material Product 
Yield [%]b ee [%] Yield [%]b ee [%] sc 
1d 70a 1 0 46 96 35 90 31 
2 70b 2 0 34 99 34 93 44 
3 70c 22 rt - n.d. 33 43e 3 
4 70c 1 rt 21 >99 39 12 1 
5 70c 1 0 31 90 46 90 44 
6f 70d 1 0 44 95 41g 91g 41 
a) (±)-69 (0.5 mmol), 70 (0.24 mmol), Pd2(dba)3 (1.2 mol%, 2.3 mol% Pd based on the nucleophile), (R,R)-72 (3.7 
mol% based on the nucleophile) in DCM (2 mL); results by Tirayut Vilaivan. b) isolated yield. c) selectivity 
factor.118 d) absolute configuration of 71a was obtained by comparison of specific rotation value with literature 
(see Experimental Part). e) R-enantiomer. f) absolute configuration of 71d was obtained by comparison of specific 
rotation value with literature (see Experimental Part). g) 34%, 93% ee after single recrystallization from 
EtOH/H2O. 
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Displayed in the following scheme and table are the experiments conducted with various N-
nucleophiles. 
Table 30: Kinetic resolution with N-nucleophiles.a 
 
Entry NuH t [h] T [°C] 
Recovered Starting 
Material 
Product 
Yield [%]b ee [%] Yield [%]b ee [%] sc 
1d 70g 18 rt 31 >99 50 96 194 
2d 70g 1 0 44 94 49e 96e 163 
3d,f 70g 7 0 42 >99 48 96 146 
4 70j 1 rt 20 >99 43 55 5 
5 70j 23 0 44 57 39g 94g 60 
6 70k 18 rt 39 >99 32 1 1 
a) (±)-69 (0.5 mmol), 70 (0.24 mmol), Pd2(dba)3 (1.2 mol%, 2.3 mol% Pd based on the nucleophile), (R,R)-72 (3.7 
mol% based on the nucleophile) in DCM (2 mL); reactions in this table by Tirayut Vilaivan. b) isolated yield. c) 
selectivity factor.118 d) absolute configuration of 70g was determined by X-ray crystallography (see Figure 6 or 
Appendix). e) 36%, 99% ee after single recrystallization from EtOH. f) Pd2(dba)3 (0.575 mol%, 1.15 mol% Pd 
based on the nucleophile), (R,R)-72 (1.85 mol% based on the nucleophile). g) 33%, 95% ee after single 
recrystallization from EtOH/H2O. 
Here especially phthalimide 70g has to be pointed out, which showed exceptionally good results 
with selectivity factors of about 150–200 (entry 1–3, Table 30). Conveniently the reaction at rt 
also gave a quantitative yield and an ee of 96% concerning product (S)-71g, although the 
recovery rate for the starting material (R)-69b was higher in cases of lower temperature. 
Moreover, using only half of the catalyst gave the same excellent results. Boc-protected 
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tosylamine 70j as nucleophile provided only a moderate selectivity at rt, however, at 0 °C the 
ee of the product was 94% (entry 4 and 5, Table 30). In contrast when 3,5-dimethoxyaniline 
70k was used, the product (±)-71k was obtained as a racemic mixture and in moderate yield 
(entry 6, Table 30). However, the starting material (R)-69b was recovered in good yield and an 
excellent ee of >99%, which indicates a racemization of the product 71k during the reaction. 
The last class of nucleophiles investigated were S-nucleophiles which are described in more 
detail in the following scheme and table. Both benzylic and aliphatic thiols could be employed 
in the kinetic resolution. With benzylthiol 175 at 0 °C high yields were obtained but the 
enantioselectivity for both the product (S)-177 and the recovered starting material (R)-82 was 
only moderate. By decreasing the temperature to –78 °C the ee values were improved to 99% 
and 93%, respectively, while still obtaining a high yield. Also dodecylthiol 176 was employed 
in this reaction successfully with ee values over 90% for both the product (S)-178 and the 
recovered starting material (R)-82. 
Table 31: Kinetic resolution with S-nucleophiles.a 
 
Entry NuH t [h] T [°C] 
Recovered Starting 
Material 
Product 
Yield [%]b ee Yield [%]b ee sc 
1 70e 1 0 49 40 41 81 17 
2 70e 17 –78 33 >99 42 93 56 
3 70f 17 –78 38 92 39 93 50 
a) (±)-69 (0.5 mmol), 70 (0.24 mmol), Pd2(dba)3 (1.2 mol%, 2.3 mol% Pd based on the nucleophile), (R,R)-72 (3.7 
mol% based on the nucleophile) in DCM (2 mL); reactions in this table by Tirayut Vilaivan. b) isolated yield. c) 
selectivity factor. 118 
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2.4 Scale-Up Experiments 
To prove the practicability of the kinetic resolution for synthesis, two of the most effective 
nucleophiles were selected to perform a ten times scaled-up version of this reaction (5 mmol 
instead of 0.5 mmol of (±)-69b). 1-Naphtylcarboxylic acid 70c and phthalimide 70g both 
showed a high selectivity and yield on a small scale, and furthermore afforded nicely crystalline 
products allowing to improve the enantiomeric excess by recrystallization if necessary. 1-
Naphthylcarboxylic acid 70c was one of the best suited nucleophiles for this reaction (entry 5, 
Table 29) and the scale-up worked smoothly (Table 32). Here also the tendency was observed 
that lower temperatures are beneficial for achieving better enantioselectivities and yields. At –
20 °C the best results were obtained affording both the (R)-enantiomer of 4-BocO-2-
cyclopentenone (R)-69b as recovered starting material and (S)-enantiomer of 4-(1-
naphtylcarboxylic)-2-cyclopentenone (S)-71c in almost quantitative yields and ee values over 
99% (entry 3, Table 32). In this particular case the remarkably high value of 501 for the 
selectivity factor was calculated, which can only be achieved by a combination of exceptionally 
high ee values and excellent yields. 
Table 32: Kinetic resolution with 1-naphtylcarboxylic acid 71c as nucleophile.a 
 
Entry t [h] T [°C] 
Recovered Starting Material Product 
Yield [%]b ee [%] Yield [%]b ee [%] sc 
1 1 rt 34 >99 41d 48d 4 
2 1 0 44 >99 49e 86e 34 
3 4 –20 43 >99 45 >99 501 
a) (±)-69b (5 mmol), 70c (2.4 mmol), Pd2(dba)3 (0.5 mol%; 1 mol% of Pd based on the nucleophile), (R,R)-72 (2 
mol % based on the nucleophile). b) isolated yield. c) selectivity factor.118 d) 17%, 57% ee after single 
recrystallization from EtOH. e) 45%, >99% ee after single recrystallization from EtOH; [α]20D = +143.7. 
 
B. Main Part 
___________________________________________________________________________ 
71 
 
The upscaling of the reaction with phthalimide 70g went smoothly and gave equally good 
results as on a smaller scale (Table 33). The yields of both recovered starting material (R)-69b 
and the product (S)-71g were almost quantitative and an excellent ee value for (R)-69b of more 
than 99% and a good enantioselectivity for (S)-71g of 95% were observed. The ee of the product 
(S)-71g could be improved by recrystallization to 97%. 
Table 33: Kinetic resolution with phthalimide 70g as nucleophile.a 
 
t [h] T [°C] 
Recovered Starting Material Product 
Yield [%]b ee [%] Yield [%]b ee [%] sc 
16 rt 42 > 99 48d 95d 113 
a) (±)-69b (5 mmol), 70g (2.4 mmol), Pd2(dba)3 (0.5 mol%; 1 mol% of Pd based on the nucleophile), (R,R)-72 (2 
mol % based on the nucleophile); absolute configurations of 70g was determined by X-ray crystallography (see  
Figure 6 or Appendix). b) isolated yield. c) selectivity factor.118 d) 43%, 97% ee after single recrystallization from 
ethanol. 
 
 
 
 
 
 
Figure 6: Crystal structure of (S)-4-phthalimidylcyclopent-2-enone. 
The absolute stereochemistry was confirmed by x-ray crystallography to be the (S)-enantiomer. 
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2.5 Application for the Kinetic Resolution 
An application for the kinetic resolution was discovered in the field of the synthesis of 
carbocyclic nucleosides. These compounds are analogous to natural nucleosides with a 
methylene group replacing the oxygen in the carbohydrate ring. Two prominent representatives 
of this compound class are aristeromycin 146 and neplanocin A 147 (Scheme 48), two naturally 
occurring carbocyclic nucleosides. They both exhibit significant antitumor and antiviral 
activity, which is attributed to their inhibition of the enzyme S-adenosyl-L-homocysteine 
hydrolase.120 Less cytotoxic than the two latter compounds is the synthetic 5'-noraristeromycin 
73, which also shows antiviral behaviour and was first synthesized in 1992 by Schneller et al.121 
 
Scheme 48: Aristeromycin 146, neplanocin A 147 and 5'-noraristeromycin 73. 
Various syntheses of 5'-noraristeromycin 73 commence with the enantiomerically pure starting 
material (1R,4S)-4-hydroxycyclopent-2-en-1-yl acetate 148 (Scheme 49), or make use of 
enzymatic resolution methods122 with cis-1,3-acetoxy-2-cyclopentenone to achieve the 
preparation of enantiopure (1R,4S)-148.123,124,125 
The implementation of palladium-catalyzed allylic substitution to introduce the N-heterocycles 
in the synthesis of carbocyclic nucleosides is well-established (example in Scheme 
49),122,123,124,125,126 but to our knowledge a chiral catalyst was never used to induce 
enantioselectivity by this method in the molecule. 
 
Scheme 49: Pd-catalyzed allylic substitution with 6-chloropurine.125 
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By applying the method developed for the kinetic resolution of (±)-69b, a short formal synthesis 
of the other enantiomer of 5'-noraristeromycin (ent)-73 was established. Also (ent)-73, first 
synthesized by Schneller et al.,124b shows antiviral activity, in particular it is selectively active 
against the Hepatitis B virus, in which case 73 was proven to be inactive.126 On the other hand, 
73 shows, contrary to (ent)-73, significant activity against cytomegalovirus (CMV).124b 
Compound (ent)-73 can be synthesized from intermediate (S)-71h by literature known 
protocols, which comprise first the cis-selective reduction of the carbonyl-group of (S)-71h 
affording alcohol (1R,4S)-149.127 Aminolysis of the Cl-moiety gives amine (1R,4S)-150,125 
which can be subjected to selective dihydroxylation with osmium tetroxide resulting eventually 
in the desired product (ent)-73.124b 
  
Scheme 50: Formal synthesis of (ent)-noraristeromycin ent-73. 
The intermediate compound (S)-71h can be directly synthesized by kinetic resolution of 4-
BocO-2-cyclopentenone (±)-69b with the nucleophile 6-chloropurine 70h (Scheme 50). The 
great advantage over the other methods is the utilization of the inexpensive and readily available 
racemic starting material (±)-2a, which can be obtained from renewable resources. 
Furthermore, by switching the stereochemistry of the ligand access to both enantiomers of the 
product 73 could be enabled theoretically.  
The first two entries in Table 34 represent experiments conducted on a small scale with 0.5 
mmol of racemic 4-BocO-2-cyclopentenone (±)-69b as starting material. As the reaction at rt 
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only afforded the product (S)-71h with a moderate ee value of 76% (entry 1, Table 34), the 
temperature was decreased and at 0 °C appreciable results were obtained giving the product 
(S)-71h in 47% yield and 96% ee (entry 2, Table 34). To adapt the method to a synthetically 
more useful scale, the amount of starting material (±)-69b was increased to 5 mmol (entry 3 
and 4, Table 34). At 0 °C and 4 h of reaction time the ee of the product (S)-71h reached 94%, 
but the recovered starting material (R)-69b showed only 88% ee.  
Table 34: Kinetic resolution with 6-chloropurine 70h as nucleophile.a 
 
Entry t [h] T [°C] NaH 
Recovered Starting 
Material Product 
Yield [%]b ee [%] Yield [%]b ee [%] sc 
1 16 rt 1 equiv 46 >99 40d 76d 61 
2 4 0 1 equiv 47 >99 47 96 80 
3e 4 0 1 equiv 59 88 39f 94f 60 
4e 22 0 1 equiv 46 >99 46g 94g 80 
5 19 rt - 32 >99 47h 89h 41 
6e 19 rt - 45 96 46i 90i 44 
7e 24 0 - 47 98 46j 94j 80 
a) (±)-69 (0.5 mmol), 70 (0.24 mmol), Pd2(dba)3 (1.2 mol%, 2.3 mol% Pd based on the nucleophile), (R,R)-72 (3.7 
mol% based on the nucleophile) in DCM (2 mL). b) isolated yield. c) selectivity factor.118 d) 7%, 94% ee after 
single recrystallization from PE/EA. e) 5 mmol scale, Pd2(dba)3 (0.5 mol%; 1 mol% of Pd based on the 
nucleophile), (R,R)-72 (2 mol % based on the nucleophile). f) 27%, 99% ee after single recrystallization from 
PE/EA; [α]20D = -114.5. g) 40%, 98% ee after single recrystallization from PE/EA. h) 32%, 94% ee after single 
recrystallization from PE/EA. i) 31%, 94% ee after single recrystallization from PE/EA. j) 39%, 98% ee after 
single recrystallization from PE/EA. 
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The moderate ee value for (R)-69b in this case can be attributed to an incomplete conversion of 
only 41% (entry 3, Table 34). Prolonging the reaction time to 22 h led eventually to a full 
conversion with 46% yield and 94% ee of the product (S)-71h (entry 4, Table 34). Additionally, 
compound (S)-71h could be recrystallized to improve the ee up to 99%. By examining various 
literature reactions122,123,124,125,126 (compare Scheme 49), usually sodium hydride was employed 
in similar cases, which is the reason for the addition of sodium hydride in the first four reactions 
described in Table 34. However, because the other nucleophiles previously tested could be 
consistently used without a base and beyond that by using O-Boc as a good leaving group no 
basic conditions are required in many cases,105 the kinetic resolution without any additional 
base and 6-chloropurine 70h as nucleophile was examined. This attempt proved to be successful 
and the results were similar compared to the results with sodium hydride (entry 5–7, Table 34). 
Again the best results were obtained with a reaction scale of 5 mmol at 0 °C and 24 h of reaction 
time, leading to the product (S)-71h in 46% yield and 94% ee, which could be recrystallized to 
increase the ee to 98% (entry 7, Table 34). 
 
2.6 Dynamic Kinetic Asymmetric Transformation (DYKAT) 
The concept of dynamic kinetic resolution processes in general has been reviewed128,129 and it 
has been shown that resolution resulting in more than 50% of one enantiomer can be achieved 
by palladium-catalyzed allylic substitution.111,130,131,132 In this case it was defined as dynamic 
kinetic asymmetric transformation (DYKAT) by Trost, and depends on the interconversion 
(process F, Scheme 51) and different reactivity of intermediate diastereomeric species (process 
C or D faster, Scheme 51). As the dynamic kinetic pathway is superior in efficiency compared 
to the kinetic one, because the yield of one enantiomer could theoretically reach 100% ee 
instead of 50%, this approach was also investigated for compound (±)-69b. 4-Acetoxy-2-
cyclopentenone (±)-69a as the substrate did not provide sufficient results referring to yield and 
enantiomeric excess, therefore only the O-Boc-protected derivative (±)-69b was tested. The 
substrate was subjected to similar conditions as for the kinetic resolution, but 1 equivalent of 
the nucleophile was employed to ensure a possible full conversion of the starting material (±)-
69b. In none of the cases in Table 35 a dynamic pathway could be observed, which means either 
the yield stayed under a value of 50% or if higher a poor selectivity could be denoted. 
Nonetheless, except for HOAc 70a (entry 5, Table 35) and phthalimide 70g (entry 8, Table 35) 
the reactions went to completion, which means the amount of nucleophile applied was 
consumed after the specified reaction time. 
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Table 35: Attempted dynamic asymmetric transformation (by Tirayut Vilaivan).a 
 
Entry NuH t [h] Yield [%]b ee [%] 
1 70b 19 h 63 25 
2 2-Naphth-OH 17 h 68c n.d. 
3 2,4-Cl2C6H3OH 21 h 31 n.d. ([α]20D = +6.8) 
4 70a 3 d 48d 69 
5 70a 3 d 29e n.d. ([α]20D = –2.8) 
6 BzOH 3 h 76 10 ([α]20D = –10.1)f 
7 70c 16 h 64 11 
8 70g 18 h 46g,h 68 
a) (±)-69b (0.5 mmol), 70 (0.5 mmol, 1 equiv), Pd2(dba)3 (0.5 mol%, 1 mol% Pd), (R,R)-72 (2 mol%) in DCM (2 
mL), reactions in this table by Tirayut Vilaivan. b) isolated yield. c) contains ~10% of inseparable impurities. d) 
incomplete reaction, the starting material 69b was recovered in 29% yield, [α]22D = +85.0 (22 °C, c = 1.60, CHCl3; 
>99% ee). e) using [Pd(allyl)Cl]2 as the source of Pd(0). f) (R)-isomer, lit. [α]22D of (S)-4-benzoyloxy-2-
cyclopenten-1-one (99% ee) = –147.9 (c = 0.40, CHCl3).133 g) incomplete reaction, both 69b and phthalimide were 
still present after overnight reaction. h) [α]23D = –218.8 (c = 0.82, CHCl3) after single recrystallization from EtOH. 
By looking more closely at entry 8 (Table 35) the conversion was not complete and only 46% 
of the product 71g could be isolated, which is about the value as for the kinetic resolution (the 
results for the same conditions but half the amount of nucleophile applied are 50% and 96% ee, 
entry 1, Table 30). Thus the only difference in this case is the amount of nucleophile employed 
which makes the ee drop from 96% to 68%, which can be explained by a greater availability of 
nucleophile and consequently a faster reaction and lower enantioselectivity. Nevertheless, most 
of the other nucleophiles gave complete conversion so this should be possible with phthalimide 
70g as one of the superiorly performing nucleophiles in the kinetic resolution. Moreover, either 
lower temperatures will possibly improve the enantioselectivity or the successive addition of 
70g to the reaction mixture can prevent a too high concentration of nucleophile. Therefore, this 
reaction was revised again and initially the feasibility of converting all the starting material (±)-
69b was examined, which was the case after 3 d of stirring at rt and using 1 equivalent of 
nucleophile 70g (entry 1, Table 36). The product (S)-71g could be isolated in 86% yield with 
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an ee value of 41%. It contained some impurities which predominantly consisted of the 
cyclopentadienone dimerization product 79. After one recrystallization step the clean product 
(S)-71g was obtained in 65% yield and 69% ee, which implies that 55% of the S-enantiomer 
was formed. Every value over 50% yield of one enantiomer is an indication of an occurring 
dynamic pathway of resolution. Using ten times the amount of catalyst (entry 2, Table 36) 
decreased the reaction time to 2 h and gave the product (S)-71g in 92% and 34% ee. Also in 
this case the same impurities have been observed, but to a greater extent, and recrystallization 
gave the pure product (S)-71g in 54% yield and 42% ee (38% S-enantiomer) which means that 
no occurrence of a dynamic kinetic resolution could be stated. A problem in this reaction might 
be the formation of a greater amount of side-product leading to a lower yield of product (S)-
71g. Reduction of the reaction temperature to –15 °C with 0.5 mol% Pd-catalyst and 1 mol% 
ligand gave after 13 d only about 50% conversion judging from NMR (entry 3, Table 36). No 
further analysis of this reaction was done, but it is conceivable that the catalyst suffered after 
the elongated time from a loss in efficiency. By increasing the amount of catalyst by the factor 
of ten and maintaining the reaction temperature at –15 °C a full conversion could be reached 
after 13 d (entry 4, Table 36). An annotation has to be made that in this particular case after 12 
d an additional equivalent and 0.5 mol% Pd and 1 mol% of ligand were added because the 
conversion seemed to be not complete and a possibly decomposed catalyst should be replaced. 
The enantiomeric excess of the reaction was with 90% almost in the range achievable with the 
kinetic resolution conditions and also the yield proved to be satisfying (84%). The problem with 
the impurity remained, which was solved by two consecutive recrystallizations (1. 77% yield 
and 93% ee, 2. 67% and 95% ee). As the reaction went to completion (entry 4, Table 36) after 
the addition of some more catalyst, because presumably the catalyst was not active any more 
after prolonged time, it was added stepwise in the next reaction (entry 5, Table 36). The results 
were almost the same as for the latter reaction except the ee was slightly lower. As the increase 
of nucleophile 70g resulted in very low enantiomeric excess (entry 8, Table 36), it was 
examined if a slower addition of nucleophile 70g could enhance the ee. A stepwise addition by 
syringe pump failed because of the poor solubility of phthalimide 70g in DCM. Therefore, it 
was added to the reaction mixture by hand in several steps. In the first step slightly less than 
0.5 equiv were added which should give the same values as for the kinetic resolution (entry 1, 
Table 30), and then the rest was given to the solution stepwise. 
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Table 36: Dynamic kinetic resolution attempts.a 
 
Entry NuH 
Pd2(dba)3 
[mol%] 
Ligand 
[mol%] t T [°C] Yield [%]b ee [%] 
1 70g 0.5 1 4 d rt 86c 41 
2 70g 5 10 2 h rt 92d 34 
3 70g 0.5 1 13 d –15 n.d. n.d. 
4e 70g 5 10 13 d –15 84f 90 
5g 70g 3x0.5 3x1 12 d –15 88h 74 
6i 70g 0.5 1 5 d rt 86j 52 
7k 70g 0.5 1 7 d rt 61 57 (R) 
8 70b 2x0.5 2x1 15 d – 15 72 34 
9 70c 2x0.5 2x1 10 d –15 86 3 
a) (±)-69b (0.5 mmol), 70 (0.5 mmol, 1 equiv), in DCM (2 mL). b) isolated yield. c) some impurities; 65%, 
69% ee after single recrystallization from PE/EA. d) some impurities; 54%, 42% ee after single 
recrystallization from PE/EA. e) additional equiv of nucleophile and 0.5 mol% Pd and 1 mol% ligand 
added after 12 d. f) some impurities; 77%, 93% ee after single recrystallization from PE/EA, still some 
impurities; 67%, 95% ee after second recrystallization from PE/EA. g) catalyst added after 7 d and 11 
d. h) some impurities; 70%, 82% ee after single recrystallization from PE/EA. i) nucleophile added 
stepwise. j) some impurities; 73%, 69% ee after single recrystallization from PE/EA. k) (R)-69b used.  
The results are slightly better than for the same reaction in which the nucleophile 70g was added 
at once. The clean product (S)-71g could be isolated after recrystallization with a yield of 62% 
of the S-enantiomer (entry 6, Table 36). Furthermore, when (R)-69b was employed as the 
starting material, 61% of the substituted product (R)-71g could be isolated with an ee value of 
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57% (entry 7, Table 36). Therefore, it can be concluded that part of the (R)-enantiomer can 
indeed be converted to the (S)-enantiomer, assuming that no racemization of the product (S)-
71g took place (unlikely because the product was isolated in the kinetic resolution experiments 
with excellent ee). Experiments with phenol 70b as nucleophile showed a low enantioselectivity 
(entry 8, Table 36) and 1-naphtylcarboxylic acid 70c gave only a racemic product (entry 9, 
Table 36), presumably because of racemization of the product 71c.  
A dynamic kinetic process involves racemization of either the starting material (R)-69b or the 
π-allylpalladium intermediate. As the recovered starting material always showed an 
exceptionally high ee value, the assumption can be made that no racemization of the starting 
material took place (process E, Scheme 51). Racemization of the π-allylpalladium complex has 
to take place otherwise the enhanced ee could not be explained. If this process was slower than 
the attack of the nucleophile, the product obtained would be racemic. Therefore, slowing down 
the rate of the nucleophilic attack is beneficial. In the case of phthalimide the poor solubility of 
this nucleophile might be advantageous because it dissolved gradually in the course of the 
reaction and therefore only a low concentration of nucleophile was present in the solution. 
 
Scheme 51: Reaction pathways of allylic substitution. 
That can also explain the low ee in the case of phenol (entry 1, Table 35), because it dissolved 
immediately in the reaction solution. Moreover, the results show that probably the catalyst 
decomposes after prolonged reaction times, because when additional catalyst was added after 
days of no significant conversion, the reaction was completed rapidly.  
To see whether the results were influenced by any background reactions, (±)-82 and the 
nucleophile were mixed without the addition of any catalyst or ligand (Table 37). A reaction 
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like a substitution at C4 or a 1,4-addition and elimination is conceivable. In the case of 
phthalimide 70g, no reaction was observed even when heated in the microwave at 300 W (entry 
1–4, Table 37). The addition of sodium hydride was required to give poor to moderate yields 
of 71g (entry 5–7, Table 37), which is compatible with either substitution or an 
addition/elimination sequence. Furthermore, minor amounts of compound 151 could be 
isolated, which is only explicable by an addition/elimination mechanism with a subsequent 
isomerization of the double bond.134 Also substantial amounts of the cyclopentadienone dimer 
79 were isolated. 
 
Scheme 52: By-product entry 5 Table 37. 
1-Naphthylcarboxylic acid 70c and NaOAc as substrates did not lead to any reaction (entry 11–
18, Table 37). The successful reactions of phenol 70b were again limited to the cases when 
NaH was employed (entry 21 and 22, Table 37) and were accompanied by 79 in a significant 
quantity. The only case of an observable reaction of (±)-69b without sodium hydride as additive 
and one of the nucleophiles applied previously in the kinetic resolution was with benzyl thiol 
70e (entry 23, Table 37), though the reaction was rather slow. As a conclusion, a substitution 
or 1,4-addition as a background reaction under the employed conditions of the dynamic kinetic 
resolution experiments can be excluded for the nucleophiles tested except for 70e. 
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Table 37: Investigation of background reactions.a 
 
Entry NuH Baseb T [°C] MW P [W]c MW pmax [bar]c t Yield [%]d 
1 70g - rt - - 5 d 0 
2 70g - reflux - - 5 d 0 
3 70g - 91 150 5 10 min 0 
4 70g - 113 300 9 10 min 0 
5 70g NaH rt - - 12 d 21e 
6 70g NaH reflux - - 12 d 44f 
7 70g NaH 110 variable 11 1 h 58g 
8 70g Na2CO3 rt - - 4 d 0 
9 70g Na2CO3 reflux - - 2 d 0 
10 70g Na2CO3 109 300 10 10 min 0 
11 70c - rt - - 5 d 0 
12 70c - reflux - - 5 d 0 
13 70c - 94 300 6 10 min 0 
14 70c NaH rt - - 5 d 0h 
15 70c NaH reflux - - 5 d 0 
16 NaOAc - rt - - 5 d 0 
17 NaOAc - reflux - - 22 h 0 
18 NaOAc - 105 300 7 10 min 0 
19 70b - rt - - 5 d 0 
20 70b - reflux - - 20 h 0 
21 70b NaH rt - - 5 d 34i 
22 70b NaH rt - - 2 d 46j 
23 70e - rt - - 40 d 32k 
a) (±)-69b (0.25 mmol), 70 (0.25 mmol, 1 equiv), in DCM (2 mL). b) 1 equiv. c) parameters for microwave 
reaction. d) isolated yield. e) plus 20% of cyclopentadienone dimerization product 79 and 9% 151 and 40% starting 
material cyclopentenone 69b. f) plus 30% starting material cyclopentenone (±)-69b. g) plus 30% starting material 
cyclopentenone (±)-69b. h) traces of cyclopentadienone dimerization product 79. i) plus 65% of 
cyclopentadienone dimerization product 79, complete conversion. j) plus 35% of cyclopentadienone dimerization 
product 79, complete conversion. k) 44% starting material (±)-69b recovered. 
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2.7 Conclusion 
In summary, a successful kinetic resolution of (±)-69b via Pd-catalyzed asymmetric allylic 
substitution has been demonstrated. Excellent enantioselectivities of both substitution products 
and recovered starting materials were obtained even at low catalyst loading (1 mol% Pd, 2 
mol% ligand). The scope of participating nucleophiles is very broad - phenols, carboxylic acids, 
thiols and nitrogen-containing heterocycles. This method provides a certainly useful access to 
an extensive variety of enantiomerically pure 4-substituted-2-cyclopentenone derivatives, 
particularly because the reaction could be performed on a synthetically useful scale. 
Additionally, this methodology was applied to achieve a short formal synthesis of (+)-
noraristeromycin ent-73. Moreover, experiments on a conceivable dynamic pathway have been 
conducted, which came to the conclusion that a dynamic kinetic resolution was possible to a 
limited extent with phthalimide 70g. However, this did not prove to be practical in a synthetic 
perception due to the long reaction times required. 
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3. Cyclopentenone from Furfuryl Alcohol 
3.1 Introduction 
Another approach for the conversion of 4-hydroxy-2-cyclopentenone (±)-2a into valuable 
building blocks addresses the problem already mentioned in the first chapter: The continuous 
flow method for the rearrangement, developed by our group,28 requires a dilute aqueous 
solution which causes a highly energy-consuming work-up by evaporating the water from the 
reaction mixture. Extraction with an organic solvent is no alternative as (±)-2a is fairly water-
soluble. The challenge was to completely circumvent the evaporation of water by performing a 
subsequent reaction directly in the aqueous solution obtained from the continuous flow system, 
to transform 4-hydroxy-2-cyclopentenone (±)-2a into another compound that offers a lower 
water-solubility. Another aspect was to find reaction conditions that could be implemented in 
a continuous flow-system that follows the initial rearrangement process. 
 
Scheme 53: One-pot reaction sequence to convert furfuryl alcohol 1g to cyclopentenone 105. 
The transformation into 2-cyclopentenone 105 offers a reasonable solution to this problem, as 
105 is less water-soluble than the starting compound (±)-2a. Moreover, if all the reactions 
leading to this compound could be performed in an aqueous environment just with the aid of a 
catalyst, only water as by-product should be formed and no additional organic waste would be 
created. Hence the overall process would be obviously valuable in an ecological perception. As 
described in chapter 1.1, 4-hydroxy-2-cyclopentenone (±)-2a was available by the 
rearrangement in the continuous flow system developed in our group in a concentration of about 
25 g/L in water.28 The next step would consist of hydrogenation of the double bond to yield 3-
hydroxycyclopentanone (±)-152, which would thereupon afford via elimination of the hydroxy-
moiety 2-cyclopentenone 105. This compound is less water-soluble (but still miscible with 
water at any ratio)135 than the starting material (±)-2a and can be simply extracted with a low-
boiling organic solvent which can be evaporated without using large amounts of energy. 
Cyclopentenone 105 itself is a valuable building block in chemistry (e.g. for prostaglandins)136 
and is produced on a large scale in industry. 
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Aim of this project was to use the aqueous solution of 4-hydroxy-2-cyclopentenone (±)-2a 
coming directly from the microreactor system to develop useful conditions to follow-up this 
process. The catalysts employed in this one–pot reaction sequence had to be suited for the 
aqueous environment and feasible for the subsequent implementation of this reaction in a 
continuous flow system. In fact, there is a description of a 2-cyclopentenone 105 multistep 
synthesis from furfuryl alcohol 1g in a US patent,137 and a similar approach was used to find 
suitable reaction conditions subsequent to the continuous flow rearrangement process and to 
develop a one-pot-reaction procedure. While working on this project three other 
publications31,32 appeared dealing with the synthesis of cyclopentanone 32 and cyclopentanol 
33 from furfuryl alcohol 1g or furfural 13 via a hydrogenation process in a high temperature 
aqueous solution (>30 bar H2, >140 °C), wherein 4-hydroxy-2-cyclopentenone (±)-2a and 2-
cyclopentenone 105 are intermediates. Under the therein described conditions it was not 
possible to identify 2-cyclopentenone 105 as a product, but instead a high selectivity for 
cyclopentanone 32 and cyclopentanol 33 was observed.  
 
3.2 Hydrogenation of (±)-4-Hydroxy-2-Cyclopentenone in Water 
For the hydrogenation reaction a transition metal catalyst like palladium or platinum was 
selected. The metal catalysts on solid supports like activated carbon or Al2O3 form a 
heterogeneous system with water that ensures their easy removability afterwards by simple 
filtration.  
 
Scheme 54: Hydrogenation of (±)-4-hydroxy-2-cyclpentenone in water. 
Hydrogenation of the double bond of (±)-2a with hydrogen gas at atmospheric pressure and 
Pd/C as catalyst proved to be promising. Either in MeOH or in H2O the product (±)-152 could 
be isolated in moderate yields (Table 38). The conversion was always complete concluding 
from the crude NMR spectra. Cyclopentanone 32 was observed as a by-product but not isolated, 
causing the drop in yield. As a consequence more favorable reaction conditions were required 
with a higher selectivity for 2-cyclopentenone 105. 
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Table 38: First attempts of hydrogenation (1 atm H2).a 
Entry Catalyst  Solvent t [h] Yield [%]b 
1 Pd/C MeOH 19 36 
2 Pd/C H2O 18 53 
                      a) (±)-2a (10 mmol), Pd/C 10% (0.14 mol% Pd). b) isolated yield. 
In the following experiments a study on suitable catalysts, reaction time and hydrogen pressure 
was performed to identify the optimal conditions for improving the yield of the reaction. The 
screening of different catalysts was performed in an autoclave with 5 bar hydrogen pressure for 
15 min (Table 39, Figure 7). In these experiments the crude reaction mixture produced from the 
continuous flow reactor was used. A typical reaction consisted of 10 mL of aqueous mixture 
with a concentration of 25 g/L 4-hydroxy-2-cyclopentenone (±)-2a in water. The concentrations 
of starting material (±)-2a and product 152 in the reaction before and after the hydrogenation 
were determined by GC with 1,4-butanediol as internal standard. In terms of selectivity and 
conversion the Pd catalysts on activated carbon and alumina performed best with almost 
complete conversion and a high yield of the hydrogenated hydroxycyclopentanone 152 within 
the applied reaction time (Table 39, entry 1 and 3). The carbon balance observed is high with 
about 90% and no occurrence of more than trace amounts of cyclopentanone 32 could be 
denoted. The remaining loss is attributed to several unidentified side products, presumably from 
resinification, which becomes more severe at higher temperatures.31,32 
Table 39: Screening of different catalysts.a 
Entry Catalyst Conversion [%]b Yield [%]b Selectivity [%] 
1 Pd/C 10% 98 84c 86 
2 Pt/C 10% 73 39d 54 
3 Pd/Al2O3 5% 97 89c 92 
4 Pd(OH)2/C 10–20% 32 19c 59 
a) (±)-2a (10 mL 25 g/L in H2O, 2.55 mmol), catalyst (0.15 mol% Pd or Pt), H2 (5 bar), 15 min, rt. b) determined 
by GC with internal standard (1,4-butanediol). c) by-product cyclopentanone 32 (traces). d) by-product 
cyclopentanone 32 (~10%). 
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Pd(OH)2/C as catalyst showed a three times lower conversion of the starting material (±)-2a as 
the other palladium catalysts, and moreover, the selectivity was low with various unidentifiable 
side products (Table 39, entry 4). The platinum on charcoal catalyst performed also 
unsatisfactory with a slightly higher conversion but very low selectivity caused by the further 
hydrogenation of the double bond in 2-cyclopentenone 105, leading in this case to about 10% 
of cyclopentanone 32 (Table 39, entry 2). 105 was formed by the elimination of the hydroxy 
group in the product (±)-152.  
Interestingly, the other publications31, 32 mentioned that the selectivity for cyclopentanone 32 
was very high at the elevated temperatures applied (> 140 °C), and 2-cyclopentenone 105 as 
product was not observed unless a limited amount of hydrogen was used. It can be concluded 
that at higher temperatures the elimination of the hydroxy-moiety in 3-hydroxycyclopentanone 
(±)-152 took place and that lower reaction temperatures allowed a high selectivity for (±)-152. 
 
Figure 7: Catalyst screening (Table 39, 5 bar H2, 15 min, rt, 0.15 mol% catalyst). 
As Pd/C proved to be a suitable catalyst for the hydrogenation at room temperature in water, 
optimization of this reaction system was carried out. The following charts were created using 
the results gained from experiments with the crude mixture from the continuous flow system. 
For a typical experiment 10 mL of an aqueous solution with a concentration of approximately 
25 g/L 4-hydroxy-2-cyclopentenone (±)-2a were applied, and the exact concentration was 
determined by GC before calculating conversion and yields. 0.15 mol% of palladium on 
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charcoal was employed with a hydrogen pressure of 5 bar. The yield of the hydrogenation 
product 3-hydroxy-2-cyclopentanone (±)-152 was plotted as a function of time. 
 
Figure 8: Yield/conversion as a function of time ((±)-2a (10 mL 25 g/L in H2O, 2.55 mmol)). 
The conversion was complete under these conditions after 15 minutes and yields of around 80% 
could be achieved with reaction times of 15–20 minutes. A shorter duration (≤ 10 min) at 5 bar 
was not sufficient to convert all the starting material. Within the specified reaction times no 
significant emergence of cyclopentanone 32 was observed. The yield and conversion were 
determined as before by GC using an internal standard. In the next step the effects of different 
pressures on yield and conversion were examined. Again the aqueous solution from the 
continuous flow system was used directly. 
With a reaction time of only 2.5 minutes different hydrogen pressures were tested with 
0.15 mol% of palladium on charcoal. The yield of 3-hydroxy-2-cyclopentenone (±)-152 and the 
conversion of the starting material 4-hydroxy-2-cyclopentenone (±)-2a as a function of pressure 
were plotted. 20 bar of hydrogen pressure sufficed to bring the conversion of the starting 
material (±)-2a to completion within 2.5 min. Yields of about 80-85% could be achieved with 
20 and 40 bar pressure. Cyclopentanone 32 as a side product was only observed in trace amounts 
(< 1%). The catalyst could be simply filtered off after the reaction was finished.  
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Figure 9: Yield/conversion as a function of pressure ((±)-2a (10 mL 25 g/L in H2O, 2.55 
mmol)). 
A scale-up of the hydrogenation reaction to a synthetically more valuable dimension of 10 
mmol (~ 1g (±)-2a) could also be performed in the autoclave (Table 40). Presumably because 
of a more unfavorable volume to surface ratio in the autoclave (40 mL of reaction mixture), for 
a full conversion of starting material (±)-2a the reaction time had to be increased to 35 min. In 
the first 15 min only about 50% conversion was observed, in contrast to the 10 mL reaction 
scale where this time was sufficient for a full conversion. However, after evaporation of the 
solvent and Kugelrohr distillation the product (±)-152 could be isolated in 72%. 
Table 40: Upscaling of the hydrogenation of (±)-2a.a 
Entry t [min] Conversion [%]b Yield [%] 
1 15 ~50 n.d. 
2 35 >95 72c 
             a) (±)-2a  (40 mL 25 g/L in water, 10 mmol), Pd/C 10%  (0.15 mol% Pd), H2 (5 bar). b) deter- 
                mined approximately by GC without internal standard. c) isolated yield after Kugelrohr   
                distillation. 
In comparison with the US patent137 mentioned above, the hydrogenation was performed in a 
greatly reduced reaction time (from 3 h described in the patent to minimally 2.5 min) and the 
reaction can be performed on a synthetically useful scale. Moreover, it can be directly applied 
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to the solution produced by the continuous flow process developed in our group.28 An 
implementation in a subsequent continuous flow system was already successfully tested (Peter 
Kreitmeier, Reiser group, University of Regensburg) using the commercially available system 
H-Cube Pro (ThalesNano Nanotechnology Inc.). 
 
3.3 Elimination of the Hydroxy Group 
In the publications previously mentioned,31,32 the elimination of the hydroxy group took already 
place under the therein described hydrogenation conditions (>30 bar H2, >140 °C in water), 
which resulted in cyclopentanone 32 or cyclopentanol 33 as the main products. Therefore, to 
afford 2-cyclopentenone 105 from alcohol (±)-152, the elimination can be carried out 
conveniently at elevated temperatures without applying hydrogen in water. 
 
Scheme 55: Elimination of the hydroxy group of (±)-152. 
Initially, experiments were carried out using the previously isolated starting material 3-
hydroxy-cyclopentanone (±)-152 (Table 41). An acid catalyst (HCl and in the other instance 
the acidic ion exchanger Amberlyst XN1010) or no catalyst at all was employed. The acidic ion 
exchange resin had the advantage of being easily removable and potentially applicable in a 
continuous flow system. Both catalysts gave the desired product in about 60% yield (entry 1 
and 2, Table 41). Even by heating the aqueous solution without any additional catalyst, the 
hydroxy group could be eliminated, though very slowly.  
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Table 41: Elimination reactions using conventional heating.a 
Entry Catalyst t T [°C] Yield [%]b 
1c HCl 15 min 70 57 
2d Amberlyst XN1010 4 h 70 61 
3 - 8 h 100 16e 
                     a) (±)-152 (1 mmol), H2O (4 mL), c = 25 g/L. b) isolated yield. c) pH = 1. d) (±)-152  
                       (0.4 mmol), Amberlyst XN1010 (20 mg), H2O (2 mL). e) conversion not complete. 
Therefore, the conduction of the elimination reaction in a closed vessel under microwave 
irradiation was considered, as this allows to heat the solvent over the boiling point at 
atmospheric pressure. Alcohol (±)-152 was dissolved at a concentration of 25 g/L in water and 
then subjected to the conditions described in Table 42.  
Table 42: Reaction under microwave irradiation.a 
Entry t [min] max T [°C] Yield [%]b 
1 5 180 44 
2 2x5 180 77 
3 10 180 63 
4 15 180 66 
                    a) (±)-152 (1 mmol), H2O (4 mL), c = 25 g/L MW: 300 W, closed  
                      pressure vessel. b) isolated yield.  
To avoid exceeding the pressure limitation of the microwave (CEM Discover), a temperature 
limit was set at 180 °C at which the power was regulated to maintain the temperature. A reaction 
time of 5 min did not lead to a full conversion of the starting material (±)-152 (entry 1, Table 
42), but in 10–15 min at 180 °C in the microwave yields up to 77% and full conversion was 
achieved (entry 2–4, Table 42). No plausible explanation could be given for the discrepancy in 
yields in entry 2 and 3. 
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3.4 One-Pot-Procedure Rearrangement/Hydrogenation/Elimination 
The previous experiments proved that the hydrogenation step and the elimination step could be 
performed individually, and moreover the hydrogenation step was successfully combined with 
the rearrangement in the continuous flow system. The final task in this project comprised the 
development of a one-step procedure without any additional work-up between the 
rearrangement, hydrogenation and elimination besides the filtration step to dispose of the 
catalyst. The concentration of compound (±)-2a was measured by GC before the hydrogenation 
was carried out (Pd/C, 5 bar H2, 15 min) and the catalyst was filtered off afterwards. The acidic 
ion-exchange resin Amberlyst XN1010 was added and the solution heated to 90 °C. After the 
specified periods of time the yield of 2-cyclopentenone 105 was determined via GC. 
 
 
Conditions: a) 1g (25 g/L in H2O), continuous flow system.50 b) 10 mL, H2 (5 bar), Pd/C 10% (0.15         
                     mol% Pd), rt, 15 min. c) 4 mL, Amberlyst XN1010 150 mg, 90 °C (yield/conversion      
                     determined via GC with internal standard (1,4-butanediol)). 
Figure 10: Elimination reaction of one-pot-procedure. 
B. Main Part 
___________________________________________________________________________ 
92 
 
The data is displayed in the graph in Figure 10 as yield of 2-cyclopentenone 105 and the 
conversion of 3-hydroxycyclopentenone (±)-152 as a function of time. The yield is based on 
the starting concentration of 4-hydroxy-2-cyclopentenone (±)-2a. Within 20 minutes of reaction 
time full conversion and a yield of 70% were achieved, whereas longer reaction times decreased 
the yield of the product 105. 
 
3.5 Conclusion 
Reaction conditions were developed to convert 4-hydroxy-2-cyclopentenone (±)-2a in the 
aqueous solution from the continuous flow system into the less water-soluble 2-cyclopentenone 
105 in a hydrogenation/elimination sequence. The hydrogenation step was optimized with a 
Pd/C catalyst to afford (±)-152 in 80–85% yield. The elimination step could be performed either 
by conventional heating with an acid catalyst or by heating in a microwave oven to provide the 
product 105 in up to 77% yield. It was confirmed that all the reactions could be performed in a 
one-step procedure in direct continuation to the continuous flow process in water leading to an 
overall yield of 70%. The conditions are suitable for implementation in a subsequent continuous 
flow process following the rearrangement of 1g to (±)-2a. 
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4. Investigation of the Piancatelli Rearrangement of HMF/BHMF in the Microwave 
4.1 Introduction 
The lignocellulosic feedstock provides also possibilities for the production of other furan 
derivatives. As furfuryl alcohol 1g and furfural 13 are synthesized from the hemicellulosic part 
containing pentoses, 5-hydroxymethylfurfural (HMF) 154 can be accessed by the cellulosic 
fraction (which consists of the hexose glucose). Acid catalyzed dehydration provides the 
desired compound 154 starting from various hexoses such as glucose or fructose 153.51 Two 
different mechanisms are proposed in literature describing the conversion of hexoses to HMF 
154.138 The first one proceeds via an open-chain sequence of dehydrations of the sugar molecule 
(Scheme 56).  
 
Scheme 56: Open-chain mechanism for HMF 154 generation.138 
The second mechanism involves the closed-ring structures in the dehydration process (Scheme 
57). 
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Scheme 57: Closed-ring mechanism for HMF 143 generation.138 
The reduction of HMF 154 affords bis-(2,4-hydroxymethyl)furan (BHMF) 155, another 
interesting furan derivative. In the following chapters, the reactivity of HMF 154 and BHMF 
155 in a microwave heated subcritical aqueous medium was explored, paying particular focus 
on the Piancatelli type rearrangement. 
 
4.2 Synthesis of 5-Hydroxymethylfurfural (HMF) and 2,5-Bis(hydroxymethyl)furan 
(BHMF)  
The two furan derivatives HMF 154 and BHMF 155 were synthesized following literature 
known methods (Scheme 58).139,140 Heating D-fructose 153 in a DMSO/THF solvent mixture 
with the acidic ion exchanger Amberlyst 15 afforded HMF 154 in 56% yield following the 
procedure of Rauchfuss et al.139 
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Scheme 58: Synthesis of HMF 154 and BHMF 155. 
Reduction of HMF 154 with NaBH4 provided BHMF 155 in 79% yield as a white solid that 
could be effectively recrystallized from chloroform.140 
 
4.3 HMF under microwave irradiation in subcritical aqueous medium 
The concept of microwave-assisted reactions of furan derivatives in water was investigated 
further to ascertain if similar rearrangement processes as with α-furylcarbinols could be 
observed with HMF 154 or compounds directly derived from it. Therefore, at first HMF 154 
was heated in the microwave in an aqueous medium to temperatures between 133–240 °C 
(Table 43).  
Table 43: HMF 154 in water under different microwave conditions.a 
 
Entry c [g/L] V [mL] P [W] t [min] Tmax [°C] pmax [bar] Yield [%] 
1b  25 1 300 10 133 3 0 
2b  25 1 300 30 - - 0 
3c 28 1 50–150 10 200 13 0 
4c 27 1 50–250 10 240 29 0 
a) closed pressure vessel.  b) CEM Discover, Pmax = 300 W, pressure limitation 17 bar. c) 
Anton-Paar Monowave 300, Pma x = 850 W, pressure limitation 30 bar.  
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Initially, 1 mL of an aqueous solution with a concentration of 25 g/L HMF 154 was heated in 
the CEM Discover microwave at 300 W (maximum power) for 10 minutes. Under these 
conditions the reaction mixture reached a temperature of 133 °C, but no conversion was 
observed (entry 1, Table 43).Prolonging the reaction time from 10 to 30 minutes did not result 
in any conversion, although the temperature was presumably higher (entry 2, Table 43, 
unfortunately the microwave did not record the reaction parameters in this instance). To use 
more forcing conditions the Anton Paar Monowave 300 microwave was used. It is limited to 
30 bar instead of 17 bar as the CEM device, permitting higher reaction temperatures. First HMF 
154 was heated up to 200 °C for 10 minutes, then to 240 °C for 10 minutes which seemed to be 
the maximum which was achievable (entry 3 and 4, Table 43, almost 30 bar pressure were 
reached under these conditions). However, even despite these high temperatures only starting 
material 154 could be recovered. The absence of any conversion was confirmed by NMR and 
by the quantitative reisolation of HMF 154. 
In literature, reactions of HMF 154 in subcritical water at significantly higher temperatures are 
described where various products were observed (Scheme 59). However, to obtain one of these 
compounds temperatures over 290 °C were required,141,142 which is evidently beyond the range 
of values achievable with the herein described microwave devices. 
 
Scheme 59: Products from reaction of HMF 154 in subcritical water.141,142 
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An explanation for the absent reactivity in the rearrangement reaction can be deduced from 
contemplating the mechanism, which postulates initially a leaving of the OH-group after its 
protonation. The electron withdrawing nature of the aldehyde moiety on the other side of the 
ring might inhibit this type of reaction. To reduce its electron withdrawing effect the protection 
of the aldehyde moiety of HMF 154 with ethylene glycol to provide the acetal was considered. 
The acetal was synthesized following a literature known procedure (Scheme 60).143 Starting 
from acetylated HMF 161 which was reacted with ethylene glycol using a Dean-Stark apparatus 
the acetal 162 was obtained, which gave after deacetylation the desired product 163.  
  
Scheme 60: Synthesis of HMF ethylene acetal. 
Compound 163 was subjected to microwave irradiation in an aqueous medium for 10 min at 
300 W. However, the acetal was not stable and before losing the hydroxyl-group the aldehyde 
functionality on the other side of the ring reformed. Consequently, only HMF 154 could be 
reisolated quantitatively.  
 
4.4 Microwave-assisted Piancatelli Rearrangement of BHMF in subcritical water 
Since HMF 190 reacted rather disappointing in the microwave even under forcing conditions, 
its reduction product, the bis-alcohol BHMF 155, was examined. The unreactive behaviour in 
the rearrangement reaction due to the electron-withdrawing effect of the aldehyde moiety as in 
HMF 154 should thereby be omitted. In fact, compound 155 exhibits one OH-group on each 
side of the furan ring which has the potential to be protonated and depart as leaving group to 
initiate the rearrangement. Interestingly, no literature evidence has been found dealing with the 
Piancatelli rearrangement of BHMF 155. In view of the increasing interest in using renewable 
resources the conversion of BHMF 155 into the substituted cyclopentenone (±)-164 by this 
method would be an attractive straightforward procedure. 
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Scheme 61: Piancatelli rearrangement of BHMF 155 in water. 
Considering the mechanism of the rearrangement (Scheme 62), product (±)-164 should be 
expected. This structural motif can be found in different biologically active natural products 
isolated from marine organisms. In ascidians from the family of the Didemnidae, precisely the 
species Lissoclinum sp. and Diplosoma sp., compounds 165–168 in the former and compounds 
165, 166, 169 and 171–174 in the latter, have been found. Compounds 165 and 166 were 
significantly cytotoxic against the HCT116, A431 and A549 cancer cell lines, and compounds 
167, 168, 170, 171/172 and 174 revealed cytotoxicity against the cell lines HCT116 and 
A431.144 
 
Figure 11: Natural products containing the structural motif of cyclopentenone 164.144_____ 
For the rearrangement reaction of BHMF 155, at first the optimized conditions for this reaction 
with furfuryl alcohol 1g in the microwave were applied (Table 13).28 BHMF 155 at a mass 
concentration of approximately 25 g/L in water was irradiated in the microwave (CEM 
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Discover) in a 10 mL closed pressure vessel. The first reaction conducted at 300 W and 5 
minutes reaction time reached a maximum temperature of 146 °C, but no conversion of the 
starting material 155 was observed (entry 1, Table 44). A higher reaction temperature was 
considered as the rearrangement did not occur as smoothly as with furfuryl alcohol 1g, which 
already reacts at temperatures of 100 °C (Table 13).28 Since 300 W indicates the power limit of 
the CEM device, longer reaction times had to be applied for reaching higher temperatures to 
force the rearrangement to occur (temperature increase becomes slower at higher values). This 
led to a maximum temperature of 195 °C after 23 minutes which was eventually sufficient to 
allow a reaction to take place (entry 2, Table 44). The resulting complex mixture could not be 
separated efficiently. Additionally the reaction volume was on a small scale (1 mL), but 
nevertheless it included the desired product judging from NMR measurements.  
Table 44: Conditions for the rearrangement reaction of BHMF 155 in the microwave (CEM).a 
 
a) closed pressure vessel. b) in parentheses: manually adjusted reaction time; outside parentheses: actual 
reaction time (caused by switching-off due to excessive pressure development). c) isolated yield. d) 
some impurities. 
Entry c [g/L] V [mL] Power [W] Tmax [°C] pmax [bar] t [min]b Yield [%]c 
1  33 1 300 146 7 5 0 
2  25 1 300 195 17 23 (30) - 
3  50 1 300 188 17 14 (20) 59d  
4  25 10 300 199 18 1.54 (30) 0 
5  25 10 variable 185 14 21 60d 
6 21 10 variable 181 12 12 67 
7 25 10 variable 182 12 7 59 
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An enhancement of the concentration to 50 g/L BHMF 155 in water resulted again in a mixture 
which could not be separated completely due to significant generation of by-products. 
Nevertheless, the desired product of the reaction could again be observed in the NMR spectra 
(entry 3, Table 44). To render the separation more facile and to still have the benefit of low 
concentrations (higher concentrations in this rearrangement reaction ordinarily favor the 
development of more side products), a larger reaction volume of 10 mL in a 35 mL reaction 
vessel was chosen (entry 4, Table 44). Applying again 300 W (maximum energy input for this 
microwave), the reaction stopped automatically after less than 2 minutes because the 
temperature reached rapidly almost 200 °C and the pressure exceeded the microwave´s pressure 
limitations (17 bar, CEM discover). Therefore, a temperature limit was set at 180 °C to prevent 
the pressure to excel the safety value. This approach proved to be successful and the next 
reaction could be conducted for about 20 min leading to 60% yield of the product (entry 5, 
Table 44). Unfortunately, the product was still contaminated with several side products that 
could not be separated. Reduction of reaction time should probably reduce the formation of side 
products, and this assumption was confirmed as shown in entry 6 and 7 (Table 44), where the 
clean product (±)-164 could be isolated in 67% and 59% yield.  
There is no literature evidence concerning the particular rearrangement of 155 to (±)-164, but 
a publication describing the hydrogenation of HMF 154 at high temperatures (160 °C, 4 h, 
40 bar H2) in water over a Ni-Cu bimetallic catalyst describes the observation of BHMF 155 as 
hydrogenation product. Therefore, BHMF 155 was exposed to 160 °C in water for a prolonged 
time. They could not observe any rearrangement products or hydrogenation products of 155 
under the described conditions, thus a temperature over 160 °C is apparently required to achieve 
this transformation. 
Piancatelli proposed a mechanism for the rearrangement of α-furylcarbinols,1 and a slightly 
adapted version concerning the different substitution pattern is proposed in Scheme 62. It shows 
that protonation of the hydroxy group of α-furylcarbinol 155 leads to the expulsion of a water 
molecule forming oxocarbenium ion B/C. On the other side of the furan ring where the second 
hydroxymethyl moiety is situated a water molecule can attack as nucleophile. After a 
prototropic shift and ring opening intermediate G undergoes a 4π-conrotatory electrocyclic ring 
closure which leaves one hydroxy group and the hydroxymethyl moiety on the same carbon 
atom of the newly formed racemic carbocyclic compound (±)-164. 
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Scheme 62: Mechanism of Piancatelli rearrangement of BHMF. 
 
4.5 Synthesis of BHMF Derivative 
As the rearrangement of BHMF 155 was successful, another objective was to use a different 
derivative of BHMF 155 to evaluate its behavior when subjected to similar conditions and to 
find a conceivable application. A derivative containing an ethyl substituent adjacent to one of 
the hydroxy functionalities was synthesized (Scheme 63). Starting again from D-fructose 153 
HMF 154 was synthesized as before.139 The free hydroxy group was protected with TBDMSCl 
to provide 175 in 89% yield. This compound was then subjected to a Grignard reaction with 
EtMgBr to afford (±)-176 in 89% yield. Almost quantitative deprotection led to the desired 
product (±)-177. 
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Scheme 63: Synthesis of BHMF derivative (±)-177. 
The inefficiency regarding the atom economy of this reaction sequence utilizing the 
protection/deprotection method with the bulky TBDMS-protecting group could be avoided by 
using 2 equivalents of EtMgBr without any protection of the hydroxy functionality. This 
resulted in the desired product (±)-177 directly from HMF 154 in 65% yield and in 2 steps from 
D-fructose 153. 
 
Scheme 64: Alternative route to BHMF derivative (±)-177.______ 
 
4.6 Piancatelli Rearrangement of 1-(5-(Hydroxymethyl)furan-2-yl)propan-1-ol  
BHMF derivative (±)-177 was exposed to a high temperature aqueous environment under 
microwave irradiation to study its rearrangement. Full conversion was detected with a small 
scale reaction of 1 mL with 33 g/L concentration of starting material (±)-177 in water in 30 
minutes of reaction time, leading to a maximum temperature of 187 °C (entry 1, Table 45). In 
the crude NMR spectra a diastereomeric mixture of compound 178 was observed, however, 
only one diastereomer could be isolated after column chromatography. This may be due to 
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isomerization on the column at the C5 carbon. The diastereomeric ratio could not be determined 
because of overlapping signals in the NMR. Increasing the reaction volume to 6 mL with a 
concentration of 25 g/L led to a lower maximum temperature, but the conversion was still 
complete after 20 or 30 minutes affording the product in 67% or 74% yield, respectively (entry 
2 and entry 3, Table 45).  
Table 45: Rearrangement of (±)-177 in the microwave (CEM, P = 300 W).a 
 
Entry c [g/L] V [mL] max T [°C] max p [bar] t [min] Yield [%]b 
1 33 1 187 13 30 30 
2 25 6  133 4 20 67 
3 25 6  144 5 30 74  
         a) closed pressure vessel. b) isolated yield, one diastereomer after column chromatography. 
At temperatures exceeding 180 °C a significant loss of material could be stated, observed as a 
solid black material at the surface of the glass vials used. Concluding from the mechanism 
(Scheme 65) and observations in other publications, typically the substituent in 5-position and 
the OH-group formed exclusively a trans-relation on the ring (in some cases as the major 
diastereomer),145,61 therefore it was assumed that the diastereomer with trans-configuration 
concerning the ethyl- and the hydroxy-moiety was also the major product in this particular case. 
In own experiments on substituted furfuryl alcohols also the trans-isomer was the major 
product, however, the minor isomer could not be isolated on column chromatography, 
presumably due to isomerisation.61 
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Scheme 65: Mechanism of Piancatelli rearrangement of BHMF derivative (±)-177. 
 
4.7 Formal Synthesis of Phytoprostane B1 Type II 
As application for this reaction a one-pot hydrogenation/elimination sequence in aqueous 
solution ensuing the rearrangement of (±)-177 can be utilized to obtain intermediate 179, which 
is used in the synthesis of phytoprostane B1 type II (S,E)-180 (Scheme 66). The obvious 
advantage of this method is the use of renewable starting materials and a straightforward 
synthetic procedure. Any difficulties with the separation of diastereomeric mixtures of products 
in the rearrangement reaction could be omitted by this strategy by simply converting trans-178 
and cis-178 into intermediate 179, which can be further transformed by two literature known 
steps146 into PPB1 type II (S,E)-180. 
 
Scheme 66: PPB1 type II from compound 178 (final 2 steps literature known).146___ 
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Phytoprostanes147,148 are like the isoprostanes149,150,151 a family of compounds known as 
biomarkers for oxidative stress from the free radical catalyzed peroxidation of polyunsaturated 
fatty acids (Scheme 67). Unlike the 20 carbon containing isoprostanes which derive from 
arachidonic acids and occur in mammals, the phytoprostanes are produced from α-linolenic 
acids in plants and constitute an 18 carbon scaffold. They have presumably a possible function 
of a plant defense mechanism in response to oxidative stress.152 PPE1 and PPF1 were described 
by Parchmann and Mueller147 in 1998 and Imbusch and Mueller152 in 2000 and the 
phytoprostanes A1 and B1 type I 186 and type II 180 by Mueller in 2003.150 Zanoni et al. 
reported the first synthesis of phytoprostane A1
153
 and Spur et al. published the synthesis of 15-
E2-isoP(PPE2).
154 Phytoprostanes F1 were first synthesized by Durand et al.
155  
 
 
B. Main Part 
___________________________________________________________________________ 
106 
 
 
Scheme 67: Phytoprostane pathway from α-linolenic acid.147 
Up to now 4 methods appeared in literature to synthesize the natural products PPB1 186 and 
180. The first synthetic procedure (Scheme 68) appeared in 2005 published by Durand and co-
workers, providing both enantiomers of the phytoprostanes B1 of type I 186 and II 180 in 
enantiomerically pure form.156 Type I compound 186 was synthesized starting from furfural 13 
in 11 steps and 5.3% overall yield. For PPB1 type II 180 they used the furan derivative 2-
propylfuran 187 which they obtained commercially as starting material, but the synthesis is 
rather tedious (all in all 9 steps with 8.3% overall yield, Scheme 68). 
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Conditions: a) DMF (1.3 equiv), POCl3 (1.1 equiv), 70 °C, 3 h, 75%. b) HC(OMe)3 (1.6 equiv), p-
TsOH (0.014 equiv), MeOH, 0 °C – rt, 2 h, 93%. c) Na2CO3 (1.5 equiv), Br2/MeOH (2.25 M, 1.05 
equiv), –30 °C, 2 h. d) citric acid (0.1 N), Na2HPO4, dioxane, 55 °C, 2 h. e) Na2HPO4 (0.2 N), 75 °C, 2 
h, 75% after three steps. f) H2, Pd/C 10% (3% Pd), MeOH, 30 min. g) HCl 3% in MeOH, 20 °C, 3 h, 
69% after two steps. h) HCl (1 N), THF, rt, 5 h. i) LiHMDS (1 M in THF, 1.9 equiv), THF, –78 °C, 20 
min, 23% after two steps. 
Scheme 68: Synthesis of PPB1 type II according to Durand et al.156 
n-Propylfuran 187 was subjected to a Vilsmeier formylation leading to aldehyde 188, which 
was protected subsequently with trimethyl orthoformate under acidic conditions to yield 189. 
Oxidation of the furan ring led to bis-acetal 190, which underwent ring opening under acidic 
hydrolytic conditions. Ring closure was achieved by treatment with base providing 
cyclopentenone 192. Hydrogenation of 192 followed by dehydration and hydrolysis gave 
aldehyde 195, which could be coupled with phosphonium salt (S)-196 to yield the desired 
product (S,E)-180. 
In 2006 a protocol for synthesizing phytoprostanes B1 type I 186 and II 180 was published by 
Boland et al. wherein the very straightforward method provides the products in racemic form.157 
The starting material for the type II synthesis, 197, was commercially available (Scheme 69). 
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Conditions: a) PPh3 (1.125 equiv), I2 (1.125 equiv), Et3N (1.1 equiv), CH3CN, 24 h, 77%. b) 
CH2CHCH(OTHP)R2 (1.67 equiv), Et3N (2 equiv), Pd(OAc)2·2 PPh3, 24 h, 100 °C. c) HOAc/THF/H2O, 
45 °C, 20 h, 69%. 
Scheme 69: Synthesis of PPB1 type II according to Boland et al.157 
The vinyliodine 198 was prepared from vinylalcohol 197 by iodination with I2 and PPh3 in 
acetonitrile. The side chain was introduced by a Heck type alkylation to give 199 which was 
deprotected to afford the free alcohol 180.  
The third example was published by Mikolajczyk et al. and appeared in 2009. It describes the 
synthesis of phytoprostane B1 type I 186 in both of its enantiomerically pure forms in 25% 
overall yield (Scheme 70).158 
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Conditions: a) NaH (1 equiv), DMSO, 45%. b) DBU (2 equiv), LiClO4 (1 equiv), 78%. c) MeOH, 
K2CO3 (1 equiv), 70-75%. 
Scheme 70: Synthesis of PPB1 type I according to Mikolajczyk et al.158 
Alkylation of cyclopentenone 200 with bromide 201 afforded compound 203 which could be 
further coupled in a Horner reaction with aldehyde 202. Methanolysis of the ester 204 gave the 
desired free alcohol 186. 
The fourth and last example describes the synthesis of PGB1, PPB1 type I 186 and II 180 and 
was also published in 2009 by Verdaguer and Riera et al. (Scheme 71).146 In the synthetic 
procedure intermediate 179 appears which could be obviously synthesized from the 
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rearrangement product 178 by hydrogenation and elimination which all can be theoretically 
performed in a one-pot-process in water.  
 
Conditions: a) TBDMSCl, 91%. b) Co2(CO)8 (1.8 equiv), CH2CH2, 6 bar, DCM, 4 Å MS, NMO (6.7 
equiv), rt, 67%. c) HF·pyr, 0 °C, quant. d) (COCl)2 (2 equiv), DMSO, Et3N, DCM, 75%. e) LiHMDS 
(1.9 equiv), THF, 23%. 
Scheme 71: Synthesis of PPB1 type II according to Verdaguer and Riera et al.146 
In the publication by Verdaguer and Riera (Scheme 71), commercially available pent-2-yn-1-
ol 205 was protected as the tert-butyldimethylsilyl ether 206. The key step of the synthesis 
consisted of a Pauson-Khand reaction to generate the cyclopentenone core structure and 
providing compound 207 which could be deprotected to free alcohol 179. Oxidation to the 
aldehyde 208 and coupling with the phosphonium salt (S)-209 afforded the desired product 
PPB1 type II (S,E)-180. Despite the conciseness of the synthesis the drawback of using 
stoichiometric amounts of Co2(CO)8 persists. This disadvantage can be eliminated by preparing 
intermediate 179 by the previously mentioned synthesis from HMF 154.  
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Initially, the hydrogenation of cyclopentenone 178 was examined (Table 46) to find the most 
suitable reaction conditions for this step. Under high pressure conditions (20 bar H2, Pd/C) 
complete conversion of 178 was observed, providing the product 179 in 37% yield. Under these 
conditions, not cyclopentanone 210 but the product 179 was isolated, hence the elimination of 
the hydroxy group of intermediate 210 already took place (entry 1, Table 46). To prevent side 
reactions, like the hydrogenation of the double bond in 179 which could explain the low yield, 
the reaction was conducted at lower pressures. Hydrogenation at ambient pressure gave full 
conversion after 24 h, but in this case the elimination of the hydroxy group was not observed 
as in entry 1. However, intermediates 210 could not be isolated, as on column chromatography 
partially elimination occurred and a mixture of 210 and 179 was obtained. Therefore, after 
hydrogenation of 178 the resulting mixture was heated for 2 h in the presence of an acidic ion 
exchange resin prior to work-up, which proved to be successful and afforded the product 179 
in 48% yield (entry 2, Table 46). 
Table 46: Hydrogenation of rearrangement products 178.a 
 
Entry Pd/C [mol%] p [bar] t  Yield [%]b 
1  1 20 15 min 37 
2  0.46 1 24 h 48c 
                           a) 178 (0.4 mmol), H2O (5 mL). b) isolated yield. c) after hydrogenation refluxed 
                           for 2 h with Amberlyst XN1010 (60 mg).                    
As the hydrogenation step turned out to be successful, the final task comprised the 
rearrangement/hydrogenation/elimination one-pot sequence. The reaction was performed as 
before with 25 g/L of α-furylcarbinol (±)-177 in water, which first was exposed to subcritical 
conditions under microwave irradiation and then subjected to palladium catalyzed 
hydrogenation without work-up in between. 
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The first reaction (entry 1, Table 47) was performed in the Anton-Paar Monowave 300 
microwave device, therefore the reaction parameters deviate from the previously reported ones 
(Table 45). After the rearrangement under microwave irradiation, the resulting solution was 
subjected hydrogenation conditions at 20 bar, which resulted in 19% of the desired product 179. 
As stated before the elimination of the hydroxy moiety under the described conditions could be 
observed.  
Table 47: One-pot rearrangement/hydrogenation/elimination.a 
 
Entry 
         Rearrangement (MW)             Hydrogenation 
Yield [%] 
T [°C]  P [W]  p [bar]  t [min]   p [bar]  t [min] 
1b  170 variable 10 10  20 15 19d 
2c 137 300 5 20  1 18 h 20d,e  (31)f 
3c,g 142 300 5 30  1 20 40d 
 a) (±)-177 (25 g/L in water, 1 mmol), Pd/C 10% (0.43 mol% Pd). c) Anton-Paar Monowave 300. c) CEM 
Discover. d) isolated yield. e) plus additionally a mixture of product 179 and compound 210 as a diastereomeric 
mixture. f) heating the rest of the isolated material which is not the product 179 with Amberlyst XN1010 gives 
additional 11% yield of product 179. g) before work-up refluxed for 2 h with Amberlyst XN1010.                  
Considering that the hydrogenation under high pressure afforded very complex mixtures, 
hydrogenations at atmospheric pressure were examined (entry 2, Table 47). After the 
rearrangement, this time with the optimized conditions for the CEM device, the reaction 
mixture was subjected to hydrogenation conditions at atmospheric pressure to provide the 
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product 179 in 20% yield and additionally an inseparable combination of the product and 
presumably intermediates 210 as diastereomeric mixture after column chromatography. It can 
be concluded from those observations that a partial elimination of the hydroxy moiety had 
occurred, probably during the purification step. Nonetheless, it was considered to increase the 
yield by subjecting the isolated rest with the mixture of alcohols 210 to conditions promoting 
the elimination. This was demonstrated by heating the rest of the isolated material with acidic 
ion exchanger in water, which afforded another 11% of the desired product 179. Therefore, this 
step was included in the reaction sequence (entry 3, Table 47), leading to compound 179 with 
a yield of 40%. Compared to the synthesis of Riera et al. (Scheme 71),146 which afforded 60% 
of the product 179 in overall yield, the herein described procedure can provide intermediate 179 
starting from HMF 154 in 2 steps (26% overall yield). Despite the lower yields, this strategy 
possesses the advantage of reducing waste by eliminating any protection group chemistry and 
the usage of stoichiometric amounts of Co2(CO)8. Moreover, the second step requires solely 
water as solvent and produces only water as a by-product. 
 
4.8 Conclusion 
HMF 154 could not be converted at all under the applied conditions, nevertheless BHMF 155 
underwent a Piancatelli rearrangement in water at high temperatures to yield the respective 
carbocycle (±)-164 in good yield. The utilized conditions made the use of any additional 
additives besides water unnecessary. The BHMF derivative 1-(5-(hydroxymethyl)furan-2-
yl)propan-1-ol (±)-177 was employed successfully in the same type of rearrangement and the 
carbocyclic product 178 could be further exploited to achieve a short and facile formal synthesis 
of phytoprostane B1 type I 180. This was achieved by preparing intermediate 179 from HMF 
154 in 2 steps and 26% yield. 
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5. Tests for Biological Activity 
5.1 Compounds 
Selected compounds of the 4-substituted cyclopentenone class were tested for their in vitro 
cytotoxic and anti-inflammatory activity (data kindly provided by Hannelore Rücker, group of 
Dr. Sabine Amslinger, University of Regensburg). Cytotoxicity tests were carried out by using 
an MTT assay159 and the anti-inflammatory properties were determined by analyzing the nitrite 
production in a Griess assay.160 The compounds (±)-4-hydroxy-4-(hydroxymethyl)cyclopent-
2-enone (±)-164, (±)-tert-butyl(4-oxocyclopent-2-en-1-yl) carbonate (±)-69b, (S)-4-
oxocyclopent-2-en-1-yl 1-naphthoate (S)-71c, (±)-methyl(4-oxocyclopent-2-en-1-yl) carbonate 
(±)-69c, (±)-4-((tert-butyldimethylsilyl)oxy)-cyclopent-2-enone (±)-211, (S)-2-(4-
oxocyclopent-2-en-1-yl)isoindoline-1,3-dione (S)-71g, (S)-4-(6-chloro-9H-purin-9-
yl)cyclopent-2-enone (S)-71h and (±)-4-oxocyclopent-2-en-1-yl acetate (±)-69a were 
investigated.  
 
Figure 12: Compounds tested for cytotoxicity and anti-inflammatory activity. 
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5.2 Cytotoxicity Test 
The cytotoxicity of the specified compounds (Figure 12) was determined via MTT assay against 
the murine macrophage cell line RAW264.7 at the three different concentrations of 100 μM, 
10 μM and 1 μM. The MTT assay is a colorimetric method by which the cell viability can be 
evaluated by determining the mitochondrial function of living cells on the basis of their ability 
to reduce the yellow dye, tetrazolium salt 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium 
bromide (MTT), into violet formazan by the mitochondrial dehydrogenases. The percentage of 
living cells can then be deduced by the amount of formazan formation, which can be measured 
by a spectrophotometer. The cell viability is illustrated by the following diagram (Figure 13) as 
indicator of the examined compounds’ cytotoxicity. In this context a higher cell viability value 
for the respective substance denotes a lower cytotoxicity. 
 
Figure 13: Cytotoxicity tests. 
At the highest test concentration of 100 μM, for all compounds except (S)-71g less than 10% 
viability of the cells was measured, hence a significant cytotoxicity at this concentration can be 
asserted. Compound (S)-71g in contrast showed with slightly more than 60% only a moderate 
cytotoxicity. The cell viability for the compounds (±)-69b, (±)-69c, (±)-211, (S)-71h and (±)-
69a at the medium concentration of 10 μM was still on a considerable low level (20-30%). 
Compounds (±)-164 and (S)-71c showed a moderate viability with about 70-80% and 
compound (S)-71g featured no activity at all at this concentration. All examined compounds 
did not exhibit any cytotoxic activity at the lowest concentration of 1 μM.  
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Conclusively, the concentration of 1 μM was designated for the measurement of the anti-
inflammatory activity in the following test (Griess-assay). As for the activity test a cell viability 
of 80% is intended, no cytotoxic activity at this concentration should be present and therefore 
the concentration of 1 μM was suited best. 
 
5.3 Anti-Inflammatory Activity 
In order to determine the anti-inflammatory activity of the specified compounds, the inhibition 
of the pro-inflammatory protein iNOS (inducible NO synthase) was measured by determining 
the nitrite production in LPS-stimulated RAW264.7 cells. This method works by adding LPS 
(lipopolysaccharide) to the cell cultures which induces the protein expression of iNOS in RAW 
cells. NO-synthases catalyze the production of nitric oxide from L-arginine, which plays a role 
in inflammatory processes.161 Nitrite accumulation in the culture medium was used as an 
indicator of nitric oxide production in the macrophages. A lower value of nitrite compared to 
control cells implies a higher iNOS-inhibition and hence a higher anti-inflammatory activity of 
the compound. To evaluate the nitrite production the Griess assay was employed and the 
acquired data is displayed in the following diagram (Figure 14).  
 
Figure 14: Influence on NO production (Griess assay). 
The vast majority of the compounds ((±)-69b, (S)-71c, (±)-69c, (S)-71g, (S)-71h, (±)- 69a) 
showed only moderate to diminutive inhibition of iNOS and therefore a low or no anti-
inflammatory activity, deducible from values of about 60% to 90% of the reference. However, 
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compound (±)-164 even appears to have a pro-inflammatory activity as the value of 116% 
suggests. The exception from the mostly moderate active examples made compound (±)-211, 
showing an exceedingly high inhibition of iNOS (28% of the reference NO-production), which 
means it has a rather high anti-inflammatory activity. 
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C. Summary 
In the first chapter, an application for 4-hydroxy-2-cyclopentenone (±)-2a on the basis of 
cycloaddition reactions was investigated. The main task to produce benzoic acid by Diels-Alder 
reactions with cyclopentadienone 76 and a suitable dienophile was not accomplished, however, 
the dimerization product 79 was observed. Adduct 79 could be synthesized from 4-acetoxy-2-
cyclopentenone (±)-69a in a facile procedure with decent yields (path a/b, Scheme 72). The 
dimerization adduct 79 can be utilized to prepare another aromatic compound, 1-indanone 81, 
by decarbonylation. Oxidations of 4-hydroxy-2-cyclopentenone (±)-2a and subsequent Diels-
Alder reactions under sustainable conditions were not accomplished, only the oxidation with 
MnO2 in DCM was successful (path e, Scheme 72). 
In the second chapter, a successful kinetic resolution of protected (±)-2a via Pd-catalyzed 
asymmetric allylic substitution has been demonstrated. Excellent enantioselectivities of both 
substitution products and recovered starting materials were obtained even at low catalyst 
loadings (1 mol% Pd, 2 mol% ligand). The scope of participating nucleophiles is very broad - 
phenols, carboxylic acids, thiols and nitrogen-containing heterocycles could be applied. This 
method provides a potentially useful access to a variety of optically active 4-substituted-2-
cyclopentenone derivatives. Moreover, a short formal synthesis of noraristeromycin ent-85 via 
kinetic resolution was developed (path d, Scheme 72). 
The third chapter explicates the conversion of 4-hydroxy-2-cyclopentenone (±)-2a, directly in 
the aqueous solution obtained from the continuous flow system developed by Reiser et al., into 
the less water-soluble 2-cyclopentenone 105 via a hydrogenation/elimination sequence. It was 
confirmed that all the reactions could be performed in a one-pot procedure. The conditions are 
suitable for implementation in a continuous flow process subsequent to the rearrangement of 
1g to (±)-2a, which was already accomplished for the hydrogenation step (path c, Scheme 72). 
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Scheme 72: Overview of furfuryl alcohol 1g applications. 
The forth chapter covers the Piancatelli rearrangement of BHMF 155, a derivative thereof and 
its application in the formal synthesis of a phytoprostane. Whereas HMF 154 could not be 
converted at all under the applied conditions, BHMF 155 underwent a Piancatelli rearrangement 
in water at high temperatures to yield the respective carbocycle (±)-164 in good yield. The 
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applied conditions made the use of any additives besides water unnecessary. The BHMF 
derivative 1-(5-(hydroxymethyl)furan-2-yl)propan-1-ol (±)-177 was employed in the same type 
of rearrangement successfully and the carbocyclic product 178 was further exploited to achieve 
a short and facile formal synthesis of the phytoprostane B1 type I (S,E)-180. 
 
Scheme 73: Overview HMF 154 applications. 
The last chapter contains the testing of several cyclopentenone derivatives on cytotoxicity and 
anti-inflammatory activity. The test results show that only compound (±)-211 exhibits a high 
anti-inflammatory activity, whereas the other compounds showed moderate to low activity. 
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D. Experimental 
1. General comments 
All reagents of which the preparation is not described were obtained from commercial suppliers 
and used without further purification. All reactions were carried out in oven dried glassware 
under atmospheric conditions unless otherwise stated. DCM and THF were taken from a 
MBraun MB SPS solvent purification system. In case of the Pd-catalyzed allylic substitutions 
DCM was degassed by three freeze-pump-thaw cycles. Hexanes and EA for chromatographic 
separations were distilled prior to usage. Furfuryl alcohol 1g was distilled and cyclopentadiene 
cracked prior to its use. Analytical thin layer chromatography was carried out on Merck TLC 
aluminium sheets silica gel 60 F 254. Visualization was accomplished with UV light (254 nm) 
and vanillin sulfuric acid solution followed by heating. Column chromatography was performed 
using Merck silica gel 60 (70-230 mesh ASTM).  
 
1H- and 13C-NMR:  
NMR spectra were recorded using a Bruker Avance 300 (300 MHz for 1H and 75 MHz for 13C) 
and Bruker Avance 400 (400 MHz for 1H and 101 MHz for 13C). Chemical shifts are reported 
in ppm from internal CHCl3 (7.26 ppm) as standard on the δ scale. Multiplicity (s = singlet, d 
= doublet, t = triplet, dd = doublet of doublet, ddd = doublet of doublet of doublet, td = triplet 
of doublet, tdd = triplet of doublet of doublet, dtd = doublet of triplet of doublet and m = 
multiplet), integration, coupling constant (Hz) and assignment of peaks are given in 
parentheses. 13C chemical shifts are reported in ppm from internal CHCl3 (77 ppm) as standard 
on the δ scale. The 13C signals were assigned with the help of DEPT 90 and DEPT 135. The 
assignment of the signals is given in parentheses. 
 
Melting points: 
Melting points were measured on a Büchi SMP-20 apparatus in a silicon oil bath or on a SRS 
MPA 100 OptiMelt. Values thus obtained were not corrected. 
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Mass spectrometry: 
High resolution mass spectra (HRMS) were recorded on a Varian MAT 311A, Finnigan MAT 
95, Thermoquest Finnigan TSQ 7000 or Agilent Technologies 6540 UHD Accurate-Mass Q-
TOF LC/MS mass spectrometer at the Central Analytical Department (University of 
Regensburg). 
 
IR spectroscopy: 
ATR-IR spectroscopy was carried out on a Biorad Excalibur FTS 3000 spectrometer, equipped 
with a Specac Golden Gate Diamond Single Reflection ATR-System. 
 
Optical rotation: 
The optical rotation was determined in a Perkin Elmer 241 polarimeter at 589 nm wavelength 
(sodium-d-line) in a 1.0 dm measuring cell of ca. 2 mL volume. 
 
HPLC: 
High performance liquid chromatography was carried out using Varian 920-LC with PDA and 
a for each compound specified chiral stationary phase (Phenomenex Lux Cellulose-1, Chiralcel 
AS-H, Chiralcel OJ-H). 
 
GC: 
Gas chromatography was performed on a Fisons GC 8000 with a DBWAX (30 m, 0.25 mm Di, 
0.25 μm film) column with helium at 150 mbar as carrier gas and flame ionization detector. 
 
Microwave: 
For the microwave reactions a CEM Discover S-Class or an Anton-Paar Monowave 300 
microwave were used with either 10 mL or 35 mL closed vessels. 
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Autoclave: 
For hydrogenation reactions a 100 mL stainless steel autoclave with an insertable glass vial, 
external hydrogen gas tank, manual control of hydrogen-pressure by a valve and integrated 
magnetic stirring was used.  
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2. Synthesis of compounds 
 
2.1 Cycloaddition Approach 
 
(±)-4-hydroxy-2-cyclopentenone (2a) 
 
 
 
The compound was prepared according to a literature protocol.28,61 The spectroscopic data is in 
accordance with literature.162 The data is also related to chapter 2.2 (Enantioselective Synthesis 
of 4-Heterosubstituted Cyclopentenones), chapter 2.3 (Cyclopentenone from Furfuryl Alcohol) 
and chapter 2.5 (Tests for Biological activity). 
Colorless oil. Rf = 0.13 (PE/EA 1:1). GC (DBWAX, 100 °C to 200 °C (10 °C/min), 200 °C (10 
min)): tR = 14.1 min (1,4-butanediol as internal standard, tR = 10.5 min). 
1H-NMR (300 MHz, 
CDCl3): δ = 2.16 (dd, 1H, J = 18.6, 2.1 Hz, CH2) 2.65 (dd, 1H, J = 18.6, 6.0 Hz, CH2), 4.13 (bs, 
1H, OH), 4.94 (m, 1H, CHOH), 6.10 (dd, 1H, J = 5.6, 1.2 Hz, CH=CH-C=O), 7.52 (dd, 1H, J 
= 5.6, 2.3 Hz, CH=CH-C=O). 13C-NMR (75 MHz, CDCl3): δ = 44.2 (CH2), 70.1 (CHOH), 
134.7 (CH=CH-C=O), 164.6 (CH=CH-C=O), 207.9 (C=O). 
 
(±)-4-acetoxy-2-cyclopentenone (69a) 
 
The preparation was carried out according to a literature procedure.103 The data is also related 
to chapter 2.2 (Enantioselective Synthesis of 4-Heterosubstituted Cyclopentenones) and chapter 
2.5 (Tests for Biological activity). (±)-Hydroxy-2-cyclopentenone 2a (500 mg, 5.1 mmol, 1.0 
equiv) was cooled down to 0 °C in 5 mL of dry DCM under N2. To the cold solution 0.8 mL 
dry pyridine (786 mg, 10 mmol, 2.0 equiv) was added and the solution was stirred for 10 min. 
Then 0.72 mL Ac2O (778 mg, 7.62 mmol, 1.5 equiv) was added dropwise at 0 °C. The resulting 
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solution was stirred for 15 h at rt. Cold diluted HCl was added to the reaction mixture and the 
organic layer was washed four times with a 1:4 mixture of brine and dilute HCl solution, 
followed by washing with cold water, 10% sodium bicarbonate solution and brine. The organic 
layer was dried over MgSO4 and concentrated under vaccuum. The crude product was subjected 
to column chromatography (SiO2, PE/EA 5:1) to afford the pure product in 71% yield (507 mg, 
3.62 mmol, lit. 80%).103 The spectroscopic data is in accordance with literature.163  
White solid. Rf = 0.70 (PE/EA 2:1). 
1H-NMR (300 MHz, CDCl3): δ = 2.06 (bs, 3H, CH3), 2.28 
(dd, 1H, J = 18.7, 2.1 Hz, CH2), 2.79 (dd, 1H, J = 18.7, 6.4 Hz, CH2), 5.81 (m, 1H, CHOH), 
6.29 (dt, 1H, J = 5.7, 1.4 Hz, CH=CH-C=O), 7.53 (dd, 1H, J = 5.7, 2.4 Hz, CH=CH-C=O). 13C-
NMR (75 MHz, CDCl3): δ = 20.9 (CH3), 41.0 (CH2), 71.9 (CHOH), 137.0 (CH=CH-C=O), 
159.0 (CH=CH-C=O), 170.4 (O-C=O), 204.9 (C=O). 
 
endo-3a,4,7,7a-tetrahydro-1H-4,7-methanoindene-1,8-dione (79) 
 
(±)-4-Acetoxy-2-cyclopentenone 69a (96 mg, 0.685 mmol, 1.0 equiv) was dissolved in 20 mL 
of iPrOH together with NaOH (27 mg, 0.685 mmol, 1.0 equiv). The resulting solution was 
stirred at rt for 24 h. 75% of the solvent was evaporated and 10 mL of water was added. The 
aqueous solution was extracted with 20 mL of EA. The organic layer was dried over MgSO4 
and the solvent was evaporated. The crude product was subjected to column chromatography 
(SiO2, PE:EA 5:1) to afford the pure product in 77% yield (42 mg, 0.26 mmol). The 
spectroscopic data is in accordance with literature.164  
White solid. Rf = 0.33 (PE/EA 2:1). 
1H-NMR (300 MHz, CDCl3): δ = 2.85 (dd, 1H, J = 6.0, 
5.0, CH), 3.15 (ddt, 1H, J = 4.7, 3.6, 1.1, CH), 3.0–3.36 (m, 1H, CH), 3.43–3.5 (m, 1H, CH), 
6.11 (ddd, 1H, J = 6.8, 3.6, 1.1 Hz, CH=CH), 6.25 (ddd, 1H, J = 6.8, 3.5, 1.1 Hz, CH=CH), 
6.30 (dd, 1H, J = 5.7, 1.6 Hz, CH=CHC=O), 7.34 (dd, 1H, J = 5.5, 2.5 Hz, CH=CHC=O). 13C-
NMR (75 MHz, CDCl3): δ = 41.6 (CH), 43.3 (CH), 49.2 (CH), 50.0 (CH), 129.1 (CH=CH), 
129.6 (CH=CH), 141.4 (CH=CHC=O), 161.4 (CH=CHC=O), 199.7 (C=O), 206.6 
(CH=CHC=O). 
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(±)-4-oxocyclopent-2-en-1-yl acrylate (82) 
 
To a solution of (±)-4-hydroxy-2-cyclopentenone 2a (5 g, 51 mmol, 1.0 equiv) in 80 mL dry 
DCM under N2 5 mL of dry pyridine (4.9 g, 62 mmol, 1.2 equiv) was added. At 0 °C 6.8 mL 
of acryloyl chloride (7.6 g, 84 mmol, 1.6 equiv) was added dropwise. The resulting solution 
was stirred at rt for 24 h. Then 40 mL of water was added. The organic layer was separated and 
washed with 40 mL of water and 40 mL of brine. The organic layer was dried over MgSO4 and 
the solvent was evaporated. 1663 mg of the crude product was obtained as a yellow oil. Column 
chromatography (SiO2, PE/EA 5:1) gave the pure product in 13% yield (991 mg, 6.50 mmol). 
The 1H-NMR spectrum is not in accordance with the sole literature example,165 but the herein 
reported spectra fit the structural features of compound 82 more accurate and the structure was 
confirmed additionally by 13C-NMR-, DEPT- and HRMS-spectra. 
Colorless oil. Rf = 0.71 (PE/EA 2:1). 
1H-NMR (400 MHz, CDCl3): δ = 2.31 (dd, 1H, J = 18.6, 
2.2 Hz, CH2) 2.80 (dd, 1H, J = 18.6, 6.4 Hz, CH2), 5.84 (dd, 1H, J = 10.5, 1.3 Hz, CH=CH2), 
5.86–5.90 (m, 1H, CHOH), 6.07 (dd, 1H, J = 17.3, 10.5 Hz, CH=CH2), 6.29 (dd, 1H, J = 5.7, 
1.3 Hz, CH=CH-C=O), 6.39 (dd, 1H, J = 17.3, 1.3 Hz, CH=CH2), 7.54 (dd, 1H, J = 5.7, 2.4 Hz, 
CH=CH-C=O). 13C-NMR (101 MHz, CDCl3): δ = 41.0 (CH2), 72.0 (CHOH), 127.7 (CH=CH2), 
132.0 (CH=CH2), 137.1 (CH=CH-C=O), 158.9 (CH=CH-C=O), 165.5 (O-C=O), 204.8 (C=O). 
IR (film): ν (cm-1) = 1720 (C=O), 1633 (C=O), 1407, 1293, 1265, 1180, 1101, 1049, 984, 810. 
HRMS (EI): m/z calcd for C8H9O3: 153.0546 [M+H
+]; found: 153.0544.  
 
endo-3a,4,7,7a-tetrahydro-1H-4,7-methanoinden-1-one (90) 
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 (±)-4-Acetoxy-2-cyclopentenone 69a (100 mg, 0.71 mmol, 1.0 equiv) and cyclopentadiene 
(472 mg, 7.1 mmol, 0.6 mL, 10.0 equiv) were dissolved in 1 mL of iPrOH and stirred at rt for 
72 h. The solvent was evaporated and column chromatography (SiO2, PE/EA 5:1) of the crude 
mixture afforded the clean product as a white solid in 81% yield (84 mg, 0.58 mmol). The 
spectroscopic data is in accordance with literature.71 
White solid. Rf = 0.33 (PE/EA 2:1). 
1H-NMR (300 MHz, CDCl3): δ = 1.61 (dd, 1H, J = 8.4, 0.6 
Hz, CH2), 1.74 (d, 1H, J = 8.4 Hz, CH2), 2.78 (t, 1H, J = 5.1 Hz, CH), 2.95 (s, 1H, CH), 3.2 (s, 
1H, CH), 3.4 (d, 1H, J = 2.6 Hz, CH), 5.77 (d, 1H, J = 2.9 Hz, CH=CHC=O), 5.84–6.02 (m, 
2H, CH=CH) 7.37 (dd, 1H, J = 5.7, 2.6 Hz, CH=CHC=O). 13C-NMR (75 MHz, CDCl3): δ = 
44.0 (CH), 45.0 (CH), 48.3 (CH), 50.2 (CH), 52.7 (CH), 132.4 (CH=CH), 132.6 (CH=CH), 
137.0 (CH=CHC=O), 164.6 (CH=CHC=O), 210.7 (C=O). 
 
cyclopent-4-ene-1,3-dione (103) 
 
 (±)-4-Hydroxy-2-cyclopentenone 2a (504 mg, 5.14 mmol, 1.0 equiv) and MnO2 (8.9 g, 102.75 
mmol, 20.0 equiv) were stirred in 20 mL DCM at rt for 5 h. The resulting solution was filtered 
over celite and the solvent was evaporated. The product was obtained as a yellow oil, which 
solidified in the refrigerator, in 80% yield (393 mg, 4.09 mmol). The spectroscopic data is in 
accordance with literature.166  
Yellow solid. Rf = 0.83 (PE/EA 1:2). 
1H-NMR (300 MHz, CDCl3): δ = 2.88 (s, 2H, CH2), 7.29 
(s, 2H, CH). 13C-NMR (75 MHz, CDCl3): δ = 41.4 (CH2), 150.7 (CH), 200.7 (C=O). 
 
(cis,anti,cis)-6a,6b-dihydrocyclobuta[1,2:3,4]di[5]annulene-1,4(3aH,3bH) -dione (108a), 
(cis,anti,cis)-6a,6b-dihydrocyclobuta[1,2:3,4]di[5]annulene-1,6(3aH, 3bH)-dione (108b) 
 (±)-4-Acetoxy-2-cyclopentenone 69a (140 mg, 1.0 mmol, 1.0 equiv) was dissolved in 5 mL 
MeCN under N2 in a quartz flask. Then it was irridiated for 48 h with a UV-lamp (366 nm, 40 
W, conventionally used for thin layer chromatography). The solvent was evaporated and the 
crude product (143 mg) was subjected to column chromatography (SiO2, PE/EA 2:1) to yield 
108a and 108b in a 1:1 ratio (NMR) in 80% combined yield. 
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(cis,anti,cis)-6a,6b-dihydrocyclobuta[1,2:3,4]di[5]annulene-1,4(3aH,3bH)-dione (108a) 
 
The spectroscopic data is in accordance with literature.89 
Colorless crystals. Rf = 0.07 (PE/EA 2:1). 
1H-NMR (300 MHz, CDCl3): δ = 2.71 (d, 2H, J = 
4.3 Hz, CH), 3.15–3.44 (m, 2H, CH), 6.42 (d, 2H, J = 5.6 Hz, CH=CH-C=O), 7.80 (dd, 2H, J = 
5.5, 2.8 Hz, CH=CH-C=O). 13C-NMR (75 MHz, CDCl3): δ = 42.9 (CH), 46.5 (CH), 136.6 
(CH=CH-C=O), 163.4 (CH=CH-C=O), 207.5 (C=O). 
(cis,anti,cis)-6a,6b-dihydrocyclobuta[1,2:3,4]di[5]annulene-1,6(3aH,3bH)-dione (108b) 
 
The spectroscopic data is in accordance with literature.90 
Colorless crystals. Rf = 0.16 (PE/EA 2:1). 
1H-NMR (300 MHz, CDCl3): δ = 2.78 (dd, 2H, J = 
4.8, 2.9 Hz, CH), 3.22–3.33 (m, 2H, CH), 6.39 (dd, 2H, J = 5.5, 0.9 Hz, CH=CH-C=O), 7.89 
(dd, J = 5.5, 3.3 Hz, 2H, CH=CH-C=O). 13C-NMR (75 MHz, CDCl3): δ = 41.9 (CH), 48.2 
(CH), 136.0 (CH=CH-C=O), 165.0 (CH=CH-C=O), 208.1 (C=O). 
 
 
2.2 Enantioselective Synthesis of 4-Heterosubstituted Cyclopentenones 
 
General procedure for Pd-catalyzed kinetic resolution  
To a solution of (±)-69b (0.50 mmol, 1 equiv) and the nucleophile (0.24 mmol, 0.48 equiv) in 
dry, degassed DCM (2 mL) under N2 at the specified temperature was added the catalyst 
solution, which was separately prepared by stirring Pd2(dba)3 (2.6 mg, 0.0028 mmol, 2.3 mol% 
Pd based on nucleophile) and (R,R)-Trost ligand (6.1 mg, 0.0088 mmol, 3.7 mol% based on 
nucleophile) in dry, degassed DCM (1 mL) under N2 until the initially purple solution turned 
yellow-brown (2–3 min). The progress of the reaction was monitored by TLC. Once the reaction 
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was complete, the reaction mixture was directly loaded onto a silica gel column and the product 
was eluted by an appropriate PE:EA mixture. 
 
General procedure for Pd-catalyzed kinetic resolution on larger scale 
To a solution of (±)-69b (5 mmol, 1 equiv) and the nucleophile (2.4 mmol, 0.48 equiv) in dry, 
degassed DCM (20 mL) under N2 at the specified temperature was added the catalyst solution, 
which was separately prepared by stirring Pd2(dba)3 (11 mg, 0.012 mmol, 1 mol% Pd based on 
the nucleophile) and (R,R)-Trost ligand (33 mg, 0.048 mmol, 2 mol% based on  the nucleophile) 
in dry, degassed DCM (10 mL) under N2 until the initially purple solution turned yellow-brown 
(2–3 min). The reaction mixture was monitored by TLC. Once the reaction was complete, the 
solvent was evaporated and the crude product was purified by column chromatography with 
PE:EA as eluent mixture. 
 
(S)-4-acetoxycyclopent-2-enone (69a) 
 
The compound was prepared according to the general procedure for kinetic resolution. 
White solid. 90% ee (tR major, minor = 28.7, 18.1 min, Chiralcel AS-H 4.6×250 mm 10 µm, 
heptane:iPrOH 90:10, 1.0 mL/min). Rf = 0.22 (PE/EA 8:2). [α]23D= –103.9 (c = 1.22, CHCl3) 
([α]20D of (S)-4-acetoxy-2-cyclopenten-1-one = –111 (c = 0.51, CHCl3))167. 1H-NMR (300 
MHz, CDCl3): δ = 2.09 (s, 3H, CH3), 2.32 (dd, 1H, J = 18.7, 2.2 Hz, CH2), 2.83 (dd, 1H, J = 
18.8, 6.4 Hz, CH2), 5.85 (dtd, 1H, J = 6.1, 2.3, 1.4 Hz, CH-O), 6.33 (dd, 1H, J = 5.7, 1.3 Hz, 
CH=CH-C=O), 7.57 (dd, 1H, J = 5.7, 2.4 Hz, CH=CH-C=O). 13C-NMR (75 MHz, CDCl3): δ = 
20.9 (CH3), 41.1 (CH2), 72.0 (CH-O), 137.1 (CH=CH-C=O), 159.0 (CH=CH-C=O), 170.5 (Ac 
C=O), 204.9 (C=O). IR (solid): ν (cm-1) = 2365, 1717 (C=O) 1590, 1404, 1373, 1351, 1231, 
1183, 1101, 1030, 985, 905, 794. HRMS (EI): m/z calcd for C7H8O3: 140.0473 [M·
+]; found: 
140.0476. 
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(±)-4-(tert-butoxycarbonyloxy)-2-cyclopentenone (69b) 
 
To a solution of (±)-4-hydroxy-2-cyclopentenone 36 (500 mg, 5.0 mmol, 1.0 equiv) and Boc2O 
(1.167 g, 6.0 mmol, 1.2 equiv) in 5 mL dry THF 0.84 mL triethylamine (613 mg, 6.0 mmol, 1.2 
equiv) and DMAP (10 mg) were added. After stirring at room temperature for 30 min, the 
solvent was removed and the residue purified by column chromatography to give the product 
as a white solid in 87% yield (865 mg, 4.36 mmol). The data is also related to chapter 2.5 (Tests 
for Biological activity). 
White solid. M.p. 38–39 °C. Rf = 0.33 (PE/EA 9:1). 1H-NMR (300 MHz, CDCl3): δ = 1.47 (s, 
9H, CH3), 2.41 (dd, 1H, J = 18.7, 2.3 Hz, CH2), 2.84 (dd, 1H, J = 18.7, 6.4 Hz, CH2), 5.72 (dtd, 
1H, J = 6.1, 2.3, 1.3 Hz, CH-O), 6.34 (dd, 1H, J = 5.7, 1.3 Hz, CH=CH-C=O), 7.60 (dd, 1H, J 
= 5.7, 2.4 Hz, CH=CH-C=O). 13C-NMR (75 MHz, CDCl3): δ = 27.8 (CH3), 41.0 (CH2), 74.2 
(CH), 83.3 (Boc-C), 137.2 (CH=CH-C=O), 152.7 (Boc-C=O), 158.6 (CH=CH-C=O), 204.6 
(C=O). IR (solid): ν (cm-1) = 2982, 2929, 1731 (C=O), 1716 (C=O), 1590, 1396, 1371, 1335, 
1275, 1256, 1157, 1106, 996, 842, 793. HRMS (EI): m/z calcd for C10H14O4: 198.0892 [M·
+]; 
found: 198.0896. 
 
(R)-4-(tert-butoxycarbonyloxy)-2-cyclopentenone (69b)  
 
The compound was prepared according to the general procedure for kinetic resolution 
(recovered starting material).  
99% ee (tR major, minor = 12.9, 14.2 min, Chiralcel OJ-H, 4.6 x 250 mm, 10 µm, heptane:
iPrOH 
99:1, 1.0 mL/min). [α]22D = +85.0 (c = 1.60, CHCl3). 
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(±)-methyl (4-oxocyclopent-2-en-1-yl) carbonate (69c) 
 
 (±)-4-Hydroxy-2-cyclopentenone 2a (1300 mg, 13 mmmol, 1.0 equiv), 1.3 mL 
methylchloroformate (1606 mg, 17 mmol, 1.3 equiv), 1.53 mL pyridine (1503 mg, 19 mmol, 
1.5 equiv) and DMAP (10 mg, 0.08 mmol, 0.6 mol%) were dissolved in 30 mL of dry DCM 
under N2 atmosphere at 0 °C. The resulting solution was stirred at 0 °C for 1 h. Then 30 mL of 
diluted NH4Cl-solution was added. The aqueous layer was extracted twice with 20 mL DCM. 
The organic layers were combined and washed twice with brine (each 20 mL) and dried over 
MgSO4. The solvent was evaporated and the product subjected to column chromatography 
(SiO2, 4:1 PE/EA) to give the pure product as a colorless oil in 57% yield (1153 mg, 7.38 
mmol). The data is also related to chapter 2.5 (Tests for Biological activity). 
Colorless oil. Rf = 0.56 (PE/EA 2:1). 
1H-NMR (300 MHz, CDCl3): δ = 2.38 (ddd, 1H, J = 18.7, 
2.2, 1.5 Hz, CH2), 2.82 (ddd, 1H, J = 18.7, 6.4, 1.4 Hz, CH2), 3.8 (s, 3H, CH3), 5.75 (dtt, 1H, 
J = 6.0, 2.3, 1.3 Hz, CH-OH), 6.33 (dd, 1H, J = 5.7, 1.3 Hz, CH=CHC=O), 7.57 (ddd, 1H, J = 
5.7, 2.4, 1.1 Hz, CH=CHC=O). 13C-NMR (75 MHz, CDCl3): δ = 40.8 (CH3), 55.2 (CH2), 75.2 
(CH-OH), 137.4 (CH=CHC=O), 155.1 (OC=O), 158.1 (CH=CHC=O), 204.2 (C=O). IR (film): 
ν (cm-1) = 2692, 1745 (C=O), 1719 (C=O), 1442, 1255, 1182, 993, 789. HRMS (EI): m/z calcd 
for C7H9O4: 157.0495 [M+H
+]; found: 157.0500. 
 
(S)-4-phenoxycyclopent-2-enone (71b) 
 
The compound was prepared according to the general procedure for kinetic resolution. 
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Colorless oil. 93% ee (tR major, minor = 13.5, 12.4 min, Phenomenex Lux Cellulose-1 4.6×250 
mm 5 µm, heptane:iPrOH 90:10, 1.0 mL/min). Rf = 0.20 (PE/EA 9:1). [α]22D = –7.2 (c = 1.36, 
CHCl3). 
1H-NMR (300 MHz, CDCl3): δ = 2.47 (dd, 1H, J = 18.4, 2.1 Hz, CH2), 2.90 (dd, 1H, 
J = 18.4, 6.0 Hz, CH2), 5.47 (dtd, 1H, J = 5.8, 2.2, 1.3 Hz, CH-O), 6.38 (dd, 1H, J = 5.7, 1.2 
Hz, CH=CH-C=O), 6.93 (dd, 2H, J = 8.7 Hz, Ph ortho-CH), 7.01 (t, 1H, J = 7.4 Hz, Ph para-
CH), 7.33 (dd, 2H, J = 8.6, 7.5 Hz, Ph meta -CH), 7.72 (dd, 1H, J = 5.7, 2.3 Hz, CH=CH-C=O). 
13C-NMR (75 MHz, CDCl3): δ = 41.9 (CH2), 75.1 (CH-O), 115.3 (Ph ortho-CH), 121.8 (Ph 
para-CH), 129.8 (Ph meta-CH), 136.6 (CH=CH-C=O), 157.3 (CH=CH-C=O), 159.7 (Ph C), 
205.1 (C=O). IR (film): ν (cm-1) = 3063, 2355, 2342, 1720 (C=O), 1597, 1491, 1352, 1227, 
1187, 1102, 1035, 787, 754, 692. HRMS (EI): m/z calcd for C11H10O2: 174.0681 [M·
+]; found: 
174.0677. 
 
(S)-4-(1-naphthoyl)oxycyclopent-2-enone (71c)  
 
The compound was prepared according to the general procedure for kinetic resolution. The data 
is also related to chapter 2.5 (Tests for Biological activity). 
White solid. M.p. 60-62 °C. 90% ee (tR major, minor = 16.9, 14.7 min, Phenomenex Lux 
Cellulose-1 4.6×250 mm 5 µm, heptane:iPrOH 90:10, 1.0 mL/min). Rf = 0.44 (PE/EA 8:2). 
[α]22D= –140.8 (c = 1.05, CHCl3). 1H-NMR (300 MHz, CDCl3): δ = 2.56 (dd, 1H, J = 18.8, 2.2 
Hz, CH2), 3.01 (dd, 1H, J = 18.8, 6.4 Hz, CH2), 6.20 (tdd, 1H, J = 4.6, 3.6, 1.8 Hz, CH-O), 6.42 
(dd, 1H, J = 5.7, 1.3 Hz, CH=CH-C=O), 7.47–7.57 (m, 2H, Ar-CH), 7.64 (ddd, 1H, J = 8.6, 
6.9, 1.5 Hz, Ar-CH), 7.76 (dd, 1H, J = 5.7, 2.4 Hz, Ar-CH), 7.90 (dd, 1H, J = 8.1, 1.4 Hz, Ar-
CH), 8.05 (d, 1H, J = 2.0 Hz, Ar-CH), 8.20 (dd, 1H, J = 7.3, 1.3 Hz, CH=CH-C=O), 8.94 (d, 
1H, J = 8.8 Hz, Ar-CH). 13C-NMR (75 MHz, CDCl3): δ = 41.3 (CH2), 72.5 (CH-O), 124.5 (Ar-
CH), 125.6 (Ar-CH), 125.9 (Ar-C) , 126.5 (Ar-CH), 128.1 (Ar-CH), 128.8 (Ar-CH), 130.7 (Ar-
CH), 131.4 (Ar-C), 133.9 (Ar-C), 134.1 (Ar-CH), 137.3 (CH=CH-C=O), 159.1 (CH=CH-
C=O), 166.8 (Naphthoyl C=O), 205.0 (C=O). IR (solid): ν (cm-1) = 2364, 2342, 1774. 1712 
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(C=O), 1388, 1364, 1184, 1094, 954, 878, 793, 718. HRMS (EI): m/z calcd for C16H12O3: 
252.0786 [M·+]; found: 252.0784. 
 
(S)-4-(4-bromobenzoyl)oxycyclopent-2-enone (71d) (by Tirayut Vilaivan) 
 
The compound was prepared according to the general procedure for kinetic resolution. 
White solid. M.p. 92–93 °C (lit.168 m.p. 89 °C). 91% ee (tR major, minor = 13.8, 15.3 min; 
Phenomenex Lux Cellulose-1 4.6×250 mm 5 µ, heptane:iPrOH 70:30, 0.5 mL/min). Rf = 0.20 
(PE/EA 9:1). [α]22D = –166.0 (c = 1.46, CHCl3) {lit.168 [α]D = –167.7 (c 0.43, CHCl3)}. The 
spectroscopic data is in accordance with literature.168 1H-NMR (300 MHz, CDCl3): δ = 2.48 
(dd, 1H, J = 2.2, 18.8 Hz, CH2), 2.95 (dd, 1H, J = 6.4, 18.8 Hz, CH2), 6.10 (dtd, 1H, J = 1.2, 
2.2, 6.1 Hz, CH-O), 6.41 (dd, 1H, J = 1.2, 5.7 Hz, CH=CH-C=O), 7.60 (d, 2H, J = 8.6 Hz, Ar-
CH), 7.68 (dd, 1H, J = 2.4, 5.7 Hz, CH=CH-C=O), 7.89 (d, 2H, J = 8.6 Hz, Ar-CH). 13C-NMR 
(101 MHz, CDCl3): δ = 41.1 (CH2), 72.7 (CH-O), 128.2 (Ar-C), 128.8 (Ar-C), 131.3 (Ar-CH), 
132.0 (Ar- CH), 137.4 (CH=CH-C=O), 158.7 (CH=CH-C=O), 165.3 (BrBz C=O), 204.7 
(C=O). IR (solid): ν (cm-1) = 2362, 1784, 1704, 1590, 1485, 1398, 1266, 1174, 1103, 1012, 849, 
756. HRMS (EI): m/z calcd for C12H9BrO3: 279.9733 [M
·+]; found: 279.9740. 
 
(±)-4-(benzylthio)cyclopent-2-enone (71e) 
 
 Tests for background reaction for the kinetic resolution: (±)-4-(tert-butoxycarbonyloxy)-2-
cyclopentenone 69b (50 mg, 0.25 mmol, 1.0 equiv) and 29 μL benzyl mercaptane (31 mg, 0.25 
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mmol, 1.0 equiv) in 2 mL DCM were stirred at rt for 38 d. The solvent was evaporated and the 
crude reaction mixture subjected to column chromatography (SiO2, PE/EA 20:1) to provide the 
product (±)-71e in 32% (16 mg, 0.08 mmol) and the recovered starting material (±)-69b in 44% 
(22 mg, 0.11 mmol) yield. 
 
(S)-4-(benzylthio)cyclopent-2-enone (71e) 
 
The compound was prepared according to the general procedure for kinetic resolution. 
Colorless oil. 93% ee (tR major, minor = 16.0, 14.8 min, Chiralcel OJ-H 4.6×250 mm 10 µm, 
heptane:iPrOH 85:15, 1.0 mL/min). The spectoscopic data is in accordance with literature.169 
Rf = 0.15 (PE/EA 9:1). [α]26D = –163.2 (c = 1.13, CHCl3). 1H-NMR (300 MHz, CDCl3): δ = 
2.30 (dd, 1H, J = 19.2, 2.1 Hz, CH2), 2.73 (dd, 1H, J = 19.2, 6.5 Hz, CH2), 3.74–3.84 (m, 2H, 
PhCH2), 3.91 (tdd, 1H, J = 6.5, 2.6, 2.0 Hz, CH-S), 6.19 (dd, 1H, J = 5.6, 1.8 Hz, CH=CH-
C=O), 7.24–7.37 (m, 5H, Ar-CH), 7.46 (dd, 1H, J = 5.6, 2.6, Hz, CH=CH-C=O). 13C-NMR 
(101 MHz, CDCl3): δ= 35.7 (PhCH2 S), 42.7 and 43.3 (CH2 and CH-S), 127.5 (CH=CH-C=O), 
128.8 and 128.9 (Ar-CH), 134.6 (Ar-CH), 137.6 (Ar-C), 163.4 (CH=CH-C=O), 207.3 (C=O). 
IR (film): ν (cm-1) = 3028, 2917, 2362, 1715 (C=O), 1582, 1494, 1454, 1400, 1340, 1240, 1179, 
1096, 1071, 1028, 940, 770, 698. HRMS (EI): m/z calcd for C12H12OS: 204.0609 [M·
+]; found: 
204.0606.  
 
(S)-4-(dodecylthio)cyclopent-2-enone (71f) (by Tirayut Vilaivan)  
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The compound was prepared according to the general procedure for kinetic resolution. 
Colorless oil. 93% ee (tR major, minor = 18.47, 15.60 min; Chiralcel AS-H 4.6×250 mm 10 µ, 
heptane:iPrOH 85:15, 1.0 mL/min). Rf = 0.18 (PE/EA 9:1). [α]22D = – 193.8 (c = 1.56, CHCl3). 
1H-NMR (300 MHz, CDCl3): δ = 0.87 (t, 3H, J = 6.7 Hz, CH3), 1.25 (m, 16H, 8×CH2), 1.36 
(m, 2H, CH2CH2CH2S), 1.58 (m, 2H, CH2CH2CH2S), 2.37 (dd, 1H, J = 2.1, 19.2 Hz, CH2-
C=O), 2.51 (dd, 2H, J = 7.1, 7.7 Hz, CH2CH2CH2S), 2.84 (dd, 1H, J = 6.6, 19.2 Hz, CH2-C=O), 
4.01 (tdd, 1H, J = 2.0, 2.5, 6.5 Hz, CH-S), 6.22 (dd, 1H, J = 1.8, 5.6 Hz, CH=CH-C=O), 7.57 
(dd, 1H, J = 2.6, 5.6 Hz, CH=CH-C=O). 13C-NMR (75 MHz, CDCl3): δ = 14.2 (CH3CH2), 22.7 
(CH3CH2), 29.0, 29.2, 29.5, 29.6, 29.7, 29.7 and 29.7 (8×CH2), 32.0 (CH2S), 42.8 (CH2-C=O), 
43.5 (CH-S), 134.3 (CH=CH-C=O), 163.9 (CH=CH-C=O), 207.6 (C=O). IR (film): ν (cm-1) = 
2923 (C-H), 2853, 1720 (C=O), 1717, 1177, 784. HRMS (ESI+): m/z calcd for C17H30OS: 
282.2017 [M·+]; found: 282.2021.  
 
(S)-4-phthalimidylcyclopent-2-enone (71g) 
 
The compound was prepared according to the general procedure for kinetic resolution. The data 
is also related to chapter 2.5 (Tests for Biological activity). 
Long white needles. M.p. 156–159 °C. 96% ee (tR major, minor = 27.2, 30.2 min, Phenomenex 
Lux Cellulose-1 4.6×250 mm 5 µm, heptane:iPrOH 90:10, 1.0 mL/min). Rf = 0.15 (PE/EA 8:2). 
[α]23D = –230.8 (c = 1.07, CHCl3). 1H-NMR (300 MHz, CDCl3): δ = 2.75 (dd, 1H, J = 18.3, 3.5 
Hz, CH2), 2.85 (dd, 1H, J = 18.2, 6.8 Hz, CH2), 5.54 (tdd, 1H, J = 6.8, 3.5, 2.3 Hz, CH-N), 6.44 
(dd, 1H, J = 5.7, 2.2 Hz, CH=CH-C=O), 7.52 (dd, 1H, J = 5.7, 2.4 Hz, CH=CH-C=O), 7.72–
7.78 (m, 2H, Ar-CH), 7.82–7.89 (m, 2H, Ar-CH). 13C-NMR (75 MHz, CDCl3): δ = 39.6 (CH2), 
49.7 (CH-N), 123.6 (Ar-CH), 131.7 (Ar-C), 134.4 (Ar-CH), 136.2 (CH=CH-C=O), 159.6 
(CH=CH-C=O), 167.6 (Pht C=O), 205.2 (C=O). IR (solid): ν (cm-1) = 2363, 1777, 1700 (C=O), 
1593, 1510, 1275, 1240, 1195, 1131, 1015, 780. HRMS (EI): m/z calcd for C13H9NO3: 
227.0582 [M·+]; found: 227.0583. 
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(S)-4-(6-chloro-9H-purin-9-yl)cyclopent-2-enone (71h) 
 
Procedure A (with base): A solution of NaH (60% susp., 96 mg, 2.4 mmol, 0.48 equiv) and 6-
chloropurine (371 mg, 2.4 mmol, 0.48 equiv) in dry, degassed dichloromethane (20 mL) under 
N2 at rt was stirred for 10 minutes. Then at 0 °C (±)-69b (991 mg, 5 mmol, 1 equiv) and the 
catalyst solution were added, which was separately prepared by stirring Pd2(dba)3 (11 mg, 0.012 
mmol, 0.5 mol% Pd) and (R,R)-Trost ligand (33 mg, 0.048 mmol, 1 mol% Pd) in dry, degassed 
dichloromethane (10 mL) under N2 until the initially purple solution turned yellow-brown (2-3 
min). After 22 h stirring at 0 °C 20 mL of water was added. The layers were separated and the 
aqueous phase was extracted 3 times with 30 mL of DCM. The organic phase was dried over 
MgSO4 and the solvent was evaporated. The crude product was purified by column 
chromatography with PE:EA (10:1 for recovering starting material and neat EA for product as 
eluent mixture). The clean product was obtained as a white solid (46% yield, 456 mg, 1.94 
mmol) which gave colorless crystals after recrystallization from PE/EA (40% yield, 396 mg, 
1.69 mmol).  
Procedure B (without base): To a solution of (±)-69b (991 mg, 5 mmol, 1 equiv) and 6-
chloropurine (371 mg, 2.4 mmol, 0.48 equiv) in dry, degassed dichloromethane (20 mL) under 
N2 at 0 °C the catalyst solution was added. It was separately prepared by stirring Pd2(dba)3 (11 
mg, 0.012 mmol, 1 mol% Pd) and the (R,R)-Trost ligand (33 mg, 0.048 mmol, 2 mol% Pd) in 
dry, degassed dichloromethane (10 mL) under N2 until the initially purple solution turned 
yellow-brown (2-3 min). After 24 h stirring at 0 °C the solvent was evaporated. The crude 
product was purified by column chromatography with PE:EA (10:1 for recovering starting 
material and neat EA for product as eluent mixture). The product was obtained as a white solid 
(46% yield, 536 mg, 2.28 mmol, 94% ee) which gave colorless crystals after recrystallization 
from PE/EA (39% yield, 463 mg, 1.97 mmol, 98% ee). The spectroscopic data is in accordance 
with literature.127 The data is also related to chapter 2.5 (Tests for Biological activity). 
Colorless crystals. M.p. 131-133 °C (135.5-136 °C)127. 98% ee (tR major, minor = 24.43, 20.55 
min, Chiralcel AS-H 4.6×250 mm 10 µm, heptane:iPrOH 50:50, 0.5 mL/min). Rf = 0.25 (EA). 
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[α]22D = –114.5 (c = 0.98, CHCl3). 1H-NMR (300 MHz, CDCl3): δ = 2.69 (dd, 1H, J = 18.8, 2.8 
Hz, CH2), 3.18 (dd, 1H, J = 18.8, 7.2 Hz, CH2), 6.01 (ddd, 1H, J = 7.2, 4.8, 2.5 Hz, CH-N), 
6.65 (dd, 1H, J = 5.7, 2.0 Hz, CH=CH-C=O), 7.69 (dd, 1H, J = 5.7, 2.5 Hz, CH=CH-C=O), 
8.08 (s, 1H, imidazole CH), 8.76 (s, 1H, pyrimidine CH).13C-NMR (75 MHz, CDCl3): δ = 41.7 
(CH2), 54.5 (CH-N), 131.9 (NNC=CCN), 138.4 (CH=CH-C=O), 142.8 (CH=CH-C=O), 151.4, 
151.6, 152.3 (imidazol CH), 157.0 (pyrimidine CH), 203.5 (C=O). IR (solid): ν (cm-1) = 3070, 
2354, 1720 (C=O), 1591, 1560, 1490, 1401, 1336, 1204, 1183, 1148, 951, 912, 857, 792, 636. 
HRMS (ESI+): m/z calcd for C7H7ClN4O: 235.0381 [M
·+]; found: 235.0384. 
 
(S)-4-(N-tert-butoxycarbonyl-N-p-toluenesulfonylamino)cyclopent-2-enone (71j) (by 
Tirayut Vilaivan)  
 
The compound was prepared according to the general procedure for kinetic resolution. 
White solid. M.p. 114–116 °C. 94% ee (tR major, minor = 13.4, 14.5 min; Phenomenex Lux 
Cellulose-1 4.6×250 mm 5 µ, heptane:iPrOH 70:30, 0.5 mL/min). Rf = 0.21 (PE/EA 8:2). [α]26D 
= –85.0 (c = 1.19, CHCl3). 1H-NMR (300 MHz, CDCl3): δ = 1.30 (s, 9H, Boc CH3), 2.45 (s, 
3H, Ts CH3), 2.60 (dd, 1H, J = 3.3, 18.1 Hz, CH2), 2.82 (dd, 1H, J = 7.0, 18.1 Hz, CH2), 5.79 
(tdd, 1H, J = 2.5, 3.1, 6.9 Hz, CH-N), 6.25 (dd, 1H, J = 2.4, 5.1 Hz, CH=CH-C=O), 7.34 (d, 
2H, J = 8.7 Hz, Ts Ar CH), 7.52 (dd, 1H, J = 2.4, 5.7 Hz, CH=CH-C=O), 7.79 (d, 2H, J = 8.4 
Hz, Ts Ar CH). 13C-NMR (101 MHz, CDCl3): δ = 21.7 (Ts CH3), 27.9 (Boc CH3), 40.5 (CH2), 
56.8 (CH-N), 85.6 (Boc C), 127.9 (Ts Ar CH), 129.6 (Ts Ar CH), 134.5 (CH=CH-C=O), 136.8 
(Ts Ar C), 144.8 (Ts Ar C), 150.1 (Boc C=O), 161.9 (CH=CH-C=O), 205.2 (C=O). IR (solid): 
ν (cm-1) = 2983, 2942, 2363, 2338, 1713 (C=O), 1596, 1457, 1351, 1284, 1251, 1140, 1089, 
1053, 949, 917, 815, 772, 728, 670. HRMS (ESI+): m/z calcd for C17H21NO5S+H
+: 352.1213 
[M+H]+; found: 352.1213.  
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(±)-4-(3,5-dimethoxyphenylamino)cyclopent-2-enone (71k) (by Tirayut Vilaivan)  
 
The compound was prepared according to the general procedure for kinetic resolution. 
Light brown oil. 1% ee (tR = 46.2, 51.9 min; Phenomenex Lux Cellulose-1 4.6×250 mm 5 µ, 
heptane:iPrOH 70:30, 0.5 mL/min). Rf = 0.10 (PE/EA 8:2). [α]22D = +1.2 (c=1.37, CHCl3). 1H-
NMR (300 MHz, CDCl3): δ = 2.20 (dd, 1H, J = 2.4, 18.6 Hz, CH2), 2.89 (dd, 1H, J = 6.2, 18.4 
Hz, CH2), 3.75 (s, 6H, 2×CH3O), 3.81 (br m, 1H, NH), 4.73 (br m, 1H, CH-N), 5.84 (d, 2H, J 
= 2.1 Hz, Ar ortho-CH), 5.95 (t, 1H, J = 2.1 Hz, Ar para-CH), 6.28 (dd, 1H, J = 1.7, 5.7 Hz, 
CH=CH-C=O), 7.65 (dd, 1H, J = 2.4, 5.7 Hz, CH=CH-C=O). 13C-NMR (101 MHz, CDCl3): δ 
= 42.9 (CH2), 53.9 (CH-N), 55.3 (CH3O), 90.7 (Ar-C), 92.5 (Ar-CH), 135.5 (CH=CH-C=O), 
148.3 (Ar-C), 161.9 and 162.2 (Ar-CH and CH=CH-C=O), 206.9 (C=O). IR (film): ν (cm-1) = 
3372, 2936, 2842, 1783, 1716, 1615, 1598, 1518, 1482, 1458, 1204, 1152, 1069, 812. HRMS 
(ESI+): m/z calcd for C13H14NO3+H
+: 234.1125 [M+H] +; found: 234.1127.  
 
 N,N'-((1R,2R)-cyclohexane-1,2-diyl)bis(2-(diphenylphosphino)benzamide) (Trost ligand) 
(72) 
 
The Trost ligand 72 was prepared according to a known procedure and the spectra are consistent 
with literature data.117 (1R,2R)-cyclohexane-1,2-diamine (400 mg, 3.5 mmol, 1.0 equiv), 2-
(diphenylphosphino)benzoic acid (2140 mg, 7 mmol, 2.0 equiv), DCC (1446 mg, 7 mmol, 2.0 
equiv) and DMAP (40 mg, 0.32 mmol, 10 mol%) were dissolved under N2 in 100 mL of dry 
DCM. The solution was stirred overnight at rt. A white precipitate formed which was filtered 
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over celite. The solvent was evaporated to give the crude product as a yellow foam. Column 
chromatography (SiO2, 5:1 PE/EA) afforded the product as a white solid in 89% yield (2165 
mg, 3.13 mmol).  
White solid. Rf = 0.41 (PE/EA 2:1).
 1H-NMR (300 MHz, CDCl3): δ = 0.96–1.26 (m, 4H, CH2), 
1.60–166 (m, 2H, CH2), 1.83–1.87 (m, 2H), 3.76 (m, 2H, CH), 6.31 (m, 2H, NH), 6.90 (m, 2H), 
7.18–7.32 (m, 24H, arom.), 7.57 (m, 2H, arom.). 13C-NMR (75 MHz, CDCl3): δ = 24.6 (CH2), 
32.0 (CH2), 53.9 (CHN), 127.6 (arom.), 128.4 (arom.), 128.5 (arom.), 128.5 (arom.), 128.6 
(arom.), 128.6 (arom.), 128.8 (arom.), 130.2 (arom.), 133.9 (d, J = 20.2, arom.), 134.3 (arom.), 
136.5 (d, J = 21.8, arom.), 137.6 (d, J = 4.9 Hz, arom.), 137.8 (d, J = 4.9 Hz, arom.), 141.0 (d, 
J = 24.7 Hz, arom.), 169.3 (C=O). 
 
(±)-tert-butyl (5-oxo-2,5-dihydrofuran-2-yl) carbonate (121) 
 
 (±)-5-hydroxyfuran-2(5H)-one 134 (350 mg, 3.5 mmol, 1.0 equiv) was dissolved in 50 mL dry 
DCM under N2 at 0 °C, then 0.57 of mL pyridin (554 mg, 7 mmol, 2.0 equiv) and Boc2O (1146 
mg, 5.25 mmol, 1.5 equiv) were added. The reaction was stirred for 24 h at rt. Water was added 
and the organic layer was separated, dried over MgSO4 and the solvent evaporated. Column 
chromatography (SiO2, PE/EA 20:1) gave the product as white solid in 45% yield (313 mg, 
1.56 mmol). The spectroscopic data is in accordance with literature.170  
White solid. Rf = 0.38 (PE/EA 5:1).
 1H-NMR (300 MHz, CDCl3): δ = 1.52 (s, 9H, CH3), 6.30 
(dd, 1H, J = 5.7, 1.2, CH=CH-C=O), 6.84 (t, 1H, J = 1.3 Hz, CHOH), 7.31 (dd, 1H, J = 5.7, 1.4 
Hz, CH=CH-C=O). 13C-NMR (75 MHz, CDCl3): δ = 27.6 (CH3), 84.8 (CHOH), 95.9 (C), 125.4 
(CH=CH-C=O), 149.2 (CH=CH-C=O), 151.0 (C=O), 169.5 (C=O). 
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 (±)-5-hydroxyfuran-2(5H)-one (134) 
 
Preparation (except for the following reported deviations) and spectra are in accordance with 
literature.171 A photoreactor was filled with a solution consisting of furan-1-carboxylic acid 133 
(4.0 g, 36 mmol, 1.0 equiv) and Rose Bengal (50 mg, 0.1 mol%) in 110 mL MeOH. O2 was 
bubbled through the pink solution for 10 min at rt. As there was no 450 W lamp available which 
was recommended in the literature example, a 125 W mercury-vapor lamp was used for 
irradiating the reaction mixture. Over a syringe pump with a flow rate of 1.6 mL/min a solution 
of 50 mg Rose Bengal in 10 mL MeOH was added, preventing the solution from adopting a 
brown color. After 7 h the solvent was evaporated. The crude product (3.38 g, 94%) was used 
without further purification. It could be recrystallized from CHCl3 to give a white solid.  
White solid. Rf = 0.39 (PE/EA 1:1). 
1H-NMR (300 MHz, acetone-d6): δ = 6.22 (dd, 1H, J = 5.7, 
1.1 Hz, CH=CH-C=O), 6.26 (bs, 1H, OH), 6.73 (bs, 1H, CHOH), 7.45 (d, 1H, J = 5.7 Hz, 
CH=CH-C=O). 13C-NMR (75 MHz, CDCl3): δ = 99.1 (CHOH), 124.4 (CH=CH-C=O), 152.6 
(CH=CH-C=O), 172.1 (C=O). 
 
(±)-5-oxo-2,5-dihydrofuran-2-yl acetate (135) 
 
To (±)-5-hydroxyfuran-2(5H)-one 134 (480 mg, 4.8 mmol, 1.0 equiv) and 0.68 mL pyridin (760 
mg, 9.6 mmol, 2.0 equiv) in 50 mL dry DCM 0.77 mL of Ac2O (735 mg, 7.2 mmol, 1.5 equiv) 
was added dropwise under N2 at 0 °C. The reaction was stirred for 24 h at rt. Water was added 
and the organic layer was separated, dried over MgSO4 and the solvent evaporated. Column 
chromatography (SiO2, PE/EA 4:1) gave the product as colorless oil in 65% yield (439 mg, 3.1 
mmol). The spectroscopic data is in accordance with literature.172  
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Colorless oil. Rf = 0.68 (2:1 PE/EA).
 1H-NMR (300 MHz, acetone-d6): δ = 2.10 (s, 3H, CH3), 
6.25 (dd, 1H, J = 5.7, 1.2 Hz, CH=CH-C=O), 6.92 (t, 1H, J = 1.2 Hz, CHOH), 7.29 (dd, 1H, 
J = 5.7, 1.4 Hz, CH=CH-C=O). 13C-NMR (75 MHz, CDCl3): δ = 20.5 (CH3), 93.8 (CHOH), 
124.9 (CH=CH-C=O), 150.2 (CH=CH-C=O), 160.1 (C=O), 169.8 (C=O). 
 
 (±)-5-phenoxyfuran-2(5H)-one (136) 
 
From (±)-121: To a solution of (±)-121 (61 mg, 0.31 mmol, 1.0 equiv) and phenol (43 mg, 0.46 
mmol, 1.5 equiv) in dry DCM (2 mL) under N2 at rt was added the catalyst solution, which was 
separately prepared by stirring Pd2(dba)3 (14 mg, 0.015 mmol, 3.2 mol%, 6.4 mol% Pd based 
on the nucleophile) and PPh3 (18 mg, 0.067 mmol, 15 mol% based on the nucleophile) in dry 
DCM (1 mL) under N2 until the initially purple solution turned yellow-brown (2–3 min). The 
resulting solution was stirred at rt for 3.5 h. Once the reaction was complete, the solvent was 
evaporated and the crude product was purified by column chromatography (SiO2, PE/EA 5:1) 
to yield the pure compound (±)-136 in quantitative yield (55 mg, 0.31 mmol). 
From (±)-135: To a solution of (±)-135 (44 mg, 0.31 mmol, 1.0 equiv) and phenol (43 mg, 0.46 
mmol, 1.5 equiv) in dry DCM (2 mL) under N2 at rt was added the catalyst solution, which was 
separately prepared by stirring Pd2(dba)3 (14 mg, 0.015 mmol, 3.2 mol%, 6.4 mol% Pd based 
on the nucleophile) and PPh3 (18 mg, 0.067 mmol, 15 mol% based on the nucleophile) in dry 
DCM (1 mL) under N2 until the initially purple solution turned yellow-brown (2–3 min). The 
resulting solution was stirred at rt for 3.5 h. Once the reaction was complete, the solvent was 
evaporated and the crude product was purified by column chromatography (SiO2, PE/EA 5:1) 
to afford the pure compound (±)-136 in 93% yield (51 mg, 0.31 mmol). The spectroscopic data 
is in accordance with literature.173 
White solid. Rf = 0.25 (PE/EA 5:1). 
1H-NMR (300 MHz, CDCl3): δ = 6.34 (dd, 1H, J = 5.7, 1.3 
Hz, CH=CH-C=O), 6.43 (t, 1H, J = 1.3 Hz, CH-OPh), 7.09–7.18 (m, 3H, arom. ortho-, para-
CH), 7.31–7.43 (m, 3H, 2 arom. meta-CH and CH=CH-C=O). 13C-NMR (75 MHz, CDCl3): δ 
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= 100.7, 116.9, 125.3 (arom.), 123.8 (arom.), 129.8 (CH=CH-C=O), 149.8 (OC=O), 156.3 
(CH=CH-C=O), 170.9 (C=O). 
 
2-(3-oxocyclopent-1-en-1-yl)isoindoline-1,3-dione (151) 
 
Phthalimide (37 mg, 0.25 mmol, 1 equiv) and NaH (60% susp., 10 mg, 0.25 mmol, 1 equiv) 
were stirred in 2 mL of dry DCM for 30 min at rt. Then (±)-4-(tert-butoxycarbonyloxy)-2-
cyclopentenone 69b (50 mg, 0.25 mmol, 1 equiv) was added and the resulting solution was 
stirred at rt for 12 d. The solvent was evaporated and the crude mixture was subjected to column 
chromatography (SiO2, PE/EA 5:1) to give 21% of (±)-4-phthalimidylcyclopent-2-enone 71g 
(12 mg, 0.05 mmol), 20% of endo-3a,4,7,7a-tetrahydro-1H-4,7-methanoindene-1,8-dione 79 (4 
mg, 0.03 mmol) and 9% of 2-(3-oxocyclopent-1-en-1-yl)isoindoline-1,3-dione 151 (5 mg after 
one recrystallization from PE/EA, 0.02 mmol). 
Colorless crystals. M.p. 130 °C. Rf = 0.76 (2:1 PE/EA). 
1H-NMR (300 MHz, CDCl3): δ = 2.53–
2.46 (m, 2H, CH2), 3.39–3.44 (m, 2H, CH2), 6.90 (t, 1H, J = 1.7 Hz, CH), 7.85 (dd, 2H, J = 5.5, 
3.0 Hz, aryl-H), 7.97 (dd, 2H, J = 5.5, 3.0 Hz, aryl-H).13C-NMR (101 MHz, CDCl3): δ = 28.9 
(CH2), 33.2 (CH2), 119.3 (C=CH), 124.4 (aryl-CH), 131.4 (C=CH), 135.4 (aryl-CH), 163.2 
(aryl-C), 165.8 (N-C=O), 207.7 (C=O). IR (solid): ν (cm-1) = 2983, 2904, 2361, 2338, 1736, 
1708, 1393, 1359, 1337, 1243, 1221, 1188, 1055, 716. HRMS (ESI+): m/z calcd for C13H10NO3: 
228.0655 [M+H+]; found: 228.0655. 
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2.3 Cyclopentenone from Furfuryl Alcohol 
 
cyclopentanone (32) 
 
By-product of the hydrogenation experiments. 
Colorless liquid. Rf = 0.2 (PE/EA 10:1). GC (DBWAX, 100 °C to 200 °C (10 °C/min), 200 °C 
(10 min)): tR = 3.0 min (1,4-butanediol as internal standard, tR = 10.5 min). 
1H-NMR (300 MHz, 
CDCl3): δ = 1.89–1.97 (m, 4H, CH2-CH2-CO), 2.10–2.17 (m, 4H, CH2-CH2-CO). 13C-NMR 
(75 MHz, CDCl3): δ = 23.3 (CH2-CH2-CO), 38.4 (CH2-CH2-CO), 220.7 (C=O). 
 
2-cyclopentenone (105) 
 
Elimination of hydroxy-moieity from (±)-3-hydroxycyclopentanone 152 with acidic ion-
exchanger: (±)-3-hydroxycyclopentanone 152 (40 mg, 0.4 mmol, 1.0 equiv) and 20 mg of 
Amberlyst XN1010 were dispersed in 1 mL of deionized water (c (152) = 40 g/L). The resulting 
solution was heated to 70 °C for 4 h. After the reaction was complete the aqueous phase was 
extracted 3 times with 2 mL of DCM. The combined organic layers were dried over MgSO4 
and the solvent was carefully evaporated (bp (105) = 150 °C). This afforded the pure product 
in 61% yield (20 mg). The spectroscopic data is in accordance with literature.174 
Elimination of hydroxy-moiety from (±)-3-hydroxycyclopentanone 152 in the microwave: (±)-
3-hydroxycyclopentanone 152 (100 mg, 1 mmol, 1.0 equiv) was dissolved in 4 mL deionized 
water in a 10 mL closed microwave pressure vessel (c (152) = 25 g/L in water). The resulting 
solution was heated in the microwave at 300 W for 15 min, reaching a maximum temperature 
of 180 °C. After the reaction was complete the aqueous phase was extracted 3 times with 2 mL 
of DCM. The organic phase was dried over MgSO4 and the solvent carefully evaporated (bp 
(105) = 150 °C). This afforded the clean product in 66% yield (54 mg). The spectroscopic data 
is in accordance with literature.174 
D. Experimental  
___________________________________________________________________________ 
 
144 
 
One-pot-procedure from 4-hydroxy-2-cyclopentenone (±)-2a: To a 10 mL aqueous solution 
(c = 25 g/L, concentration determined by GC with 1,4-butanediol as internal standard) of 4-
hydroxy-2-cyclopentenone (±)-2a (250 mg, 2.5 mmol, 1 equiv, obtained from continuous flow 
system)28 Pd/C (10% Pd, 4 mg, 0.4 mg Pd, 0.0038 mmol Pd, 0.15 mol% Pd) was added. The 
autoclave was sealed and purged with hydrogen to exclude air. The desired hydrogen pressure 
was applied and the reaction stirred at rt for the appropriate time (chapter 3.4, Figure 10). After 
the reaction was complete the concentration of product 3-hydroxy-2-cyclopentenone (±)-152 
was determined via GC (1,4-butanediol as internal standard). To perform the subsequent 
elimination of the hydroxy group the solution obtained from the hydrogenation procedure was 
heated with 150 mg Amberlyst XN1010 in a closed vessel at 90 °C for 2 h. The concentration 
of product 2-cyclopentenone 105 was determined via GC (1,4-butanediol as internal standard) 
in different time intervals. 
Colorless liquid. Rf = 0.5 (PE/EA 2:1). GC (DBWAX, 100 °C to 200 °C (10 °C/min), 200 °C 
(10 min)): tR = 4.5 min (1,4-butanediol as internal standard, tR = 10.5 min). 
1H-NMR (300 MHz, 
CDCl3): δ = 2.32–2.37 (m, 2H, CH2), 2.69 (ddd, 2H, J = 7.0, 4.7, 2.3 Hz, CH2), 6.19 (dt, 1H, J 
= 5.7, 2.2 Hz, CH), 7.72 (dt, 1H, J = 5.4, 2.7 Hz, CH). 13C-NMR (75 MHz, CDCl3): δ = 29.0 
(CH2-CH2-CO), 34.0 (CH2-CH2-CO), 134.5 (CH=CH-CO), 165.0 (CH=CH-CO), 210.7 (C=O). 
 
(±)-3-hydroxycyclopentanon (152) 
 
At atmospheric pressure: (±)-4-hydroxy-2-cyclopentenone 2a (981 mg, 10 mmol, 1.0 equiv) 
and Pd/C (5%, 30 mg, 1.5 mg Pd, 0.014 mmol Pd, 0.14 mol% Pd) were dispersed in 20 mL 
deionized water. The reaction flask was equipped with a balloon filled with H2 and the reaction 
mixture stirred at rt for 18 h. Then the solution was filtered over celite and the solvent was 
evaporated. The crude product (827 mg) was subjected to column chromatography to afford the 
clean compound (±)-152 in 53% yield (532 mg, 5.31 mmol). The NMR data is in accordance 
with literature example.175  
In the autoclave: To a 10 mL aqueous solution (c = 25 g/L, concentration determined by GC 
with 1,4-butanediol as internal standard) of (±)-4-hydroxy-2-cyclopentenone 2a (250 mg, 2.5 
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mmol, 1 equiv, obtained from continuos flow system)28 Pd/C (10% Pd, 4 mg, 0.4 mg Pd, 0.0038 
mmol Pd, 0.15 mol% Pd) was added. The autoclave was sealed and purged with hydrogen to 
exclude air. Then the desired hydrogen pressure was applied and the reaction was stirred at rt 
for the appropriate time. After the reaction was complete the pressure was released and a sample 
was taken from the solution, filtered through a syringe filter to remove Pd/C and analyzed via 
GC (internal standard 1,4-butanediol).  
Colorless oil. Rf = 0.29 (EA/PE 2:1). GC: (DBWAX, 100 °C to 200 °C (10 °C/min), 200 °C (10 
min)): tR = 12.0 min (1,4-butanediol as internal standard, tR = 10.5 min). 
1H-NMR (300 MHz, 
CDCl3): δ = 1.98–2.51(m, 7H, 2xCH2 and OH), 4.60 (s, 1H, CH). 13C-NMR (75 MHz, CDCl3): 
δ = 32.0 (CH2), 35.6 (CH2), 47.7 (CH2), 69.5 (CH), 218.7 (C=O). 
 
 
2.4 Experiments on the Piancatelli Rearrangement of HMF and BHMF in the Microwave 
 
5-hydroxymethylfurfural (HMF) (154) 
 
The compound was prepared as described in literature.139 D-fructose 153 (20 g, 111 mmol, 1.0 
equiv) was dissolved in 5.6 mL DMSO and heated to 90 °C. After cooling to rt 60 mL THF and 
4.7 g Amberlyst 15 were added. The mixture was stirred at 90 °C for 8 h. The ion exchanger 
was filtered off. Then the filtrate was treated with 50 mL of water and extracted with diethyl 
ether. Evaporation of the solvent gave the crude product in 56% (7.871 g, 62 mmol, lit. 75%) 
yield. The product can be distilled by Kugelrohr distillation at 0.1 Torr and 100 °C providing 
the product in 43% yield. The spectroscopic data is in accordance with literature.176  
Yellow solid. Rf  = 0.17 (PE/EA 2:1). 
1H-NMR (300 MHz, CDCl3): δ = 2.65 (bs, 1H, OH), 4.71 
(s, 2H, CH2), 6.51 (d, 1H, J = 3.5 Hz, CH-CCH2OH), 7.21 (d, 1H, J = 3.6 Hz, CH-CCHO), 9.57 
(s, 1H, CHO). 13C-NMR (75 MHz, CDCl3): δ = 57.6 (CH2), 110.0 (CH-CCH2OH), 123.1 (CH-
CCHO), 152.3 (C-CH2OH), 160.8 (C-CHO), 177.8 (CHO).  
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2,5-bis(hydroxymethyl)furan (155) 
 
The compound was prepared as described in literature.140 5-Hydroxymethylfurural 154 (1.25 g, 
9.9 mmol, 1.0 equiv) was dissolved in 5 mL EtOH and NaBH4 (375 mg, 10 mmol, 1.1 equiv) 
was added. The reaction mixture was stirred at rt for 19 h. A small amount of water was added 
and the solvent evaporated. The residue was subjected to column chromatography (SiO2, 
CHCl3/2% MeOH) to give the product in 79% (1002 mg, 7.8 mmol) yield. The product can be 
recrystallized from CHCl3. The spectroscopic data is in accordance with literature.
177 
White solid. Rf  = 0.49 (EA/PE 2:1). 
1H-NMR (300 MHz, CDCl3): δ = 2.04 (bs, 2H, OH), 4.59 
(s, 4H, CH2), 6.24 (s, 2H, CH). 
13C-NMR (75 MHz, CDCl3): δ = 57.5 (CH2), 108.6 (CH), 154.0 
(C). 
 
(5-formylfuran-2-yl)methyl acetate (161) 
 
The compound was prepared as described in literature.143 HMF 154 (201 mg, 1.59 mmol, 1 
equiv) was dissolved in 10 mL MeCN under N2 atmosphere. 0.28 mL Ac2O (358 mg, 3 mmol, 
1.9 equiv) and 0.032 mL pyridine (31 mg, 0.25 equiv) were added. The resulting solution was 
stirred at rt for 3 h. The solvent was evaporated and the crude product subjected to column 
chromatography (SiO2, PE/EA 2:1) to afford the pure product as a yellow oil in 84% yield (225 
mg, 1.34 mmol). The spectroscopic data is in accordance with literature.143  
Yellow oil. Rf  = 0.64 (EA/PE 1:1). 
1H-NMR (300 MHz, CDCl3): δ = 2.08 (s, 3H, CH3), 5.09 
(s, 2H, CH2), 6.75 (d, 1H, J = 3.6 Hz, CH-CCH2OAc), 7.19 (d, 1H, J = 3.6 Hz, CH-CCHO), 
9.61 (s, 1H, CHO). 13C-NMR (75 MHz, CDCl3): δ = 20.7 (CH3), 57.8 (CH2), 112.6 (CH-
CCH2OH), 121.8 (CH-CCHO), 152.8 (C-CH2OH), 155.4 (C-CHO), 170.3 (OC=O), 177.8 
(HC=O). 
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(5-(1,3-dioxolan-2-yl)furan-2-yl)methyl acetate (162) 
 
The compound was prepared as described in literature.143 (5-formylfuran-2-yl)methyl acetate 
161 (529 mg, 3.5 mmol, 1 equiv), 0.39 mL ethylene glycol and a catalytic amount of PTSA 
were dissolved in 15 mL benzene. The mixture was refluxed in a Dean-Stark-apparatus for 6 h. 
The organic phase was washed with 10 mL of water, 10 mL of saturated NaHCO3-solution and 
again 10 mL of water. It was dried over MgSO4 and the solvent evaporated. The product was 
obtained as a yellow oil in 69% yield (512 mg, 2.41 mmol). The spectroscopic data is in 
accordance with literature.143  
Yellow oil. Rf = 0.32 (EA/PE 1:5). 
1H-NMR (300 MHz, CDCl3): δ = 2.06 (s, 3H, CH3), 4.06 
(m, 4H, 2xCH2), 5.02 (s, 2H, CH2), 5.89 (s, 1H, OCHO), 6.33 (d, 1H, J = 3.3 Hz, furyl-CH), 
7.40 (d, 1H, J = 3.3 Hz, furyl-CH). 13C-NMR (75 MHz, CDCl3): δ = 20.9 (CH3), 58.0 (CH2), 
65.2 (2x, CH2CH2), 97.6 (CH), 109.6 (furyl-CH), 111.2 (furyl-CH), 150.1 (C), 151.8 (C), 170.6 
(OC=O). 
 
(5-(1,3-dioxolan-2-yl)furan-2-yl)methanol (163) 
 
The compound was prepared as described in literature.143 (5-(1,3-dioxolan-2-yl)furan-2-
yl)methyl acetate 162 (434 mg, 2 mmol, 1.0 equiv) was dissolved in 10 mL of MeOH. A small 
piece of sodium was added and the solution stirred at rt for 1 h. The mixture was neutralized 
with AcOH and the solvent was evaporated. The residue was dissolved in DCM and filtered. 
The filtrate was concentrated in vacuum to give 333 mg of the crude product which was purified 
by column chromatography (SiO2, PE/EA 2:1, instead of distillation as in the literature 
example) to give the pure product in 60% yield (201 mg, 1.2 mmol, 91% lit.). The spectroscopic 
data is in accordance with literature.143 
Yellow oil. Rf  = 0.36 (PE/EA 2:1). 
1H-NMR (300 MHz, CDCl3): δ = 2.11 (s, 1H, J = 19.2 Hz) 
OH), 3.92–4.18 (m, 4H, 2xCH2), 4.58 (d, 2H, J = 2.9 Hz, CH2), 5.88 (s, 1H, CH), 6.25 (d, 1H, 
J = 3.2 Hz, furyl-CH), 6.39 (d, 1H, J = 3.3 Hz, furyl-CH). 13C-NMR (75 MHz, CDCl3): δ = 
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57.5 (CH2), 65.1 (CH2CH2), 97.7 (CH), 108.3 (furyl-CH), 109.7 (furyl-CH), 150.8 (C), 154.9 
(C). 
 
(±)-4-hydroxy-4-(hydroxymethyl)cyclopent-2-enone (164) 
 
BHMF 155 (216 mg, 1.69 mmol, 1.0 equiv) in 10 mL deionized water (21 g/L) was heated in 
a 35 mL closed microwave pressure vessel in the microwave at 180 °C for 12 min. The aqueous 
phase was washed with 6 mL of toluene. The solvent of the aqueous phase was evaporated to 
give the crude product (179 mg) as a brown oil. Column chromatography (SiO2, PE/EA 1:1) 
afforded the clean product (±)-164 in 67% yield (144 mg, 1.12 mmol). The data is also related 
to chapter 2.5 (Tests for Biological activity). 
Colorless oil. Rf = 0.16 (EA/PE 2:1). 
1H-NMR (300 MHz, MeOD): δ = 2.28 (d, 1H, J = 18.2 
Hz, CH2), 2.57 (d, 1H, J = 18.2 Hz, CH2), 3.57 (d, 1H, J = 11.0 Hz, CH2-OH), 3.63 (d, 1H, J = 
11.0 Hz, CH2-OH), 4.87 (s, 2H, OH), 6.17 (d, 1H, J = 5.7 Hz, CH), 7.51 (d, 1H, J = 5.7 Hz, 
CH). 13C-NMR (75 MHz, MeOD): δ = 47.1 (CH2), 67.9 (CH2-OH), 80.0 (C), 135.2 (CH), 166.7 
(CH), 209.6 (C=O). IR (film): ν (cm-1) = 3350 (OH), 2928, 2362, 2027, 1707 (C=O), 1589, 
1401, 1337, 1270, 1197, 1144, 1066, 1032, 937, 887, 805. HRMS (EI): m/z calcd for C6H8O3: 
129.0546 [M+H·+]+; found: 129.0546. 
 
5-(((tert-butyldimethylsilyl)oxy)methyl)furan-2-carbaldehyde (175)  
 
HMF 154 (288 mg, 2.275 mmol, 1.0 equiv), TBSCl (377 mg, 2.5025 mmol, 1.1 equiv), 0.475 
mL Et3N (345 mg, 3.4125 mmol, 1.5 equiv) and 10 mg DMAP were dissolved under N2 in 10 
mL of dry THF. The resulting solution was stirred for 19 h at rt. 10 mL of water was added and 
the aqueous layer extracted twice with 10 mL Et2O. The combined organic layers were dried 
over MgSO4 and the solvent was evaporated. The crude product (651 mg) was purified by 
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column chromatography (SiO2, 20:1 PE/EA) to give compound 175 in 89% yield (486 mg, 2.02 
mmol) as a colorless oil. NMR data is in accordance with literature, except for the C-NMR peak 
at 122.5 which is missing in the literature examples wherein the signal at 109.4 is assigned to 
both the carbons 3 and 4 of the furan ring. 178,179 This may be due to the fact that this peak 
exhibits a very small integral and it might have been overlooked. A comparison with the NMR 
data of HMF 154 and its derivatives indicates that the furyl-carbons in 3 and 4 position show 
chemical shifts of about 110 respectivly 120 ppm. The electron-withdrawing nature of the 
aldehyde group shifts the C4 signal more downfield in the NMR. 
Colorless oil. Rf = 0.53 (PE/EA 10:1). 
1H-NMR (300 MHz, CDCl3): δ = 0.06 (s, 6H, Si-CH3), 
0.87 (s, 9H, CH3), 4.68 (s, 2H, CH2), 6.42 (d, 1H, J = 3.5 Hz, CH-CCH2OTBS), 7.15 (d, 1H, 
J = 3.6 Hz, CH-CCHO), 9.54 (s, 1H, CHO). 13C-NMR (75 MHz, CDCl3): δ = –5.37 (Si-CH3), 
18.3 (C(CH3)3), 25.8 (C(CH3)3), 58.6 (CH2), 109.4 (CH-CCH2OTBS), 122.5 (CH-CCHO), 
152.2 (C-CH2OTBS), 161.5 (C-CHO), 177.6 (CHO). 
 
(±)-1-(5-(((tert-butyldimethylsilyl)oxy)methyl)furan-2-yl)propan-1-ol (176) 
 
EtBr (668 mg, 6.19 mmol, 0.458 mL, 2.6 equiv) in 5 mL dry THF was added dropwise to a 
solution of Mg (133 mg, 5.47 mmol, 2.3 equiv) and a small piece of I2 in 8 mL dry THF under 
N2. The solution was heated briefly with a heatgun until the reaction mixture started to boil 
without external heating. After the boiling stopped the reaction was refluxed another 10 
minutes. The solution was cooled down to 0 °C and 175 (300 mg, 2.38 mmol, 1 equiv) in 5 mL 
dry THF was added dropwise. The solution was stirred for another 30 minutes at rt. 10 mL of 
water were added. The aqueous phase was seperated and extracted with 3x 20 mL Et2O. The 
combined organic layers were dried over MgSO4 and the solvent evaporated. The crude product 
(393 mg) was subjected to column chromatography (SiO2, PE/EA 5:1), which afforded the pure 
product (±)-176 in 65% yield (240 mg, 0.89 mmol).  
Colorless liquid. Rf = 0.40 (PE/EA 10:1). 
1H-NMR (300 MHz, CDCl3): δ = 0.08 (s, 6H, Si-
CH3), 0.9 (s, 9H, CH3), 0.95 (t, 3H, J = 7.4 Hz, CH3), 1.87 (m, 2H, CH2CH3), 1.96 (bs, 1H, 
OH), 4.56 (t, 1H, J = 6.8 Hz, CH), 4.61 (s, 2H, CH2), 6.16 (bs, 2H, furyl-CH). 
13C-NMR (75 
MHz, CDCl3): δ = 5.2 (Si-CH3), 10.0 (CH2CH3), 18.4 (C(CH3)3), 25.9 (C(CH3)3), 28.6 
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(CH2CH3), 58.2 (CH2), 69.3 (CH), 106.5 (furyl-CH), 107.8 (furyl-CH), 153.7 (furyl-C), 156.3 
(furyl-C). IR (film): ν (cm-1) = 2929, 2859, 1463, 1254, 1077, 833, 776. HRMS (EI): m/z calcd 
for C14H26O3Si: 271.1724 [M+H
·+]+; found: 271.1716. 
 
(±)-1-(5-(hydroxymethyl)furan-2-yl)propan-1-ol (177) 
 
Desilylation of 176: (±)-1-(5-(((tert-butyldimethylsilyl)oxy)methyl)furan-2-yl)propan-1-ol 176 
(221 mg, 0.82 mmol, 1 equiv) and TBAF (284 mg, 0.9 mmol, 1.1 equiv) were dissolved in 10 
mL THF and the resulting mixture was stirred at rt for 10 min. Then 10 mL of H2O were added 
and the aqueous phase was extracted 4 times with 20 mL ethylacetate. The combined organic 
layers were dried over MgSO4 and the solvent was evaporated. Column chromatography (SiO2, 
PE/EA 1:1) of the crude product (206 mg) afforded the pure compound 177 in 94% yield (121 
mg, 0.77 mmol). 
Direct Grignard reaction with HMF 154: Mg (133 mg, 5.47 mmol, 2.3 equiv) and a small crystal 
of I2 were stirred under N2 at rt in 8 mL dry THF. 0.458 mL EtBr (668 mg, 6.19 mmol, 2.6 
equiv) in 5 mL of dry THF was added dropwise. The solution started to reflux independently 
after briefly heating the mixture with a heatgun. When the boiling ceased, the solution was 
refluxed for another 10 min. Then the reaction mixture was cooled down to 0 °C and HMF 154 
(300 mg, 2.38, 1 equiv) in 5 mL of dry THF was added dropwise. The solution was stirred at 0 
°C for another 30 min and 10 mL of H2O was added. The aqueous phase was extracted three 
times with 20 mL Et2O. The combined organic layers were dried over MgSO4 and the solvent 
was evaporated. Column chromatography (SiO2, PE/EA 5:1) afforded the pure product in 65% 
yield (240 mg, 1.54 mmol). 
 Colorless liquid. Rf = 0.20 (PE/EA 1:1). 
1H-NMR (300 MHz, CDCl3): δ = 0.95 (t, 3H, J = 7.4 
Hz, CH3), 1.85 (qd, 2H, J = 7.2, 3.7 Hz, CH2-CH3), 2.34 (bs, 2H, OH), 4.55 (m, 3H, CH2 + 
CH), 6.16 (d, 1H, J = 3.2 Hz, furyl-CH), 6.21 (d, 1H, J = 3.1 Hz, furyl-CH). 13C-NMR (75 
MHz, CDCl3): δ = 10.0 (CH3), 28.4 (CH2CH3), 57.4 (CH2), 69.2 (CH-OH), 106.7 (furyl-CH), 
108.4 (furyl-CH), 153.4 (C), 156.7 (C). IR (film): ν (cm-1) = 3341 (OH), 2968, 2934, 2876, 
1667, 1456, 1188, 1011, 792. HRMS (ESI): m/z calcd for C8H12O3: 179.0679 [M+Na
+]; found: 
179.0675. 
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trans-5-ethyl-4-hydroxy-4-(hydroxymethyl)cyclopent-2-enone (178)    
 
(±)-1-(5-(hydroxymethyl)furan-2-yl)propan-1-ol 177 (140 mg, 0.96 mmol, 1 equiv) in 6 mL of 
deionized water was heated in a 35 mL closed vessel for 30 min at 300 W in the microwave. 
The temperature reached 144 °C and the pressure 5 bar. After the reaction the solvent was 
evaporated and the crude product was purified by column chromatography (SiO2, PE/EA 3:1) 
to afford the trans-diastereomer in 74% yield (103 mg, 0.66 mmol). The other diastereomer 
was visible in the crude NMR spectra in minor amounts (ratio not determinable due to 
overlapping signals) but could not be isolated, assumingly by reason of isomerization on C5. 
Colorless liquid. Rf = 0.24 (PE/EA 1:2). 
1H-NMR (300 MHz, CDCl3): δ = 1.16 (t, 3H, J = 7.4 
Hz, CH3), 1.48 (m, 1H, CH2-CH3), 1.80 (m, 1H, CH2-CH3), 2.37 (dd, 1H, J = 8.1, 6.1 Hz, CH), 
3.59 (dd, 1H, J = 10.6, 5.0 Hz, CH2-OH), 3.87 (dd, 1H, J = 10.6, 2.7 Hz, CH2-OH), 6.24 (d, 
1H, J = 5.9 Hz, CH=CH), 7.52 (d, 1H, J = 5.9 Hz, CH=CH) . 13C-NMR (75 MHz, CDCl3): δ = 
13.2 (CH3), 17.6 (CH2CH3), 58.9 (CH), 66.3 (CH2-OH), 81.3 (C), 133.6 (C=C), 162.4 (C=C), 
206.0 (C=O). IR (film): ν (cm-1) = 3403 (OH), 2964, 2938, 2881, 1702 (C=O), 1108,1059. 
HRMS (ESI): m/z calcd for C8H13O3: 157.0859 [M+H
+]; found: 157.0861. 
 
2-ethyl-3-(hydroxymethyl)cyclopent-2-enone (179) 
 
Hydrogenation of 178: 5-ethyl-4-hydroxy-4-(hydroxymethyl)cyclopent-2-enone 178 (64 mg, 
0.41 mmol, 1.0 equiv) and Pd/C 10% (2 mg, 0.2 mg Pd, 0.0019 mmol Pd, 0.46 mol% Pd) in 5 
mL water were stirred at rt and 1 atm of H2 for 24 h. 60 mg of Amberlyst XN1010 was added 
and the solution refluxed for 2 h. The reaction mixture was decanted and the solvent evaporated. 
The crude product (54 mg) was purified by column chromatography (SiO2, PE/EA 2:1) to give 
compound 179 in 48% yield (28 mg, 0.20 mmol).  
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One-pot-procedure from 177: (±)-1-(5-(hydroxymethyl)furan-2-yl)propan-1-ol 177 (143 mg, 
0.92 mmol, 1.0 equiv) in 6 mL deionized water (c = 25 g/L) was heated in the microwave (CEM 
Discover) at 300 W for 30 min. The temperature reached 142 °C and the pressure 5 bar. After 
adding Pd/C 10% (4 mg, 0.4 mg Pd, 0.0038 mmol, 0.41 mol%), the resulting solution was 
stirred at rt and 1 atm of H2 for 20 h. Then 120 mg of Amberlyst XN1010 was added and the 
solution refluxed for 2 h. The reaction mixture was decanted and the solvent was evaporated. 
The crude product (125 mg) was purified by column chromatography (SiO2, PE/EA 2:1) to give 
compound 179 in 40% yield (47 mg, 0.34 mmol). The spectroscopic data is in accordance with 
literature.146 
Colorless oil. Rf = 0.44 (PE/EA 1:2). 
1H-NMR (300 MHz, CDCl3): δ = 0.99 (t, J = 7.6 Hz, 3H, 
CH3), 1.71 (bs, 1H, OH), 2.22 (q, J = 7.6 Hz, 1H, CH2-CH3), 2.37-2.43 (m, 2H, CH2), 2.61-2.68 
(m, 2H, CH2), 4.59 (s, 2H, CH2-OH). 
13C-NMR (75 MHz, CDCl3): δ = 13.3 (CH3), 16.4 
(CH2CH3), 26.8 (CH2), 34.1 (CH2), 60.7 (CH2-OH), 142.0 (C=C), 169.6 (C=C), 209.7 (C=O). 
 
 
2.5 Tests for Biological Activity 
 
(±)-((tert-butyldimethylsilyl)oxy)cyclopent-2-enone (211) 
 
The compound was prepared according to a literature procedure.180 (±)-4-Hydroxy-2-
cyclopentenone 2a (2370 mg, 24.16 mmol, 1.0 equiv), 5 mL Et3N (3628 mg, 35.85 mmol, 1.5 
equiv) and DMAP (64 mg, 0.52 mmol, 2 mol%) were dissolved in 13 mL dry THF at 0 °C. 
TBSCl (3651 mg, 24.22 mmol, 1.0 equiv) was added stepwise at 0 °C. The reaction was stirred 
at rt for 20 h. 26 mL 0.5 M HCl was added and the layers separated. The aqueous layer was 
extracted 3 x with 15 mL PE. The combined organic layers were washed 2 x with 15 mL 0.5 M 
HCl, 1 x with 5% NaHCO3-solution and 1 x with 15 mL brine. The organic layer was dried 
over MgSO4 and the solvent evaporated. The crude product (yellow oil, 4474 mg) was subjected 
to column chromatography (SiO2, PE/EA 20:1, instead of Kugelrohr distillation as described in 
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the literature procedure) to afford the pure product in 76% yield (3.909 mg, 18.4 mmol, lit. 
63%180). The spectroscopic data is in accordance with literature.180 
Colorless solid. Rf = 0.55 (PE/EA 10:1). 
1H-NMR (300 MHz, CDCl3): δ = 0.09 (s, 3H, CH3), 
0.10 (s, 3H, CH3), 0.88 (s, 9H, 
tbutyl-CH3), 2.20 (ddd, 1H, J = 18.2, 2.2, 0.5 Hz, CH2), 2.67 
(dd, 1H, J = 18.2, 6.0 Hz, CH2), 4.95 (ddd, 1H, J = 5.7, 3.4, 2.1 Hz, CH-OH), 6.14 (d, 1H, J = 
5.1 Hz, CH=CH-C=O), 7.42 (dd, 1H, J = 5.7, 2.3 Hz, CH=CH-C=O). 13C-NMR (75 MHz, 
CDCl3): δ = 4.7 (CH3), 4.8 (CH3), 18.1 (tbutyl-C), 25.7 (3x tbutyl-CH3), 44.9 (CH2), 70.8 (CH-
OH), 134.4 (CH=CH-C=O), 163.8 (CH=CH-C=O), 206.4 (C=O). 
 
Biological Tests (performed by Hannelore Rücker, group of Dr. Sabine Amslinger University 
of Regensburg) 
Griess-Assay (Nitrite Assay) and MTT/LPS-Assay (Viability Assay) 
Cell culture: 
Murine macrophages, RAW264.7 were grown in RPMI supplemented with 10% (v/v) heat 
inactivated fetal calf serum and 2 mM glutamine. Macrophages were cultured at 37 °C in a 
humidified air containing 5% CO2.  
Cytotoxicity Test by MTT-Assay: 
Cell viability was evaluated by determining mitochondrial function of living cells on the basis 
of their ability to reduce the yellow dye, tetrazolium salt 3-[4,5-dimethylthiazol-2-yl]-2,5-
diphenyltetrazolium bromide (MTT), into violet formazan by the mitochondrial 
dehydrogenases. Stock solutions of test compounds were prepared in DMSO (100 mM) and 
stored at -20 °C. Test concentrations were freshly prepared by diluting the stock solution in 
culture media and the final concentration of DMSO in the medium was ≤ 0.1%. Cells (5 × 
103/well) were plated into 96-well plates and allowed to attach for 24 h. Test compounds were 
added to wells in several concentrations (100/10/1 µM) in presence of LPS 
(Lipopolysaccharide, 10 ng/ml) and incubated for 20 h. Total assay volume was 100 µl. 10 µL 
of 4 mg/mL MTT in PBS was added to each well. After 4 h the culture medium was removed 
and 100 µL of a 10% SDS solution in water was put in each well to solubilize the formazan 
product. The absorbance was measured at 560 nm in a microplate reader (Multiskan Spectrum, 
Thermo) after 24 h incubation in the dark at room temperature.  
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Nitrite Assay 
RAW264.7 macrophages (8 x 104 cell/well) were plated in 96-well plates, allowed to attach for 
24 h and stimulated with test compounds (100/10/1 µM) in the presence of LPS (10 ng/ml) for 
24 h. The culture media was then collected (50 µl/well), mixed with an equal volume of Griess 
reagent (0.1% NED (N-(1-Naphthyl)ethylenediamine dihydrochloride), 1% sulfanilamine, 
0.35% phosphoric acid in water) and incubated for 15 min at room temperature. The absorbance 
was measured at 560 nm. 
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E. Appendix 
1. NMR Spectra 
 
 
1H-NMR (300 MHz or 400 MHz):                    -upper image  
  
13C-NMR (75 MHz or 101 MHz):                     -lower image 
  
DEPT-135 (75 MHz or 101 MHz):                   -upper image 
 
DEPT-90 (75 MHz or 101 MHz):                     -lower image 
 
Used solvent and frequency are stated at the actual spectra. 
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(±)-4-hydroxycyclopent-2-enone (2a)                                                 (CDCl3, 300 MHz) 
 
                                                                                                                             (CDCl3, 75 MHz) 
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 (±)-4-acetoxy-2-cyclopentenone (69a)                                                 (CDCl3, 300 MHZ) 
 
                                                                                                                   (CDCl3, 75 MHz) 
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(endo)-3a,4,7,7a-tetrahydro-1H-4,7-methanoindene-1,8-dione (79)         
                                                                                                                 (CDCl3, 300 MHz)          
 
                                                                                                                (CDCl3, 75 MHz) 
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  (±)-4-oxocyclopent-2-en-1-yl acrylate (82)                                         (CDCl3, 400 MHz) 
 
                                                                                                                 (CDCl3, 101 MHz) 
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                                                                                                                (CDCl3, 101 MHz) 
  
                                                                                                                 (CDCl3, 101 MHz) 
 
E. Appendix 
___________________________________________________________________________ 
161 
 
 (endo)-(3aS,7aR)-3a,4,7,7a-tetrahydro-1H-4,7-methanoinden-1-one (90)   
                                                                                                                (CDCl3, 300 Mhz) 
 
                                                                                                                                                                            (CDCl3, 75 MHz) 
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cyclopent-4-ene-1,3-dione (103)                                                           (CDCl3, 300 MHz)                                         
 
                                                                                                                    (CDCl3, 75 MHz) 
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    6a,6b-dihydrocyclobuta[1,2:3,4]di[5]annulene-1,4(3aH,3bH)-dione (108a)  
                                                                                                                (CDCl3, 300 MHz) 
  
                                                                                                                  (CDCl3, 75 MHz)  
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    6a,6b-dihydrocyclobuta[1,2:3,4]di[5]annulene-1,6(3aH,3bH)-dione (108b)  
                                                                                                                 (CDCl3, 300 MHz) 
  
                                                                                                      (CDCl3, 75 MHz)  
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(±)-4-(tert -butoxycarbonyloxy)-2-cyclopentenone (69b)                    (CDCl3, 300 MHz)  
 
                                                                                                                  (CDCl3, 75 MHz)                 
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                                                                                                                   (CDCl3, 75 MHz) 
  
                                                                                                                  (CDCl3, 75 MHz) 
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(±)-methyl(4-oxocyclopent-2-en-1-yl)carbonate (69c)                       (CDCl3, 300 MHz)  
 
                                                                                                                   (CDCl3, 75 MHz) 
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                                                                                                                  (CDCl3, 75 MHz) 
 
                                                                                                                   (CDCl3, 75 MHz) 
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(S)-4-phenoxycyclopent-2-enone (71b)                                               (CDCl3, 300 MHz)  
 
                                                                                                                  (CDCl3, 75 MHz)  
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(S)-4-(1-naphthoyl)oxycyclopent-2-enone (71c)                                 (CDCl3, 300 MHz) 
 
                                                                                                                  (CDCl3, 75 MHz) 
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                                                                                                                  (CDCl3, 75 MHz)  
 
                                                                                                                  (CDCl3, 75 MHz)  
 
 
E. Appendix 
___________________________________________________________________________ 
172 
 
(S)-4-(4-bromobenzoyl)oxycyclopent-2-enone (71d)                          (CDCl3, 300 MHz)  
 
                                                                                                                (CDCl3, 101 MHz)  
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(S)-4-(benzylthio)cyclopent-2-enone (71e)                                          (CDCl3, 300 MHz)  
 
                                                                                                                  (CDCl3, 101 MHz) 
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(S)-4-(dodecylthio)cyclopent-2-enone (71f)                                        (CDCl3, 300 MHz)       
     
                                                                                                                  (CDCl3, 75 MHz)  
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                                                                                                                  (CDCl3, 75 MHz)  
 
                                                                                                                   (CDCl3, 75 MHz)  
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(S)-4-phthalimidylcyclopent-2-enone (71g)                                        (CDCl3, 300 MHz) 
 
                                                                                                                   (CDCl3, 75 MHz) 
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                                                                                                                   (CDCl3, 75 MHz) 
 
                                                                                                                   (CDCl3, 75 MHz) 
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(S)-4-(6-chloro-9H-purin-9-yl)cyclopent-2-enone (71h)                    (CDCl3, 300 MHz) 
 
                                                                                                                   (CDCl3, 75 MHz)  
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(S)-4-(N-tert-butoxycarbonyl-N-p-toluenesulfonylamino)cyclopent-2-enone (71j)                                                                           
                                                                                                                  (CDCl3, 300 MHz)  
 
                                                                                                                  (CDCl3, 101 MHz)  
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                                                                                                                  (CDCl3, 101 MHz)  
 
                                                                                                                  (CDCl3, 101 MHz)  
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  (±)-4-(3,5-dimethoxyphenylamino)cyclopent-2-enone) (71k)            (CDCl3, 300 MHz) 
  
                                                                                                                  (CDCl3, 101 MHz) 
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                                                                                                                  (CDCl3, 101 MHz) 
  
                                                                                                                  (CDCl3, 101 MHz) 
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    N,N'-((1R,2R)-cyclohexane-1,2-diyl)bis(2-(diphenylphosphino)benzamide)          (73) 
                                                                                                               (CDCl3, 300 MHz) 
 
                                                                                                                                                                           (CDCl3, 75 MHz) 
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 (±)-tert-butyl(5-oxo-2,5-dihydrofuran-2-yl)carbonate (121)             (CDCl3, 300 MHz)       
 
                                                                                                                                                                            (CDCl3, 75 MHz) 
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 (±)-5-hydroxyfuran-2(5H)-on (134)                                              (acetone-d6, 300 MHz)  
 
                                                                                                                  (CDCl3, 75 MHz) 
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(±)-5-oxo-2,5-dihydrofuran-2-yl acetate (135)                                   (CDCl3, 300 MHz) 
 
                                                                                                                   (CDCl3, 75 MHz) 
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(±)-5-phenoxyfuran-2(5H)-one (136)                                                   (CDCl3, 300 MHz) 
  
                                                                                                                  (CDCl3, 75 MHz) 
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2-(3-oxocyclopent-1-en-1-yl)isoindoline-1,3-dione (151)                   (CDCl3, 300 MHz)  
 
                                                                                                                 (CDCl3, 101 MHz) 
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                                                                                                                 (CDCl3, 101 MHz)  
 
                                                                                                                 (CDCl3, 101 MHz) 
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(±)-3-hydroxycyclopentanon (152)                                                      (CDCl3, 300 MHz)  
 
                                                                                                                   (CDCl3, 75 MHz) 
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2-cyclopentenone (105)                                                                         (CDCl3, 300 MHz)  
 
                                                                                                                   (CDCl3, 75 MHz)  
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5-hydroxymethylfurfural (HMF) (154)                                              (CDCl3, 300 MHz) 
 
                                                                                                                   (CDCl3, 75 MHz) 
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2,5-bis(hydroxymethyl)furan (155)                                                     (CDCl3, 300 MHz)   
 
                                                                                                                   (CDCl3, 75 MHz) 
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(5-formylfuran-2-yl)methyl acetate (161)                                           (CDCl3, 300 MHz) 
 
                                                                                                                   (CDCl3, 75 MHz) 
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(5-(1,3-dioxolan-2-yl)furan-2-yl)methylacetate (162)                        (CDCl3, 300 MHz)   
 
                                                                                                                   (CDCl3, 75 MHz) 
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(5-(1,3-dioxolan-2-yl)furan-2-yl)methanol (163)                                (CDCl3, 300 MHz)  
 
                                                                                                                  (CDCl3, 75 MHz) 
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(±)-4-hydroxy-4-(hydroxymethyl)cyclopent-2-enone (164)              (MeOD, 300 MHz)   
 
                                                                                                                   (MeOD, 75 MHz) 
 
E. Appendix 
___________________________________________________________________________ 
198 
 
                                                                                                                   (MeOD, 75 MHz)  
 
                                                                                                                   (MeOD, 75 MHz) 
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    5-(((tert-butyldimethylsilyl)oxy)methyl)furan-2-carbaldehyde (175) 
                                                                                                                 (CDCl3, 300 MHz) 
 
                                                                                                                 (CDCl3, 75 MHz) 
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     (±)-1-(5-(((tert-butyldimethylsilyl)oxy)methyl)furan-2-yl)propan-1-ol (176) 
                                                                                                                (CDCl3, 300 MHz)  
 
                                                                                                                 (CDCl3, 75 MHz)  
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(±)-1-(5-(hydroxymethyl)furan-2-yl)propan-1-ol (177)                    (CDCl3, 300 MHz) 
 
                                                                                                                    (CDCl3, 75 MHz) 
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                                                                                                                    (CDCl3, 75 MHz) 
 
                                                                                                                    (CDCl3, 75 MHz) 
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   trans-5-ethyl-4-hydroxy-4-(hydroxymethyl)cyclopent-2-enone (178)   
                                                                                                                (CDCl3, 300 MHz)   
 
                                                                                                                  (CDCl3, 75 MHz) 
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                                                                                                                  (CDCl3, 75 MHz)  
 
                                                                                                                  (CDCl3, 75 MHz)  
 
E. Appendix 
___________________________________________________________________________ 
205 
 
2-ethyl-3-(hydroxymethyl)cyclopent-2-enone (179)                          (CDCl3, 300 MHz)   
 
                                                                                                                   (CDCl3, 75 MHz) 
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(±)-4-((tert-butyldimethylsilyl)oxy)cyclopent-2-enone) (211)           (CDCl3, 300 MHz)      
                                                                                                                             
                                                                                                                    (CDCl3, 75 MHz) 
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2. HPLC Data 
rac-4-acetoxycyclopent-2-enone (69a) 
 
(S)-4-acetoxycyclopent-2-enone (69a) 90% ee 
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rac-4-(tert-butoxycarbonyloxy)-2-cyclopentenone (69b) 
 
(R)-4-(tert-butoxycarbonyloxy)-2-cyclopentenone (69b) >99% ee
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rac-4-phenoxycyclopent-2-enone (71b)
 
(S)-4-phenoxycyclopent-2-enone (71b) 93% ee
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rac-4-(1-naphthoyl)oxycyclopent-2-enone (71c)
 
(S)-4-(1-naphthoyl)oxycyclopent-2-enone (71c) >99% ee
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rac-4-(4-bromobenzoyl)oxycyclopent-2-enone (71d) 
 
(S)-4-(4-bromobenzoyl)oxycyclopent-2-enone (71d) 93% ee
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rac-4-(benzylthio)cyclopent-2-enone (71e) 
 
(S)-4-(benzylthio)cyclopent-2-enone (71e) 93% ee
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rac-4-(dodecylthio)cyclopent-2-enone (71f)
 
(S)-4-(dodecylthio)cyclopent-2-enone (71f) 93% ee
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rac-4-phthalimidylcyclopent-2-enone (71g)
 
(S)-4-phthalimidylcyclopent-2-enone (71g) 99% ee
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rac-4-(6-chloro-9H-purin-9-yl)cyclopent-2-enone (71h)
 
(S)-4-(6-chloro-9H-purin-9-yl)cyclopent-2-enone (71h) 94% ee
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rac-4-(N-tert-butoxycarbonyl-N-p-toluenesulfonylamino)cyclopent-2-enone (71j) 
 
 
(S)-4-(N-tert-butoxycarbonyl-N-p-toluenesulfonylamino)cyclopent-2-enone (71j) 94% ee 
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3. Crystallographic Data 
 
(S)-4-Phthalimidylcyclopent-2-enone (71g)  
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Table 1. Crystal data and structure refinement for 71g.  
Empirical formula C13H9NO3 
Formula weight 227.21 
Crystal size 0.28 x 0.10 x 0.09 mm 
Crystal description rod 
Crystal colour colourless 
Crystal system Orthorhombic 
Space group P 21 21 21 
Unit cell dimensions               a = 8.3790(1) Å       alpha = 90 deg. 
 b = 9.7970(1) Å       beta = 90 deg. 
 c = 12.8620(2) Å     gamma = 90 deg. 
Volume 1055.83(2) Å3 
Z 4 
Calculated density 1.429 Mg/m3 
Absorption coefficient 0.856 mm-1 
F(000) 472 
Measurement device type SuperNova, Single source at offset, Atlas 
Measurement method \w scans 
Temperature 123(1) K 
Wavelength 1.54178 Å 
Monochromator graphite 
Theta range for data collection 5.68 to 74.93 deg. 
Index ranges -9<=h<=10, -12<=k<=12, -16<=l<=15 
Reflections collected / unique 9890 / 2156 [R(int) = 0.0282] 
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Reflections greater >2\s(i) 2121 
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 1.00000 and 0.81056 
Refinement method Full-matrix least-squares on F2 
Hydrogen treatment refall 
Data / restraints / parameters 2156 / 0 / 190 
Goodness-of-fit on F2 1.051 
Final R indices [I>2sigma(I)] R1 = 0.0320, wR2 = 0.0829 
R indices (all data) R1 = 0.0325, wR2 = 0.0837 
Absolute structure parameter -0.09(19) 
Largest diff. peak and hole 0.136 and -0.217 e.Å-3 
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Table 2. Atomic coordinates ( x 104) and equivalent isotropic displacement parameters (Å2 
x103) for 71g. U(eq) is defined as one third of the trace of the orthogonalized Uij tensor. 
    x    y     z  U(eq)  
O(1) 8337(1) 2227(1) 7474(1) 22(1)  
O(2) 5725(1) 2221(1) 4346(1) 29(1)  
O(3) 5970(2) 5349(1) 8759(1) 44(1)  
N(1) 6899(1) 2559(1) 5960(1) 20(1)  
C(1) 7894(1) 1830(1) 6624(1) 18(1)  
C(2) 8225(2) 508(1) 6101(1) 18(1)  
C(3) 9145(2) -593(1) 6411(1) 22(1)  
C(4) 9231(2) -1700(2) 5729(1) 26(1)  
C(5) 8404(2) -1704(2) 4789(1) 26(1)  
C(6) 7470(2) -591(1) 4489(1) 22(1)  
C(7) 7413(2) 507(1) 5161(1) 20(1)  
C(8) 6557(2) 1824(1) 5053(1) 20(1)  
C(9) 6239(2) 3906(1) 6187(1) 23(1)  
C(10) 5344(2) 3982(2) 7231(1) 28(1)  
C(11) 6242(2) 5047(2) 7859(1) 27(1)  
C(12) 7478(2) 5639(2) 7189(1) 28(1)  
C(13) 7516(2) 4989(2) 6285(1) 27(1)  
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Table 3. Bond lengths [Å] and angles [deg] for 71g. 
O(1)-C(1) 1.2175(16)  
O(2)-C(8) 1.2096(17)  
O(3)-C(11) 1.2167(18)  
N(1)-C(1) 1.3913(17)  
N(1)-C(8) 1.4004(17)  
N(1)-C(9) 1.4607(18)  
C(1)-C(2) 1.4851(18)  
C(2)-C(3) 1.3842(19)  
C(2)-C(7) 1.3880(18)  
C(3)-C(4) 1.397(2)  
C(4)-C(5) 1.394(2)  
C(5)-C(6) 1.396(2)  
C(6)-C(7) 1.3811(19)  
C(7)-C(8) 1.4829(19)  
C(9)-C(10) 1.540(2)  
C(9)-C(13) 1.512(2)  
C(10)-C(11) 1.519(2)  
C(11)-C(12) 1.467(2)  
C(12)-C(13) 1.326(2)  
C(3)-H(1) 0.989(17)  
C(4)-H(2) 0.995(17)  
C(5)-H(3) 0.957(18)  
C(6)-H(4) 1.021(17)  
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C(9)-H(5) 0.955(16)  
C(10)-H(6) 0.970(19)  
C(10)-H(7) 0.99(2)  
C(12)-H(8) 0.947(19)  
C(13)-H(9) 0.97(2)  
    
C(1)-N(1)-C(8) 111.75(11)  
C(1)-N(1)-C(9) 124.62(10)  
C(8)-N(1)-C(9) 123.61(11)  
O(1)-C(1)-N(1) 124.70(12)  
O(1)-C(1)-C(2) 128.93(12)  
N(1)-C(1)-C(2) 106.34(10)  
C(1)-C(2)-C(3) 130.79(12)  
C(1)-C(2)-C(7) 107.69(11)  
C(3)-C(2)-C(7) 121.53(12)  
C(2)-C(3)-C(4) 116.97(12)  
C(3)-C(4)-C(5) 121.42(13)  
C(4)-C(5)-C(6) 121.06(13)  
C(5)-C(6)-C(7) 117.07(12)  
C(2)-C(7)-C(6) 121.94(12)  
C(2)-C(7)-C(8) 108.55(11)  
C(6)-C(7)-C(8) 129.51(12)  
O(2)-C(8)-N(1) 125.37(13)  
O(2)-C(8)-C(7) 128.96(13)  
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N(1)-C(8)-C(7) 105.67(11)  
N(1)-C(9)-C(10) 113.71(11)  
N(1)-C(9)-C(13) 112.51(12)  
C(10)-C(9)-C(13) 103.76(11)  
C(9)-C(10)-C(11) 104.80(12)  
O(3)-C(11)-C(10) 125.44(14)  
O(3)-C(11)-C(12) 126.55(14)  
C(10)-C(11)-C(12) 108.01(12)  
C(11)-C(12)-C(13) 110.00(14)  
C(9)-C(13)-C(12) 113.17(14)  
C(2)-C(3)-H(1) 121.6(10)  
C(4)-C(3)-H(1) 121.4(10)  
C(3)-C(4)-H(2) 118.0(10)  
C(5)-C(4)-H(2) 120.6(10)  
C(4)-C(5)-H(3) 120.8(11)  
C(6)-C(5)-H(3) 118.1(11)  
C(5)-C(6)-H(4) 122.4(10)  
C(7)-C(6)-H(4) 120.5(10)  
N(1)-C(9)-H(5) 103.6(10)  
C(10)-C(9)-H(5) 113.6(10)  
C(13)-C(9)-H(5) 109.9(10)  
C(9)-C(10)-H(6) 113.1(11)  
C(9)-C(10)-H(7) 109.9(12)  
C(11)-C(10)-H(6) 109.6(11)  
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C(11)-C(10)-H(7) 110.7(12)  
H(6)-C(10)-H(7) 108.7(16)  
C(11)-C(12)-H(8) 122.6(11)  
C(13)-C(12)-H(8) 127.4(11)  
C(9)-C(13)-H(9) 119.8(13)  
C(12)-C(13)-H(9) 127.0(13)  
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Table 4. Anisotropic displacement parameters (Å2 x 103) for 71g. The anisotropic displacement 
factor exponent takes the form: -2 π2 [ h2 a*2 U11 + ... + 2 h k a* b* U12]. 
              U11   U22   U33    U23    U13  U12  
O(1) 25(1) 23(1) 17(1) 0(1) -2(1) -2(1)  
O(2) 31(1) 32(1) 24(1) 1(1) -10(1) 5(1)  
O(3) 46(1) 57(1) 30(1) -13(1) 8(1) 0(1)  
N(1) 20(1) 20(1) 20(1) 0(1) -2(1) 2(1)  
C(1) 16(1) 19(1) 19(1) 3(1) 1(1) -3(1)  
C(2) 16(1) 19(1) 20(1) 1(1) -1(1) -3(1)  
C(3) 20(1) 22(1) 25(1) 4(1) -2(1) -1(1)  
C(4) 24(1) 21(1) 32(1) 2(1) -1(1) 1(1)  
C(5) 27(1) 21(1) 29(1) -4(1) 2(1) -2(1)  
C(6) 22(1) 25(1) 21(1) -2(1) 0(1) -4(1)  
C(7) 18(1) 21(1) 20(1) 1(1) 0(1) -3(1)  
C(8) 18(1) 22(1) 19(1) 1(1) -1(1) -1(1)  
C(9) 25(1) 21(1) 22(1) 1(1) -2(1) 5(1)  
C(10) 24(1) 32(1) 28(1) 0(1) 3(1) 5(1)  
C(11) 28(1) 28(1) 26(1) -2(1) -1(1) 8(1)  
C(12) 32(1) 20(1) 32(1) 0(1) -1(1) 3(1)  
C(13) 34(1) 21(1) 28(1) 4(1) 4(1) 3(1)  
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Table 5. Hydrogen coordinates (x 104) and isotropic displacement parameters (Å2 x 103) for 
71g. 
                         x      y     z    U(eq)  
H(1) 9710(20) -600(17) 7086(13) 21(4)  
H(2) 9870(20) -2507(18) 5946(13) 26(4)  
H(3) 8430(20) -2485(19) 4342(14) 32(5)  
H(4) 6850(20) -574(18) 3806(13) 23(4)  
H(5) 5580(20) 4095(18) 5599(12) 21(4)  
H(6) 5340(20) 3122(19) 7605(15) 29(4)  
H(7) 4230(30) 4270(20) 7114(16) 43(5)  
H(8) 8150(20) 6360(20) 7410(14) 38(5)  
H(9) 8220(30) 5170(20) 5707(16) 37(5)  
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Table 6. Torsion angles [deg] for 71g. 
C(8)-N(1)-C(1)-O(1) -178.14(12)  
C(9)-N(1)-C(1)-O(1) -0.1(2)  
C(8)-N(1)-C(1)-C(2) 0.00(14)  
C(9)-N(1)-C(1)-C(2) 178.05(11)  
C(9)-N(1)-C(8)-C(7) -177.80(11)  
C(1)-N(1)-C(9)-C(10) -53.58(17)  
C(8)-N(1)-C(9)-C(10) 124.25(13)  
C(1)-N(1)-C(9)-C(13) 64.01(16)  
C(1)-N(1)-C(8)-O(2) -179.80(13)  
C(9)-N(1)-C(8)-O(2) 2.1(2)  
C(1)-N(1)-C(8)-C(7) 0.28(14)  
C(8)-N(1)-C(9)-C(13) -118.16(14)  
O(1)-C(1)-C(2)-C(3) -2.3(2)  
N(1)-C(1)-C(2)-C(3) 179.70(13)  
N(1)-C(1)-C(2)-C(7) -0.30(14)  
O(1)-C(1)-C(2)-C(7) 177.73(13)  
C(1)-C(2)-C(3)-C(4) -179.41(13)  
C(7)-C(2)-C(3)-C(4) 0.6(2)  
C(1)-C(2)-C(7)-C(6) -179.58(12)  
C(1)-C(2)-C(7)-C(8) 0.47(14)  
C(3)-C(2)-C(7)-C(6) 0.4(2)  
C(3)-C(2)-C(7)-C(8) -179.53(12)  
C(2)-C(3)-C(4)-C(5) -1.1(2)  
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C(3)-C(4)-C(5)-C(6) 0.7(2)  
C(4)-C(5)-C(6)-C(7) 0.4(2)  
C(5)-C(6)-C(7)-C(8) 179.05(13)  
C(5)-C(6)-C(7)-C(2) -0.9(2)  
C(2)-C(7)-C(8)-O(2) 179.62(14)  
C(6)-C(7)-C(8)-O(2) -0.3(2)  
C(6)-C(7)-C(8)-N(1) 179.58(13)  
C(2)-C(7)-C(8)-N(1) -0.47(14)  
N(1)-C(9)-C(10)-C(11) 119.60(13)  
C(13)-C(9)-C(10)-C(11) -2.95(15)  
N(1)-C(9)-C(13)-C(12) -123.44(14)  
C(10)-C(9)-C(13)-C(12) -0.10(18)  
C(9)-C(10)-C(11)-O(3) -175.17(15)  
C(9)-C(10)-C(11)-C(12) 4.89(16)  
O(3)-C(11)-C(12)-C(13) 174.86(16)  
C(10)-C(11)-C(12)-C(13) -5.20(18)  
C(11)-C(12)-C(13)-C(9) 3.31(19)  
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Table 7. Hydrogen-bonds for 71g [Å and deg.]. 
D-H...A d(D-H) d(H...A) d(D...A) <(DHA)  
 C(4)-H(2)...O(1)#1  0.995(17)  2.541(17)  3.2562(18)  128.6(13)  
 C(6)-H(4)...O(1)#2  1.021(17)  2.363(17)  3.1218(16)  130.3(13)  
 C(9)-H(5)...O(2)  0.955(16)  2.446(17)  2.9184(17)  110.4(12)  
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